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Lower gastrointestinal (GI) symptoms are common among endurance athletes and can 
negatively impact training and competition performance. These symptoms are similar to those 
characteristic of irritable bowel syndrome (IBS), a functional GI disorder affecting 10-20% of 
the U.S. population. A more recent strategy for IBS symptom management involves dietary 
restriction of fermentable oligosaccharides, disaccharides, monosaccharides, and polyols 
(FODMAP). Since carbohydrate consumption is typically promoted to improve endurance 
performance, it is possible that specific carbohydrate types are playing a role in symptom 
genesis; however, there has been little research in this area to date. 
 The objectives of this study were to: 1) develop and validate a questionnaire to assess 
IBS diagnosis, fit to IBS diagnostic criteria, nutritional habits, GI symptoms, and symptom 
management strategies of endurance athletes, 2) characterize the IBS-related symptoms and 
treatment of endurance athletes, 3) examine the nutritional habits of endurance athletes from a 
FODMAP perspective, and 4) examine factors that influence low versus high FODMAP sports 
nutrition product use by endurance athletes. 
 A 93-item Endurance Athlete Questionnaire (EAQ) was developed, with content and face 
validity provided by experts and endurance athletes, respectively. Test-retest reliability was 
established by target population athletes (participating in a marathon, ultramarathon, half 
distance triathlon, or full distance triathlon within that year).  
 A nationwide implementation of the EAQ (n = 430) found that IBS is underdiagnosed, as 
in the general population. While 2.8% were medically diagnosed, an additional 7.0% met the 
most commonly used diagnostic criteria at the time (Rome III) and further athletes met previous, 
 iii 
less restrictive IBS criteria (Manning). Despite various symptom management strategies, even 
more athletes than those with IBS experienced at least one symptom at a frequency of sometimes 
or more during exercise, indicating that IBS and IBS-like symptoms are ineffectively treated. 
 A portion of the EAQ was also used to examine nutritional habits from a FODMAP 
perspective. Athletes commonly reported consuming potentially high FODMAP foods during 
pre-race dinners and breakfasts and more frequent consumption of various categories of sports 
nutrition products was related to increased symptom frequency. Analysis of the FODMAP 
content of the most popular beverages, gels, and commercial solid products using standardized 
methods revealed that many of these products have high FODMAP content, particularly when 
multiple servings are consumed, which is typical of use during endurance exercise. Habitual 
FODMAP intake in a sub-set of these athletes, evaluated using a previously validated, 
FODMAP-specific food frequency questionnaire, was high overall and athletes with various 
symptoms consumed higher levels of certain FODMAP groups. 
 Popular gel and solid products with lower FODMAP content received higher overall 
liking scores in a sensory acceptance test by endurance athletes. Cluster analysis revealed 
different patterns in overall liking among groups, demonstrating that liking of low FODMAP 
products was somewhat individualized. The prices and online availability of low FODMAP 
products were comparable to the higher FODMAP products. While some low FODMAP gels 
were available at aid stations of popular endurance races, many races provided products of high 
or unknown FODMAP content.  
 Overall, findings from this research support the potential application of low FODMAP 
nutritional interventions among endurance athletes by providing a scope of the symptomatic 
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athletes who may benefit from such dietary manipulations as well as nutritional target areas for 
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CHAPTER 1: INTRODUCTION 
 
1.1 Research Background 
 Gastrointestinal (GI) symptoms are common among endurance athletes and can affect 
training and competition performance (Rehrer et al. 1989, 1992; Brouns and Beckers 1993; 
Peters et al. 1999; de Oliveira and Burini 2009; Wright et al. 2009; de Oliveira et al. 2014). 
Symptoms of the lower GI range in severity and impact from flatulence to severe diarrhea. These 
symptoms and various symptom patterns mirror those of patients with irritable bowel syndrome 
(IBS), a functional gastrointestinal disorder characterized by abdominal pain and altered bowel 
habits affecting 10-20% of the U.S. population (Drossman et al. 1982, 1993, 2002; Priebe and 
Priebe 1984; Sandler 1990; Talley et al. 1995; Saito et al. 2002; Hungin et al. 2005; Lovell and 
Ford 2012; Chey et al. 2015).  
 A current, promising IBS mitigation strategy involves restriction of fermentable 
oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP), a collection of 
specific carbohydrate types known to be poorly absorbed, highly fermentable, and osmotically 
active within the GI tract (Barrett et al. 2010; Gibson and Shepherd 2010; Murray et al. 2014). A 
low FODMAP strategy may be applicable to endurance athletes, as carbohydrates are an 
important source of fuel for exercise and have been shown to increase performance when 
ingested during exercise bouts (Eberle 2008; Temesi et al. 2011; Thomas et al. 2016). Athletes 
are commonly instructed to “carbohydrate load” prior to races to maximize glycogen storage, as 
well as consume 30-90g carbohydrate per hour during endurance or ultra-endurance exercise 
(Jeukendrup et al. 2005; Eberle 2008; Jeukendrup 2008, 2011; Thomas et al. 2016). It is possible, 




consumption of these foods could be contributing to GI distress. Recent preliminary 
investigations in this area have shown the potential of low FODMAP interventions to decrease 
GI symptoms in athletes; however there are still many unanswered questions which could prove 
beneficial to endurance athletes, particularly the prevalence of IBS and current status of 
FODMAP use among this population (Lis et al. 2016a, 2016b, 2018; Gaskell and Costa 2019; 
Wiffin et al. 2019). 
 
1.2 Research Goal & Objective 
 The long-term goal of this research is to develop nutritional strategies to mitigate the GI 
symptoms experienced by endurance athletes due to training and competition. The overall 
objective of this research is to determine the role that FODMAPs currently play in the diets of 
endurance athletes, particularly in relation to their IBS and IBS-like GI symptoms. The central 
hypothesis is that foods with high FODMAP content are popular among endurance athletes and 
high FODMAP intakes within this population are correlated with GI symptoms. 
 
1.3 Aims & Hypotheses 
 In order to achieve the long-term goal, the following specific aims were proposed for this 
research: 
Aim 1: Develop and validate a questionnaire to assess IBS diagnosis, fit to IBS diagnostic  
criteria, nutritional habits, GI symptoms, and symptom management strategies of endurance 
athletes. This aim involved development of a questionnaire which included portions of a 
previous athlete GI survey as well as Rome III and Manning IBS diagnostic criteria. It was 




will provide content and face validity of the questionnaire. It was further hypothesized that test-
retest analysis of target population athlete responses will demonstrate stability of the 
questionnaire over time. Together, these hypotheses demonstrate the validity and reliability of 
the questionnaire. 
Aim 2: Characterize the IBS-related symptoms and treatment of endurance athletes. This aim 
was addressed by using the questionnaire developed in Aim 1. It was hypothesized that IBS is 
underdiagnosed and that IBS and IBS-like symptoms are ineffectively managed among 
endurance athletes. 
Aim 3: Examine the nutritional habits of endurance athletes from a FODMAP perspective. 
This aim was divided into three sub-aims in order to examine consumption of FODMAPs prior 
to and during exercise as well as habitual daily intake levels. 
3a. Determine the prevalence of potentially high FODMAP food consumption 
surrounding exercise. This sub-aim also utilized data collected from the questionnaire in 
Aim 1. It was hypothesized that endurance athletes will commonly consume potentially 
high FODMAP foods during pre-race dinners and breakfasts. These foods are termed 
“potentially” high, since details such as serving sizes, preparation methods, or exact 
products were not reported. These factors can all influence FODMAP content. A second 
hypothesis was that the majority of commonly reported sports nutrition products used 
during exercise will contain high FODMAP ingredients. 
3b. Determine the specific FODMAP content of popular sports nutrition products. 
This sub-aim involved chemical compositional analysis of sports nutrition products. The 
hypothesis was that the majority of the popular sports nutrition products reported by 




3c. Determine habitual FODMAP intake and the relationship to GI symptoms. 
A FODMAP-specific food frequency questionnaire was used to answer this sub-aim with 
hypotheses that the majority of endurance athletes will consume a habitual diet that is 
high in FODMAP and habitually high FODMAP intakes will correlate with more 
frequent GI symptoms. 
Aim 4: Examine factors that influence low versus high FODMAP sports nutrition product use 
by endurance athletes. This aim was also divided into sub-aims to look at different factors that 
are involved in food choice behavior. The products focused on in this aim were the most 
commonly reported gel and solid products from the Aim 1 questionnaire which were analyzed 
for FODMAP content in Aim 3b. 
4a. Determine the sensory acceptance of products in relation to FODMAP content. Due 
to the common use of high FODMAP sports nutrition products, it was hypothesized that 
product acceptability will be higher for products with high FODMAP content. 
4b. Compare the on-course availability of low and high FODMAP products during 
popular endurance races. The hypothesis for this sub-aim was that the majority of 
popular endurance races will provide high FODMAP products at the on-course aid 
stations.  
4c. Compare the online availability and prices of low and high FODMAP products. 
The hypothesis for this sub-aim was that high FODMAP products will be available at 







1.4 Scope & Significance 
 The research detailed in this dissertation aims to fill numerous gaps in the literature 
linking the GI symptoms experienced by endurance athletes with the FODMAP content of their 
nutrition. Promising initial support for the application of a low FODMAP diet in the 
modification of the GI symptoms displayed by athletes points to the need for additional and 
continued research in this area (Lis et al. 2016a, 2016b, 2018; Gaskell and Costa 2019; Wiffin et 
al. 2019). While some studies have linked the types of symptoms experienced by athletes with 
those characteristic of IBS (Keeffe et al. 1984; Priebe and Priebe 1984; Wright et al. 2009; Costa 
et al. 2017), to the best of our knowledge, there are no studies that looked at actual IBS diagnosis 
among endurance athletes or evaluated symptoms based on IBS diagnostic criteria. This 
knowledge would aid in determining if current IBS-mitigating strategies (i.e. diet low in 
FODMAP) have the potential to be implemented in the endurance athlete population to reduce 
GI symptoms. It would also identify which athlete groups may benefit from this type of 
nutritional modification.  
 To date, there have not been large-scale assessments of FODMAP levels of endurance 
athlete diets, either habitually or surrounding and during exercise bouts. Knowledge in this area 
will help to determine key time points for nutritional intervention. Additionally, while a 
FODMAP database does exist for many common foods, the FODMAP content is still unknown 
for many sports nutrition-specific products and has the potential to be high based on high 
carbohydrate content. It therefore becomes necessary to analytically determine these levels in 
order to more accurately analyze athlete’s diets for FODMAPs. Finally, there has been no 
previous research on the sensory acceptance, race availability, online availability, or price of 




athletes, nutrition professionals, and the food industry as it has implications for product selection 
and development. 
 This research is poised to make significant contributions to the sports nutrition and 
athletic performance fields by filling the many gaps listed above. Questionnaires on GI 
symptoms of athletes have historically been used without first being validated by experts and the 
target population. The reliability of such questionnaires is important due to the transient nature of 
GI symptoms and the fact that specific symptoms are evaluated in a general sense and not as a 
daily report. This research marks the first time that a GI questionnaire including IBS diagnostic 
questions was validated and IBS was quantified within an endurance athlete population. It is the 
first to examine the relationship between reported athlete nutritional habits and GI symptoms 
from a FODMAP perspective, both from a habitual standpoint and surrounding exercise bouts. 
The FODMAP analysis of sports nutrition products will build the FODMAP database, inform 
athletes who desire to reduce FODMAP of more suitable products, and serve as a foundation for 
future product development and marketing. Investigation of factors which may contribute to the 
use of high FODMAP sports nutrition products will also provide valuable information for 
athletes, nutrition professionals, coaches, and industry. With the critical knowledge gained from 
this research, we can be closer to designing dietary interventions specific to individual endurance 
athletes, helping to improve their exercise enjoyment, athletic performance, and overall quality 
of life. 
 
1.5 Dissertation Outline 
 Chapter 2 is a review of literature pertaining to the topics discussed within this 




the current literature involving endurance athletes and FODMAPs, with direction for future 
studies. 
 Chapter 3 is an article addressing Aim 1 that was published in Digestive Diseases and 
Sciences and included here, with permission. It details the development and validation of the 
Endurance Athlete Questionnaire (EAQ) examining lower GI symptoms, nutritional habits, 
symptom management strategies (including consultation with a medical professional), outcomes 
of management strategies, and fit to IBS diagnostic criteria. 
 Chapter 4 is an extended version of a manuscript accepted for publication by Applied 
Physiology, Nutrition, and Metabolism that focuses on Aim 2. It describes the IBS-related results 
of a national implementation of the EAQ. The target population was individuals who had 
completed or would complete a marathon, ultra-marathon, half-distance triathlon, or full-distance 
triathlon within that calendar year. 
 Chapter 5 examines the consumption of FODMAPs by endurance athletes, providing 
results from all parts of Aim 3. Aim 3a is addressed using the national implementation of the 
EAQ from Aim 2, but focusing on the nutritional components. The most commonly reported 
products on the EAQ in three sports nutrition categories (non-caffeinated beverages, solids, and 
gels/gummies) were sent to collaborators at Monash University in Melbourne, Australia for 
FODMAP analysis to address Aim 3b. A subset of the athletes completing the EAQ completed a 
follow-up validated, FODMAP-specific food frequency questionnaire (FFQ) to address the 
habitual FODMAP intake of Aim 3c. 
 The findings from Aim 4 are described in Chapter 6 which details different factors 
associated with sports nutrition product use by endurance athletes in relation to FODMAP 




sports nutrition products from the EAQ. This sensory test was performed by target population 
endurance athletes at the 2018 Illinois Marathon Expo. The availability of high and low 
FODMAP sports nutrition products at popular endurance races was examined both currently and 
at the time of the EAQ implementation (2016). Online searches provided current price points and 
availability at online retailers. 
 Chapter 7 provides overarching conclusions from this work and details potential future 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 Endurance Athlete Gastrointestinal Symptoms 
 Gastrointestinal (GI) symptoms have been reported by 30 to 70% of endurance athletes 
(Rehrer et al. 1989, 1992; Brouns and Beckers 1993; Peters et al. 1999; de Oliveira and Burini 
2009; de Oliveira et al. 2014) and can drastically affect training or competition (ter Steege et al. 
2008; Wright et al. 2009; de Oliveira and Burini 2014). Symptoms, particularly of the lower GI 
(e.g. flatulence, abdominal pain/cramps, abdominal bloating, urge to defecate, defecation, 
diarrhea, constipation), have been shown to increase with exercise duration and be more 
prevalent during running compared to cycling (Peters et al. 1993, 1999; Costa et al. 2017b). As a 
result, endurance athletes competing in extended events with running components including 
marathon, ultra-marathon, half-distance triathlon and full-distance triathlon may experience 
frequent and/or severe GI symptoms. 
 
2.1.1 Gastrointestinal Symptom Factors: Mechanical  
 Exercise-induced GI symptoms or the newly termed “exercise-induced GI syndrome” are 
hypothesized to be due to mechanical, physiological, and nutritional factors (ter Steege and 
Kolkman 2012; de Oliveira et al. 2014; Costa et al. 2017b; de Oliveira 2017). Mechanical factors 
are physical forces due to impact or body position (de Oliveira and Burini 2014). The pounding 
vibrations from repetitive foot striking during running may contribute to the increased prevalence 
of lower GI symptoms observed during running compared to cycling (Rehrer and Meijer 1991; 
Peters et al. 1999; Casey et al. 2005). Ensuring proper footwear, running on softer surfaces, and 




of internal mechanical movement is inherent in running (Riddoch and Trinick 1988).  The 
aerodynamic position in cycling may contribute to the greater prevalence of upper GI symptoms 
seen during this activity (Peters et al. 1999; Casey et al. 2005; de Oliveira et al. 2014). 
 
2.1.2 Gastrointestinal Symptom Factors: Physiological 
 Physiological factors are likely the key mechanism responsible for exercise-induced GI 
symptoms. These factors increase with exercise duration and intensity and are amplified in hot 
environments (de Oliveira and Burini 2009; ter Steege and Kolkman 2012). In a review article on 
exercise-induced GI syndrome, Costa et al. (2017b) summarized the physiological changes due 
to physical activity and their impact on gut function. These authors divided the stresses 
experienced during exercise into two different pathways: the circulatory-gastrointestinal pathway 
and the neuroendocrine pathway. In the former, splanchnic blood flow during exercise decreases 
by up to 80% as blood is diverted away from the GI tract to other body systems such as muscle, 
lungs, and skin (Brouns and Beckers 1993; Rehrer et al. 2001). This hypoperfusion results in 
varying degrees of splanchnic ischemia which damages the cells of the GI tract (Oktedalen et al. 
1992; Casey et al. 2005; ter Steege and Kolkman 2012; van Wijck et al. 2012; de Oliveira 2017). 
This, in turn, affects GI barrier function and permeability, leading first to local inflammation 
followed by endotoxemia and systemic inflammation (Oktedalen et al. 1992; Camus et al. 1997; 
Jeukendrup et al. 2000; Dokladny et al. 2016; Costa et al. 2017b). This damage also impacts 
nutrient absorption by damaging transporters, leading to malabsorption (van Nieuwenhoven et al. 
1999; Lang et al. 2006; Costa et al. 2017a). This malabsorption is further enhanced by alterations 




neuroendocrine pathway factors (Soffer et al. 1991; van Nieuwenhoven et al. 2004; de Oliveira 
et al. 2014; Costa et al. 2017b). 
 
2.1.3 Gastrointestinal Symptom Factors: Nutritional 
 Nutritional factors can also play a role in exercise-induced GI symptoms. Nutrition is 
particularly important for endurance athletes as longer distance events require consumption of 
calories both before and during the event to provide sufficient energy. Fluid, fiber, fat, protein, 
caffeine, and carbohydrates are all nutritional components previously observed to play a role in 
athlete GI distress (Rehrer et al. 1989, 1992; Stuempfle et al. 2013; de Oliveira et al. 2014). 
Lower fluid intake has been associated with increased GI symptoms in ultramarathon runners 
(Stuempfle et al. 2013) and dehydration at levels of 4-5% body weight loss resulted in marked 
increases in GI symptoms in marathon runners (Rehrer et al. 1989). This is likely to due to 
electrolyte imbalances, increased core body temperature, and further increased ischemia, all 
affecting gut function (Keeffe et al. 1984; Rehrer et al. 1989; Ho 2009). High fiber foods should 
be avoided, as they tend to promote water migration into the intestinal lumen (Rehrer et al. 1992; 
Brouns and Beckers 1993; Murray 2006). Higher fat intake was associated with less GI 
symptoms in ultrarunners (Stuempfle et al. 2013), but was associated with increased upper GI 
symptoms in half-distance triathletes, likely due to effects on gastric emptying (Rehrer et al. 
1992). Higher protein intakes have also been shown to increase upper GI symptoms (Rehrer et 
al. 1992). Additionally, caffeine has been implicated in GI symptoms, particularly in regard to 
defecation (Murray 2006; Eberle 2008; Schwellnus and Wright 2008; Ho 2009; Wright et al. 






 Carbohydrates have also been extensively investigated in relation to GI symptoms of 
endurance athletes. Carbohydrate consumption is particularly important for longer time and 
distance events. By consuming a high carbohydrate diet for a period of time leading up to an 
endurance bout, athletes are able to supercompensate their muscle glycogen levels, enhancing 
this stored energy and increasing endurance and performance in events over 90 minutes in 
duration (Hawley et al. 1997; Jeukendrup et al. 2005; Jeukendrup 2011). Athletes are also 
recommended to ingest carbohydrate during exercise to further “improve endurance capacity and 
performance” (Jeukendrup 2008).  
 
2.1.3.2 Carbohydrate Concerns 
 While carbohydrates are important as quick energy substrates during exercise, the 
type(s), concentration, and osmolality of a products such as sports nutrition beverages, gels, or 
gummies can influence GI symptoms (de Oliveira et al. 2014). Beverages of 5-8% carbohydrate 
are typically recommended during competition, with greater GI discomfort observed at higher 
concentrations (Rehrer et al. 1992; Shi et al. 2004; Ho 2009; de Oliveira and Burini 2011). 
Recommended intake guidelines are 30-60 grams/hour for exercise lasting 1-2.5 hours and up to 
90 grams/hour for exercise over 2.5 hours (Jeukendrup 2011; Thomas et al. 2016). At higher 
concentrations, osmolalities, or intake rates, intestinal secretions increase to dilute GI contents 
which can contribute to symptoms such as abdominal pain, bloating, and diarrhea (Rehrer et al. 
1992; Brouns and Beckers 1993; Jeukendrup 2008; de Oliveira and Burini 2014). Additionally, 
once intestinal carbohydrate (particularly glucose) absorption becomes saturated, residual 




2014; de Oliveira 2017). More recent research has focused on the role of multiple transportable 
carbohydrate ingestion to increase carbohydrate absorption via different transporters as well as 
training the gut to better absorb higher levels of carbohydrates (Wallis et al. 2005; Cox et al. 
2010; O’Brien and Rowlands 2011; Rowlands et al. 2012; Costa et al. 2017a). While these ideas 
show promise, high fructose foods and beverages are still not recommended as they have also 
been shown to lead to GI distress (Murray et al. 1989; de Oliveira et al. 2014). 
 
2.2 Irritable Bowel Syndrome (IBS) 
 Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by 
abdominal pain or discomfort and altered bowel action that is present in approximately 10-20% 
of the population (Drossman et al. 2002). Proposed factors in IBS pathophysiology include 
altered GI motility, visceral hypersensitivity, inflammation, genetic factors, the gut microbiome, 
the brain-gut axis, and psychosocial factors (Drossman et al. 2002; Spiller et al. 2007; Eswaran et 
al. 2011). IBS accounts for $20 billion in direct and indirect expenditures in the United States, 
largely due to medical testing costs and decreased work productivity due to problematic 
symptoms (Agarwal and Spiegel 2011; Chey et al. 2015). It is the most common disorder seen 
and diagnosed by gastroenterologists, although it is believed that only a minority of IBS sufferers 
seek medical care (Talley et al. 1995; Luscombe 2000; Olden 2002; Hungin et al. 2005). A study 
by Hungin et al. (2005) of IBS prevalence in the U.S. found that 3.3% of the population reported 
medically diagnosed IBS, while an additional 10.8% met IBS diagnostic criteria (Manning, 






2.2.1 IBS Diagnosis 
 The difficulty with IBS diagnosis is that it is a syndrome of unknown etiology, with no 
clinical biomarkers or accepted gold standard for diagnosis (Mearin and Lacy 2012; Ford et al. 
2013; Chey et al. 2015). It is commonly diagnosed by “the presence of characteristic symptoms 
and the exclusion of selected organic diseases” (Chey et al. 2015). Differential diagnoses for 
similar symptoms include celiac disease, food intolerance, lactose intolerance, inflammatory 
bowel disease, parasite infections, bacterial overgrowth, diverticulosis, and colorectal cancer 
(Hatlebakk and Hatlebakk 2004). Diagnosis based on exclusion often leads to expensive, 
prolonged, and potentially invasive testing. In order to reduce these costs and provide both 
patient and physician with more diagnostic confidence, various criteria for diagnosing IBS have 
been developed over the years (Ford et al. 2013). 
 
2.2.1.1 Manning Criteria 
 The first diagnostic criteria created for IBS was the Manning criteria published in 1978 
(Manning et al. 1978; Dang et al. 2012). Manning et al. (1978) identified 6 key characteristic 
symptoms of IBS patients from an initial list of 15 common symptoms. Additionally, they found 
that the more of these 6 symptoms that were present, the greater the likelihood of IBS in that 
patient. The 6 Manning symptoms are (Manning et al. 1978; Hatlebakk and Hatlebakk 2004): 1) 
Visible abdominal distension; 2) Relief of pain with bowel movement; 3) More frequent bowel 
movement with the onset of pain; 4) Looser stools at the onset of pain; 5) Passage of mucus per 
rectum; 6) Feeling of incomplete evacuation. 
 The Manning criteria have been studied the most extensively of the IBS diagnostic 




studies for all criteria are lacking in general (Ford et al. 2008; Dang et al. 2012). Another issue 
with this criteria is that the original article by Manning et al. (1978) did not provide a threshold 
number of the six symptoms in order to diagnose a patient with IBS (Saito et al. 2000; Ford et al. 
2008). As a result, the use of the Manning criteria in subsequent studies have used ≥ 2, 3, or 4 of 
the symptoms as a positive IBS diagnosis, making comparison between studies difficult (Saito et 
al. 2000; Ford et al. 2008, 2013). 
 
2.2.1.2 Rome Criteria 
 In 1988, a consensus of experts at the XIII International Congress of Gastroenterology 
met in Rome to develop a new set of diagnostic criteria for functional GI disorders, including 
IBS, that was published in 1989 (Thompson et al. 1989; Saito et al. 2003). The intent was to 
“build upon the strengths, while limiting the weaknesses of the Manning criteria” (Dang et al. 
2012). The Rome criteria have since been repeatedly revised and updated over the years, with the 
current version being the Rome IV criteria (Drossman 2016; Drossman et al. 2016). At the outset 
of this research, however, the Rome III criteria was the most recent version. The Rome III 
criteria for IBS are as follows (Drossman et al. 2006): 
Recurrent abdominal pain or discomfort** at least 3 days/month in the last 3 
months associated with two or more of the following: 
Improvement with defecation 
Onset associated with a change in frequency of stool 
Onset associated with a change in form (appearance) of stool  
* Criterion fulfilled for the last 3 months with symptom onset at least 6 months 




** “Discomfort” means an uncomfortable sensation not described as pain. 
 While the updated Rome criteria are mostly recommended for diagnostic use and the 
Manning criteria are now rarely used, the Rome criteria have been poorly validated over the 
years, especially the Rome III criteria (Ford et al. 2008; Dang et al. 2012; Sood et al. 2015). The 
agreement in IBS diagnosis among the criteria is good in general; however, agreement was found 
in one study to be the lowest between Manning and Rome III (Ford et al. 2013). The Rome 
criteria in general are more stringent than Manning, with the highest IBS prevalence reported 
when using ≥ 2 Manning criteria. 
 
2.2.2 IBS and Endurance Athlete GI Symptom Similarities 
 Gastrointestinal symptom patterns among endurance athletes are similar to those seen in 
IBS, including a higher prevalence among women, those of a younger age, and those 
experiencing stress (Drossman et al. 1982; Priebe and Priebe 1984; Saito et al. 2002; Hungin et 
al. 2005; Chey et al. 2015). In the case of endurance athletes, physical, mental, and emotional 
stresses are experienced during training and racing. Due to the high prevalence of GI symptoms, 
athletes may consider them a natural consequence of their activity and have therefore not 
consulted a medical professional for assessment and diagnosis (Putukian and Potera 1997). 
 
2.2.3 Current IBS Treatments 
 Current treatments to reduce IBS symptom severity include medical therapies, exercise, 
and diet (Chey et al. 2015). Medical therapies with varying qualities of evidence to support their 
efficacy include over-the-counter treatments (fibers, laxatives, antidiarrheals, probiotics, and 




antibiotics, and 5-HT3 receptor antagonists), and psychological or behavioral therapy, 
particularly to reduce stress (Chey et al. 2015). 
 
2.2.3.1 Physical Activity as an IBS Treatment 
 It has been shown that women with IBS tend to be less physically active than those 
without IBS (Lustyk et al. 2001). It is unclear whether this is because those with IBS opt out of 
physical activity due to their symptoms or if physical activity has a protective effect against GI 
symptoms and IBS. Additional studies have shown symptomatic improvement with moderate 
increases in physical activity in patients with IBS (Colwell et al. 1998; Lustyk et al. 2001; 
Villoria et al. 2006; Johannesson et al. 2011). It is believed that physical activity helps with both 
the physiological and psychological factors contributing to IBS symptomology (Lustyk et al. 
2001). Indeed, regular low to moderate physical activity is recommended for patients with IBS, 
beginning with a 20 minute walk per day and increasing in distance and/or pace as tolerated by 
the individual (Chey et al. 2015). It is believed that at these levels (≤1 hour at ≤60% VO2max) and 
under normal conditions, that the intensity and duration is low enough that the stress involved 
does not provoke the physiological effects seen in exercise-induced GI syndrome, as described 
previously (Costa et al. 2017b). These issues arise when exercise is performed for ≥2 hours at 
≥60% VO2max, or else under exacerbating conditions of hot environmental temperatures, elevated 
body temperature, or dehydration (Costa et al. 2017b). 
 
2.2.3.2 Diet as an IBS Treatment 
 Food is commonly believed by patients with IBS to cause or worsen their symptoms 




population are low, many patients report food intolerances or sensitivities; however, actual 
intolerance, as demonstrated by double-blind food elimination and challenge, is low (Dainese et 
al. 1999; Eswaran et al. 2011; Chey et al. 2015). Regardless, many patients link consumption of 
specific foods with their symptoms (Simrén et al. 2001; Hayes et al. 2014a). This leads many to 
remove specific foods from their diet, oftentimes unnecessarily restricting their diets and leading 
to potential nutritional deficiencies (Simrén et al. 2001; Spiller et al. 2007; Hayes et al. 2014a). 
Commonly cited “trigger” foods include cereal or wheat-based products, dairy, fatty foods, 
certain vegetables or fruits, spicy foods, alcohol, caffeine, or excess fiber (Drossman et al. 2002; 
Hayes et al. 2014a, 2014b). A current, promising nutritional intervention for IBS symptom 
reduction includes dietary restriction of certain types of carbohydrates known collectively as 
fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) 
(Halmos et al. 2014). 
 
2.3 Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols 
(FODMAP) 
 The term fermentable oligosaccharides, disaccharides, monosaccharides, and polyols 
(FODMAPs) was first described in 2005 by Australian researchers Peter Gibson and Sue 
Shepherd (Gibson and Shepherd 2005). These carbohydrates were grouped together based on 
existing knowledge implicating these types of foods in the development of GI symptoms as well 
as their increasing intake levels in western diets (Gibson and Shepherd 2005). Since then, 
FODMAPs have been shown to be poorly absorbed, highly fermentable, and osmotically active, 








 Oligosaccharides include both fructans and galactans. Fructans are fructose polymers, 
mainly falling under the categories of either inulins or fructo-oligosaccharides (FOS) (Gibson 
and Shepherd 2005, 2010; Muir et al. 2009; Biesiekierski et al. 2011). Common dietary sources 
of FOS are wheat, onion, and garlic (Muir et al. 2007; Gibson and Shepherd 2010). FOS and 
inulins (e.g. chicory) can also be added to foods to increase their prebiotic fiber content, which 
may have health benefits but can also cause undesirable laxation effects, particularly in patients 
with IBS (Pedersen et al. 1997; Rumessen and Gudmand-Hoyer 1998; Muir et al. 2007; Gibson 
and Shepherd 2010; Scarlata 2010). Galactans or galacto-oligosaccharides (GOS) are primarily 
raffinose and stachyose, which are common in legumes such as lentils, chickpeas, and various 
beans (Gibson and Shepherd 2010; Biesiekierski et al. 2011). 
 
2.3.2 Disaccharides 
 The disaccharide referenced in FODMAP is lactose. Lactose is perhaps the most well-
known FODMAP to be associated with GI symptoms, due to familiarity with lactose intolerance. 
It has been shown that from 2% to over 90% of different ethnic groups have a deficiency in the 
enzyme (lactase) needed to break down lactose into its composite monosaccharides (Gibson and 
Shepherd 2005; Matthews et al. 2005). Lactose is found in dairy products including milk, soft 






 The monosaccharide in FODMAP is fructose, which is considered potentially 
problematic when in excess of glucose (Gibson and Shepherd 2010). Fructose is absorbed in the 
small intestine via GLUT5 and GLUT2 transporters, the latter of which is inducibly transported 
to the apical membrane of epithelial cells, particularly in the presence of glucose (Gibson et al. 
2007; Gibson and Shepherd 2010; Biesiekierski 2014). It should be noted that excess fructose is 
malabsorbed in most individuals after a certain level; however, the degree to which it induces 
symptoms in those with IBS or other functional gastrointestinal disorders is different (Ravich et 
al. 1983; Beyer et al. 2005; Shepherd and Gibson 2006; Gibson et al. 2007; Biesiekierski 2014). 
Common foods with excess fructose are fruits such as apples, pears, and most dried fruits 
(Shepherd and Gibson 2006; Muir et al. 2009). Sweeteners including honey, high fructose corn 
syrup, fruit juice concentrates, and agave are also high in fructose (Shepherd and Gibson 2006). 
 
2.3.4 Polyols 
 The final FODMAP is polyols which are sugar alcohols that can come from both natural 
and artificial sources. Natural sources of polyols include fruits such as apples and stone fruits as 
well as vegetables including cauliflower and mushrooms (Gibson and Shepherd 2010). Artificial 
sweeteners including sorbitol, mannitol, xylitol, maltitol, and isomalt can also be sources of 
polyols in foods (Gibson and Shepherd 2010). 
 
2.4 FODMAP Analysis 
 In order to quantify the FODMAP content of foods and ingredients, Monash University 




2007, 2009). Classifying a product as high or low FODMAP cannot be necessarily be done by 
reading ingredient lists, since specific ingredients and processing techniques can influence final 
FODMAP content of a product (Varney et al. 2017). Foods and beverages tested for FODMAP 
are done so in triplicate, with commercial samples pooled from three different batches or sources 
(Muir et al. 2007, 2009). The FOS (kestose and nystose), fructose, glucose, and polyols (sorbitol 
and mannitol) within a sample are measured using high-performance liquid chromatography 
(HPLC) while GOS (raffinose and stachyose) and lactose are measured using ultra-high-
performance liquid chromatography, both with evaporative light scattering detection (ELSD) 
(Muir et al. 2007, 2009; Biesiekierski et al. 2011). Total fructans are measured via an enzymatic 
assay kit (Muir et al. 2007, 2009; Biesiekierski et al. 2011). The excess fructose content is 
determined by subtracting the glucose content from the fructose content (Muir et al. 2007, 2009). 
 Once the individual FODMAP composition of a sample has been determined, the food or 
beverage can be classified as low or high FODMAP. Cutoff values for classification of low 
FODMAP foods were developed by considering levels that are normally consumed in one sitting 
and would induce symptoms in individuals with IBS (Varney et al. 2017). The cutoff values 
(Table 2.1) were then set to be conservative enough to allow people to eat combinations of low 
FODMAP foods during one “meal” or sitting (Varney et al. 2017). A total intake cutoff of 0.5g 
of total FODMAP (minus lactose) per sitting was also applied in low FODMAP dietary studies 
for when foods were eaten in combination in one sitting (Barrett et al. 2010; Ong et al. 2010; 







2.5 A Low FODMAP Diet 
 A low FODMAP diet is not intended to be a lifelong diet due to its highly restrictive 
nature (Murray et al. 2014; Staudacher et al. 2014). Instead, it is recommended that patients with 
IBS or others wanting to use a low FODMAP approach to reduce GI symptoms see a registered 
dietitian nutritionist (RDN) with training in FODMAPs (Gibson and Shepherd 2010). A low 
FODMAP diet is implemented by following a strict, initial elimination diet restricting all 
FODMAP types for 2-6 weeks (Scarlata 2013; Tuck and Barrett 2017). Ideally, this would lead 
to symptom improvement. Following this period, individuals are encouraged to re-challenge 
each FODMAP type individually (Scarlata 2013; Tuck and Barrett 2017). This is preferably done 
step-wise, increasing the dose of a single FODMAP over a 3 day period while maintaining a low 
FODMAP diet otherwise, and using a 2-3 day washout period in between trialing FODMAP 
types (Tuck and Barrett 2017). This re-challenge is also important because not all FODMAPs are 
problematic for all individuals. By using this method, individuals can determine their specific 
FODMAP sensitivities and at what levels these become problematic. They can then increase 
their prebiotic intake, dietary variety, nutritional adequacy, and freedom of food choice (Tuck 
and Barrett 2017). 
 
2.6 FODMAP Resources 
 From the FODMAP analysis of ingredients and products, Monash University has built a 
database which can be used for research purposes to determine the FODMAP content of current 
or standard diets as well as intervention diets. Researchers at Monash University have also 
developed a validated food frequency questionnaire, the Comprehensive Nutrition Assessment 




Additionally, Monash has developed an application program that provides FODMAP 
information and, most importantly, information from the FODMAP database on FODMAP 
content of specific foods (Monash University Department of Gastroenterology 2015). This is 
provided in a convenient stoplight format with green, yellow, or red lights for oligosaccharides, 
excess fructose, polyols, and lactose individually.  
 
2.7 FODMAP and IBS 
 The concept of low FODMAP in the reduction of GI symptoms is relatively new; 
however, most studies from different parts of the world show promising results at this point and 
the diet is now often used as treatment for IBS (Tuck and Barrett 2017; O’Keeffe et al. 2018). 
Both randomized control trials and randomized, single-blind crossover studies have shown that a 
low FODMAP diet reduces GI symptoms in patients with IBS (Ong et al. 2010; Staudacher et al. 
2012, 2017; Halmos et al. 2014; Pedersen et al. 2014; Böhn et al. 2015; Eswaran et al. 2016; 
Marsh et al. 2016; Varney et al. 2017). The length of time on a low FODMAP diet varied in 
these studies between 2 days and 6 weeks, with symptom improvement in approximately 70% of 
patients (Ong et al. 2010; Staudacher et al. 2012, 2017; Halmos et al. 2014; Pedersen et al. 2014; 
Tuck et al. 2014; Böhn et al. 2015; Eswaran et al. 2016; Varney et al. 2017; O’Keeffe et al. 
2018). Modified low FODMAP diets have also demonstrated longer-term efficacy in reducing 
symptoms of patients with IBS (O’Keeffe et al. 2018). The low and high FODMAP levels in 
these studies vary, primarily depending on if the intervention provided foods and beverages or 
dietary advice for following a low FODMAP diet. A recent review of dietary therapies for 
functional bowel symptoms proposed a cutoff value of 12g total FODMAP below which 




2018).Additionally, low FODMAP interventions have also shown some success in symptom 
management of inflammatory bowel disease, other functional GI disorders, and IBS in children 
(Gibson and Shepherd 2010; Chumpitazi et al. 2015). 
 
2.8 FODMAP and Athletes Review 
2.8.1 Abstract 
Endurance athletes commonly experience gastrointestinal symptoms which can affect 
their training and competition. These symptoms, particularly those of the lower gastrointestinal 
tract, are similar to symptoms of irritable bowel syndrome (IBS). A diet restricting fermentable 
oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) has recently 
demonstrated symptom improvement in patients with IBS. Anecdotal reports and recent research 
provide preliminary evidence in support of the application of this nutritional strategy in 
endurance athletes. This dietary strategy is relevant to this population since athletes are 
commonly encouraged to increase carbohydrate consumption prior to and during endurance 
exercise. They may be unknowingly consuming fermentable carbohydrate types in sufficient 
quantities to induce symptoms, particularly at a time when the gut is experiencing other stresses. 
The following article presents the current state of this emerging field including pertinent research 
and references to athletes using low FODMAP approaches for gastrointestinal symptom 
reduction. It also provides direction for future research within this area since, while initially 








Athletes, particularly those participating in endurance activities, commonly experience 
gastrointestinal (GI) symptoms during exercise, with studies indicating prevalence in 30 to 70% 
of endurance athletes (Rehrer et al. 1989, 1992; Brouns and Beckers 1993; de Oliveira and 
Burini 2009; Wright et al. 2009; de Oliveira et al. 2014). While symptoms occur in both the 
upper and lower GI, the focus of this review will be the latter (Keeffe et al. 1984; Riddoch and 
Trinick 1988; Peters et al. 1999; Pfeiffer et al. 2012; Stuempfle and Hoffman 2015; Costa et al. 
2017b). Lower GI symptoms include issues such as bloating, flatulence, cramps, urge to 
defecate, defecation, diarrhea, bloody stool, and, in some cases, constipation (Rehrer et al. 1992; 
Peters et al. 1999; Stuempfle and Hoffman 2015; Costa et al. 2017b). Symptoms range in their 
frequency and severity and can impact the training and performance of endurance athletes (ter 
Steege et al. 2008; Wright et al. 2009; de Oliveira and Burini 2014). In some cases, GI symptoms 
are the reason that athletes do not complete races (de Oliveira and Burini 2014; Stuempfle and 
Hoffman 2015). 
The potential mechanisms contributing to athlete GI symptoms include mechanical, 
physiological, and nutritional factors (ter Steege and Kolkman 2012; de Oliveira et al. 2014; 
Costa et al. 2017b; de Oliveira 2017). A recent comprehensive review of these mechanisms can 
be found in Costa et al. (2017b), with a summary provided here. Mechanical factors are primarily 
due to the physical pounding and jostling of the GI tract by activity, which explains why 
symptoms are more prevalent in activities involving a running component (Rehrer and Meijer 
1991; Peters et al. 1999; Casey et al. 2005; de Oliveira and Burini 2014). Physiological factors 
can be grouped into two main pathways; the diversion of blood flow from the GI tract to 




Beckers 1993; Rehrer et al. 2001; Costa et al. 2017b). Together these two pathways set off a 
cascade of physiological events which include splanchnic ischemia, increased intestinal 
permeability, impaired nutrient absorption, and inflammation (Oktedalen et al. 1992; Camus et 
al. 1997; Jeukendrup et al. 2000; Casey et al. 2005; ter Steege and Kolkman 2012; van Wijck et 
al. 2012; Dokladny et al. 2016; Costa et al. 2017b; de Oliveira 2017). Finally, various nutritional 
components have been shown to correlate with symptoms including intakes of fat, protein, fiber, 
fructose, and high osmolality beverages as well as dehydration (Murray et al. 1989; Rehrer et al. 
1989, 1992; Brouns and Beckers 1993; Stuempfle et al. 2013; de Oliveira et al. 2014). Of the 
three main factors described above, athletes have the most control over their nutrition, if they 
want to continue endurance-type exercise. 
Of recent interest in the realm of athletes and GI symptoms is the concept of limiting 
fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP), which 
include foods such as wheat, onion, garlic, and beans (oligosaccharides); milk, soft cheeses, and 
yogurt (lactose); apples, dried fruits, honey, agave, high fructose corn syrup (fructose); stone 
fruits, mushrooms, and sugar alcohols (polyols) (Shepherd and Gibson 2006; Muir et al. 2007; 
Barrett et al. 2010; Gibson and Shepherd 2010; Biesiekierski et al. 2011; Shepherd et al. 2013). 
This collection of specific carbohydrates was originally introduced in relation to irritable bowel 
syndrome (IBS), a functional gastrointestinal disorder characterized by abdominal pain and 
bloating with altered bowel habits (diarrhea, constipation, or both) (Drossman et al. 2002; Dorn 
et al. 2009). FODMAPs are poorly absorbed, osmotically active, and highly fermentable and 
have been shown to contribute to the GI symptoms of patients with IBS (Barrett et al. 2010; 
Gibson and Shepherd 2010; Ong et al. 2010; Staudacher et al. 2012; Halmos et al. 2014; Murray 




symptom patterns of endurance athletes and IBS including a higher prevalence among females, 
younger demographics, and those experiencing stress (Drossman et al. 1982; Priebe and Priebe 
1984; Saito et al. 2002; Hungin et al. 2005; Chey et al. 2015). While the theory of FODMAP 
restriction for the improvement of athlete GI symptoms appears promising, the research in this 
area is still very much in its infancy, yet warrants attention and review. 
This review summarizes the current research and existing literature on the use of low 
FODMAP nutritional strategies by athletes, with a focus on endurance athletes, and provides 
potential directions for future research in this emerging area. The literature reviewed here 
encompasses foundational work, case studies, interventional uses, review articles and 
discussions, and popular media. The future directions are based on the limitations and gaps in the 
existing research. 
 
2.8.3 Setting the Stage 
Some of the earliest references to the application of FODMAP restriction in an athlete 
population were related to the success that athletes have reported with a gluten-free diet (GFD) 
and GI symptom reduction (Despain 2014; Lis et al. 2015a, 2016c). In a study examining this, 
41.2% of athletes reported consuming a GFD over 50% of the time with over 80% believing that 
gluten removal helped reduce their GI symptoms (Lis et al. 2015b). Interestingly, 70% of 
athletes in this group participated in endurance sports (Lis et al. 2015b). It has been proposed, 
however, that the symptom reduction with gluten elimination is actually due to reduction in 
FODMAPs, primarily the fructans in wheat products (Biesiekierski et al. 2013; Gibson and Muir 
2013). While this may be true for the success of GFD in individuals without celiac disease, 




endurance athlete population due to such high adherence to GFDs among this group (Lis et al. 
2015a, 2015b, 2016c).  
A more formal study of FODMAP restriction by athletes was part of the same 
questionnaire which examined GFD adherence, conducted by Lis et al. (2016a). High FODMAP 
foods and food categories were included in the possible responses of foods that were avoided by 
athletes, specifically those avoided due to GI symptoms. Lis et al. (2016a) found that 55.1% of 
athletes were already avoiding at least one high FODMAP food. Lactose was the main high 
FODMAP eliminated, but fructose, polyols, and fructans were among those listed as well. The 
word FODMAP was not used in the questionnaire to avoid bias, so it is likely that athletes were 
limiting certain foods due to perceived relationship to symptoms without specific intention to 
limit FODMAPs or follow a low FODMAP diet.  
 
2.8.4 Case Studies 
Two very distinct case studies have been published related to low FODMAP diets and 
endurance athletes (Lis et al. 2016b; Gaskell and Costa 2019). The first examined a single-blind 
intervention using a short-term (6 day) low FODMAP diet in a male multisport athlete (Lis et al. 
2016b). The athlete did not have any self-reported functional bowel disorder (i.e., IBS), self-
diagnosed GI condition, or food intolerance and tested negative for celiac disease. FODMAPs 
were reduced from 81g per day to 7.2g with daily training repeated during each diet and a focus 
on running-intensive exercise during days 4, 5, and 6. Symptom severity scores, both daily and 
during exercise, were lower during the low FODMAP intervention period. The athlete was 
advised to utilize a 2-3-day low FODMAP diet in the future prior to intense training or 




improve endurance athlete GI symptoms but also the need for more research in this area. 
Additionally, it was suggested that athletes wanting to use this strategy in the future should keep 
the length of a low FODMAP diet at a minimum in order to prevent “unnecessary dietary 
restriction,” particularly when energy demands of these athletes are so high. 
Conversely, the second case study followed a female ultra-endurance runner who had 
previously been diagnosed with IBS. She had been following a modified low FODMAP diet for 
approximately two years prior to the studied 6-day multi-stage ultramarathon (MSUM). Six days 
prior to the MSUM, she followed a more strict low FODMAP diet in accordance with Halmos et 
al. (2014) and low FODMAP diet plans meeting the athlete’s nutrient needs for the race were 
also developed. Symptoms were well controlled during the race, with scores on a 100mm visual 
analog scale (VAS) lower than those she typically experienced during exercise.  
These two studies provide further evidence for the potential application of low FODMAP 
nutritional strategies to mitigate endurance athlete GI symptoms and show the diverse applicable 
populations. Symptomatic athletes with and without IBS may be able to benefit from daily and 
during exercise symptom reduction. Both low FODMAP short term diets and during exercise 
nutrition warrant further investigation. 
 
2.8.5 Use in Interventions 
Only two randomized controlled trials to date have examined the effects of a low 
FODMAP diet on athlete GI distress (Lis et al. 2018). In this study, Lis et al. (2018) 
implemented a crossover design with 6-day low or high FODMAP diets in 11 runners with 
exercise-associated GI symptoms. Athletes did not have prior diagnoses of food intolerance, 




with prescribed running sessions on day 4 (5 x 1000m intervals) and day 5 (7km threshold). The 
low FODMAP diet significant reduced daily GI symptom area under the curve, but did not affect 
symptoms during exercise.  
The researchers proposed the short exercise duration along with no food consumption 
(either low or high FODMAP) during exercise may have resulted in the lack of difference 
between these two conditions. Exercise of ≥2 hours at 60% VO2max has been shown to be a 
threshold above which the GI is significantly impacted and more symptoms occur (Costa et al. 
2017b). The exercise bouts used by Lis et al. (2018) lasted only 45-60 minutes, thus were not 
representative of true endurance bouts. The study did show preliminary promise, since daily 
symptoms were lowered in these athletes, but the duration and extent to which low FODMAP 
nutrition is used by athletes requires further investigation. 
The second randomized controlled trial examined the effects of a 7-day low FODMAP 
diet under free-living conditions in a group of 16 recreationally-active runners (Wiffin et al. 
2019). Athletes did not have non-exercise related GI issues or diagnosed gut disorders and 
trained at least 3 days per week for at least the last 3 months. They received lists containing low 
or high FODMAP foods, from which they made selections on their own, but were advised to 
match their usual dietary and calorie intake. Athletes kept a weekly weighed food diary and 
continued to exercise as usual. GI symptoms prior to and following each dietary period were 
rated, with individual symptom scores added to calculate global IBS symptom severity scores 
(IBS-SSS), and exercise intensity, duration, and frequency were rated on a category scale. 
The low FODMAP condition resulted in decreased IBS-SSS and perceived improvement 
in habitual exercise frequency and intensity. A significant difference in perceived exercise 




athletes ran distances/durations during training length enough to simulate endurance bouts. 
Additionally, athletes consumed an average of 15.75g of FODMAP during the low FODMAP 
condition, which is above the proposed 12g cutoff level shown to have therapeutic benefit in 
clinical trials of patients with IBS (Tuck and Vanner 2018). This study strengthens the case for 
the application of low FODMAP diets in symptomatic athletes by demonstrating symptom 
improvement in less competitive athletes using a free-living diet approach, but was not without 
limitations. Most importantly, athletes consumed fewer calories (although not significantly 
different) and significantly less carbohydrate in the low FODMAP condition compared to high 
FODMAP. This has potentially significant ramifications for longer term exercise training and 
recovery since adequate calories are necessary to compensate for those expended during exercise 
(Eberle 2008; Wiffin et al. 2019). 
Despite only minimal evidence demonstrating GI symptom reduction during exercise 
with low FODMAP nutritional strategies, multiple studies by one research group have included a 
low FODMAP lead in to other nutrition and exercise interventions which examined GI 
symptoms (Costa et al. 2017a; Snipe et al. 2017; Hoffman et al. 2018; Snipe et al. 2018b, 2018a). 
Costa et al. (Costa et al. 2017a) used a low FODMAP breakfast prior to 180 minutes of steady 
state running (120 minutes at 60% VO2max) and a distance test (60 minutes). A collection of 
similar studies (Snipe et al. 2017; Hoffman et al. 2018; Snipe et al. 2018b, 2018a) examining the 
effects of heat stress had athletes follow a low FODMAP diet for 24 hours prior to a 2 hour 
running bout (60% VO2max). In all of these cases, the low FODMAP lead in was intended to 
reduce the confounding effects of potential residual fermentable substrates in the GI tract during 
exercise and was not the focus of the study in any way. While the use of a low FODMAP lead in 




effects of a low FODMAP meal or 24 hour diet prior to exercise are, and these studies are not 
evidence for its efficacy. 
 
2.8.6 Review Articles and Discussions 
Despite limited randomized, controlled studies on FODMAPs and athletes, the promising 
concept is being discussed within the athlete and GI symptom literature, particularly in review 
articles. In a comprehensive systematic review on exercise-induced gastrointestinal syndrome by 
Costa et al. (2017b), a low FODMAP diet was presented as part of a section on “dietary 
adaptation of the gastrointestinal tract pre-exercise.” The review included a summary of the case 
study by Lis et al. (2016b) along with the successes of the diet in patients with IBS. A letter to 
the editor in response to this review added other potential considerations regarding FODMAP 
contribution to symptoms during exercise to those already discussed (Costa et al. 2017b, 2017c; 
Uno 2017). Original mechanisms involved increased motility and intestinal distention due to the 
presence of osmotically active and fermentable substrates in the ileum and colon (Costa et al. 
2017b). Additional proposed considerations include further reduced colonic blood flow due 
FODMAP-induced pressure increases and increased fermentation due to intestinal shaking from 
exercise (Uno 2017). 
In 2017, de Oliveira (2017) included the idea of FODMAP avoidance in his review on 
runner’s diarrhea, one particularly problematic lower GI symptom. This author has published a 
number of reviews related to athlete GI distress over the years, each with the most current 
research at the time. Some details on FODMAPs were provided including where they can be 




by Lis et al. (2016a). The lack of research, specifically in FODMAPs and runner’s diarrhea was 
called out, but FODMAP avoidance prior to exercise was still recommended. 
A recent review by the author of the majority of the studies on FODMAPs and athletes 
examined both GFD and FODMAP restriction for GI symptom reduction in athletes (Lis 2019). 
The review discussed exercise-induced gastrointestinal syndrome, the current knowledge and 
considerations regarding GFD in this population, and the connection between GFD and 
FODMAP restriction. It also provided a comprehensive review of low FODMAP diets, 
particularly in application to athletes, with many practical suggestions for future implementation 
and research. 
Other review articles mentioning FODMAP avoidance by athletes for GI symptom 
reduction have been more specialized, with focus on ultramarathon (Costa n.d.), ketogenic 
(Christoph and Miele 2017), female (Diduch 2017), youth (Koon et al. 2017), and track-and-field 
(Lis et al. 2019) athletes. Costa (n.d.) indicated “emerging evidence” for implementing a short-
term low FODMAP diet prior to competition or intense training. Christoph and Miele (Christoph 
and Miele 2017) explained how a ketogenic diet is inherently low in FODMAPs and may benefit 
athletes with IBS. This was based on the research in patients with IBS (Ong et al. 2010) and the 
case study by Lis et al. (2016b). Diduch (2017) identified a low FODMAP diet as potentially 
beneficial for female athletes with IBS or gluten-sensitivity. Specific attention was called to the 
challenges of implementing a low FODMAP diet by athletes and the recommendation was made 
for consulting a sports dietitian. Koon et al. (2017) discussed FODMAP food avoidance as a 
potential way to prevent runner’s diarrhea among young athletes. As in the majority of these 
reviews, Koon et al. (2017) acknowledged the limited evidence in this area but also the 




of FODMAP mechanisms which may contribute to GI symptoms and discussed strategies and 
considerations for implementation by track-and-field athletes. The authors noted that symptoms 
occurring after exercise may inhibit adequate refueling, which is important in track-and-field 
when athletes may be competing in multiple races or events in the same day or over multiple 
days. A similar situation applies for some ultramarathon races occurring over multiple days, as in 
the case study of the MSUM athlete (Gaskell and Costa 2019). 
Finally, the preliminary evidence for the relief of GI symptoms by FODMAP reduction in 
endurance athletes (Lis et al. 2018) was mentioned among the limitations of an observational 
study of GI symptoms in marathon runners (Pugh et al. 2018). While nutritional intake 
information was examined in relation to GI symptoms, the authors acknowledged the 
unquantified FODMAP content of athletes’ diets may have been an unexplored factor. 
 
2.8.7 Blogs and Websites 
The initial linkages between FODMAPs and endurance athlete GI symptoms were drawn 
just a few years ago. A number of blogs and websites now offer information and advice on this 
topic. Blogs and websites approach this issue from two primary directions; athletes with GI 
symptoms who may want to consider FODMAPs and those already following a low FODMAP 
diet (primarily due to IBS) who may need resources specific to exercise nutrition. This review 
will not provide an exhaustive list of all popular media references; however, a few notable 
sources are detailed here. 
In 2014, David Despain of Outside magazine wrote about FODMAP reduction being the 
real reason that athletes have benefitted from GF diets, particularly in GI symptom reduction 




to any published studies. After some of the initial GF diet in athlete work by Lis et al. (2015a, 
2015b), Monash University Research Dietitian Marina Iacovou wrote a blog post suggesting a 3-
day low FODMAP diet prior to endurance events for athletes with IBS or IBS-like symptoms 
(Iacovou 2015). As the originators of the low FODMAP diet, Monash University curates a 
FODMAP Blog dedicated to news and research related to FODMAPs which has included 
research related athlete GI symptoms and FODMAPs (www.monashfodmap.com/blog/). 
FODMAP and IBS expert and Registered Dietitian Nutritionist Kate Scarlata blogged in 2015 
about “Tips for the low FODMAP Athlete,” focusing primarily on athletes who are already 
avoiding FODMAPs and may require suggestions of low FODMAP carbohydrate sources for 
exercise (Scarlata 2015). 
 
2.8.8 Future Directions 
As previously mentioned, the research on the use of low FODMAP nutritional strategies 
by endurance athletes for symptom reduction is still in its infancy. While review articles and 
popular media are communicating the rationale and possibilities, additional double-blind, 
randomized, controlled trials are needed to further investigate this area. This is increasingly 
important since interventions examining athlete GI symptoms in other contexts are beginning to 
use a low FODMAP run-in diet (Costa et al. 2017a; Snipe et al. 2017, 2018b, 2018a; Hoffman et 
al. 2018) to reduce variables, without adequate understanding of the implications. Exercise 
intensity and duration should be long enough to simulate endurance exercise and induce 
sufficient GI symptoms for comparison (Costa et al. 2017b; Lis et al. 2018). Exercise types 
should also be investigated to determine the effectiveness of this strategy across endurance 




athletes with and without IBS. It is reasonable that athletes with IBS would benefit from 
implementing a low FODMAP diet daily, with particular attention to prior to and during 
exercise, but symptomatic athletes without IBS, such as those with exercise-induced GI 
syndrome, may find it helpful during these times as well. 
Endurance athletes have increased energy needs due to their high levels of activity, 
making long-term implementation of a diet restricting carbohydrates particularly challenging 
(Burke et al. 2003; Jeukendrup et al. 2005; Eberle 2008; Jeukendrup 2011; Lis et al. 2016a; 
Thomas et al. 2016; Diduch 2017; Tuck and Barrett 2017; Wiffin et al. 2019). To avoid macro-
and micronutrient deficiencies, a low FODMAP diet would ideally be used for the shortest 
amount of time possible, while still allowing for significant GI symptom reduction (Gibson and 
Shepherd 2012; Lis et al. 2018). Future interventions should assess various time courses of low 
FODMAP adherence including during exercise, one meal prior, 24 hours, three days, six days, 
and further. The necessity of FODMAP restriction in post-exercise periods to enable adequate 
refueling should also be examined, particularly for multiple-stage events (Lis et al. 2019; Lis 
2019). Additionally, the effects of different FODMAPs are likely to vary by athlete based on 
their individual sensitivities, as in the FODMAP and IBS literature (Gibson and Shepherd 2012; 
Tuck and Barrett 2017), and athlete GI symptoms are also multifactorial and potentially 
individualized (de Oliveira et al. 2014; Costa et al. 2017b). Other studies are needed to examine 
if a modified, individualized low FODMAP diet may be applicable, focusing particularly on 
FODMAP types consumed in high quantities or previously demonstrated to be problematic in 
each athlete. This would ideally include education and consultation by a sports nutritionist 
trained in FODMAP (Costa n.d.; Diduch 2017; Tuck and Barrett 2017). A larger scale 




habitual levels and target foods. Further studies should also include examination of the impact of 
low FODMAP interventions on the microbiome of endurance athletes since both diet and 
exercise are known to affect microbial composition (Staudacher et al. 2012; Halmos et al. 2015; 
Diduch 2017; Bennet et al. 2018).  
Finally, research and industry efforts should focus on food products consumed by 
endurance athletes. Specific attention should be paid to sports nutrition products, since athletes 
are encouraged to consume carbohydrates during events lasting over one hour (Jeukendrup 2008; 
Thomas et al. 2016). Many products contain high FODMAP ingredients; however, since 
ingredient amounts and processing can influence the final FODMAP content (Varney et al. 
2017), actual FODMAP content needs to be analyzed. This is particularly true for products with 
fructose-type ingredients because foods are only high FODMAP if the fructose is in excess of 
glucose (Gibson et al. 2007; Muir et al. 2009; Varney et al. 2017). Knowledge in this area will 
inform researchers for designing interventions and aid athletes in selecting low FODMAP 
products for trialing this diet personally. 
 
2.8.9 Conclusions 
A low FODMAP diet has been shown to reduce GI symptoms in patients with IBS. 
Endurance athletes commonly exhibit symptoms similar to IBS patients which affect both their 
training and competition. There is emerging evidence that low FODMAP nutritional strategies 
can mitigate some of these symptoms in athletes; however, more research is needed to 
demonstrate this concept and explore the scope of this application. Future research should 
include well designed interventions of sufficient length to simulate endurance exercise with 




research opportunities include examination of commonly used products, athlete microbiomes, 
and individualized low FODMAP strategies.  
 
2.9Table 
Table 2.1. Low-FODMAP cutoff values for individual FODMAP types (per serving of food per 
sitting) adapted from Varney et al. 2017. 
Individual FODMAPs Grams per serve* 
(individual food) 
Oligosaccharides (grain products, legumes, nuts, and seeds) <0.30 
Oligosaccharides (vegetables, fruits, and all other products) <0.20 
Lactose <1.00 
Excess fructose§ <0.15 
Excess fructose§ (for fresh fruit and vegetables when “fructose in  
     excess of glucose” is the only FODMAP present) 
<0.40 
Polyols – sorbitol or mannitol <0.20 
Total polyols <0.40 
*Standard serving size 
Oligosaccharides = total fructans plus galacto-oligosaccharides (stachyose and raffinose) 
§Excess fructose = fructose - glucose 
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CHAPTER 3: QUESTIONNAIRE ON IRRITABLE BOWEL SYNDROME AND 




Background Gastrointestinal symptoms are reported in a large proportion of endurance athletes, 
with similarities in symptom type and distribution to irritable bowel syndrome (IBS).  
Aims The objective of this study was to develop and validate a questionnaire to assess IBS 
diagnoses or fit to IBS diagnostic criteria in this population along with nutritional habits, 
gastrointestinal symptoms, and symptom management strategies. 
Methods A 93-item Endurance Athlete Questionnaire was developed to address the objective, 
targeted at American endurance athletes completing a marathon, ultra-marathon, half-distance 
triathlon, and/or full-distance triathlon that year. Content validity was established by expert 
reviewers (n=6) and face validity was evaluated by endurance athletes (n=9). Test-retest 
reliability was assessed by target athletes (n=51). Participants completed two rounds of the 
questionnaire, separated by 1-2 weeks. Results were analyzed using Pearson and Spearman 
correlations and paired comparisons. 
Results Slight modifications in wording and three demographic questions were added based on 
the input of expert and athlete reviews. Pearson correlation coefficient of test-retest total 
questionnaire scores was significant at 0.839 (P<0.001). Paired comparison of individual 
                                                 
1Reprinted with permission from:  
Killian, L.A., Chapman-Novakofski, K.M., and Lee, S.-Y. 2018. Questionnaire on Irritable 
Bowel Syndrome and Symptom Management Among Endurance Athletes is Valid and Reliable. 






questions found significant differences in 10 of 236 analyzed responses; however, these did not 
affect fit to IBS diagnostic criteria for those without other GI diseases/disorders. 
Conclusions The Endurance Athlete Questionnaire proved to be a valid and reliable measure of 
IBS diagnostic criteria, gastrointestinal symptoms, nutritional habits, and symptom management 
strategies among endurance athletes. Future implementation will help inform gastroenterologists 
with endurance athlete patients and can elucidate if certain behaviors could be contributing to 
athlete gastrointestinal symptoms.  
 
3.2 Introduction 
Gastrointestinal (GI) issues have been reported by 30-70% of endurance athletes (Rehrer 
et al. 1989, 1992; Brouns and Beckers 1993; Peters et al. 1999; de Oliveira and Burini 2009; de 
Oliveira et al. 2014). These issues can drastically affect the quality of an athlete’s training or 
competition, and in some cases, even prevent them from being able to finish (Peters et al. 1999; 
Wright et al. 2009). Symptoms have been shown to increase with longer exercise duration and be 
more prevalent during running compared to cycling (Peters et al. 1993). 
GI symptoms of endurance athletes, particularly of the lower GI, mimic those of patients 
with irritable bowel syndrome (IBS), a functional bowel disorder characterized by abdominal 
pain, bloating, and altered defecation (Fass et al. 2001). In addition, symptom patterns among 
endurance athletes are similar to those seen in IBS, including a higher prevalence among women, 
those of a younger age, and those experiencing stress (Drossman et al. 1982; Priebe and Priebe 
1984; Saito et al. 2002; Hungin et al. 2005; ter Steege et al. 2008). In the case of endurance 
athletes, physiological as well as mental and emotional stresses are experienced during training 




There are no known diagnostic tests or markers for IBS, so it is commonly diagnosed based on a 
set of diagnostic criteria based on symptomology. This is typically done once other pathological 
or clinical conditions with similar symptoms are ruled out based on various alarm symptoms and 
medical testing procedures (Chey et al. 2015). Due to the high prevalence of GI issues, athletes 
may consider their symptoms a natural consequence of their activity and have, therefore, not 
consulted a medical professional (Putukian and Potera 1997; Wright et al. 2009). This makes 
determination of actual IBS prevalence within the endurance athlete population difficult; 
however, IBS diagnostic criteria have been used in the past for IBS prevalence estimates in the 
general population and can be implemented here (Drossman et al. 1993; Saito et al. 2000, 2003; 
Hungin et al. 2005). 
While some studies have linked the types of symptoms experienced by athletes with 
those characteristic of IBS (Keeffe et al. 1984; Priebe and Priebe 1984; Lis et al. 2016), to the 
best of the authors’ knowledge, there are no studies that have looked at actual IBS diagnoses 
among endurance athletes. Additionally, no studies have evaluated athlete symptoms based on 
IBS diagnostic criteria. The knowledge of IBS prevalence in this population as well as the 
prevalence of GI issues in those who are not classified as having IBS would demonstrate the 
proportion of endurance athletes who may be able to benefit from IBS-mitigating strategies. 
Endurance athlete GI symptoms are typically due to a combination of issues stemming from 
mechanical, psychological, physiological, and nutritional causes (de Oliveira et al. 2014). Of 
these factors, athletes have the most control over their nutrition, and so these behaviors are of 
interest as well, particularly since current IBS-mitigating strategies include nutritional 




Based on perceived similarities between IBS and the GI symptoms of endurance athletes 
and lack of research linking the two, the primary aim of this research was to develop and validate 
a questionnaire to assess IBS diagnosis and management in endurance athletes. This included 
assessment of the following: diagnosis by a medical professional, fit to IBS diagnostic criteria 
(both Rome III and Manning) (Manning et al. 1978; Drossman et al. 2006), general GI symptoms 
experienced, and symptom mitigation strategies. Reliability assessment of the questionnaire was 
particularly important given the transient nature of GI symptoms and the fact that specific 
symptoms were evaluated in a general sense and not as a daily report. Nutritional habits 
surrounding training and racing were also of interest to guide future research aims. A 
questionnaire of this nature will serve as a validated research tool, with the results able to be 
utilized by gastroenterologists or sports dietitians who consult with endurance athlete patients, as 
well as the athletes themselves. The information gathered via large-scale distribution of this type 
of questionnaire will reveal the link between athlete GI symptoms and IBS, highlight athlete 
actions and opinions surrounding consultation with medical professionals, identify gaps in 
athlete behaviors regarding GI symptom mitigation, and help to guide athlete nutritional habits.  
 
3.3 Methods 
A 93-item Endurance Athlete Questionnaire (EAQ) was developed following the process 
illustrated as a flow diagram in Figure 3.1. An existing endurance athlete GI questionnaire was 
used as a guide for question development, particularly questions on GI symptoms frequency (GI 
cramps/pain, bloating, flatulence, urge to defecate, defecation, diarrhea, constipation) and 
nutritional habits (use of water, sports drink/thirst quencher, sports drink/energy drink, solid 




(never, rarely, sometimes, often, always) was used to improve upon the limitations of the 4-point 
scale of Peters et al.(1999) while also being able to be compared to similar research by Keefe et 
al. (1984) For the diagnostic criteria, a portion (27 questions) of the Rome III Diagnostic 
Questionnaire for Adult Functional GI Disorders was included, focusing on IBS, functional 
constipation, and functional diarrhea (Drossman et al. 2006). The 6 Manning criteria for IBS was 
also included to provide a comparative IBS criterion (Manning et al. 1978). The EAQ 
incorporated questions on symptom mitigation strategies such as consultation with a medical 
professional or self-directed strategies, as well as the outcomes of those strategies. Demographic 
questions included race participation, training, and personal characteristics. 
The EAQ was designed to target endurance athletes who will have completed at least 1 of 
the following events within the calendar year: marathon (26.2 miles), ultra-marathon (>26.2 
miles), half-distance triathlon (70.3 miles), or full-distance triathlon (140.6 miles). These events 
were selected due to their longer duration, which also necessitates the use of nutrition during the 
event. Inclusion criteria for the target population involved the above race participation as well as 
being 18 years of age or older and currently living in the U.S. 
This study was exempt from full Institutional Review Board (IRB) review after IRB 
review (protocol #16101) by the University of Illinois IRB and the Office of Protection of 
Research Subjects (Champaign, IL). Participants in all aspects of the research received and 
completed voluntary consent forms prior to any data collection. 
 
3.3.1 Content Validity 
Experts in gastroenterology and nutrition were contacted to review the EAQ, utilizing 




and the Sports, Cardiovascular, and Wellness Nutrition Dietetic Practice Group website of the 
Academy of Nutrition and Dietetics. Gastroenterology experts were required to be board 
certified in gastroenterology. Nutrition experts were required to be Registered Dietitian 
Nutritionists (RDNs) and certified in sports dietetics. Three gastroenterologists and 3 RDNs (2 
specializing in endurance athlete nutrition) agreed to participate. Experts were compensated for 
their time.   
Experts were sent a digital copy of the EAQ for comments and a link to a 15-question 
survey, utilizing the Qualtrics survey platform (Qualtrics Research Suite, 2015, Provo, UT). The 
survey assessed the clarity, wordiness, negative wording, overlapping responses, balance, use of 
jargon, appropriateness of listed responses, and use of technical language on a 5-point Likert 
scale from strongly disagree to strongly agree. If the EAQ failed to meet the expert’s standards, 
they were able to provide feedback on specific question(s) within the survey and/or make 
comments on the questionnaire itself. Average scores were calculated for each of the 15 
questions of the expert validation survey. While all questions and comments were examined, 
questions scoring below an average of 4 (corresponds with an “agree”) were examined in greater 
detail. 
 
3.3.2 Face Validity 
Nine athletes who had completed at least 1 of the qualifying endurance events within the 
last 3 years and were 18 years of age or older agreed to assist with face validation. Participants 
were recruited through social media connections with running clubs and other connections to the 
researchers. Athletes were compensated for their time. Athletes received a digital copy of the 




applicability, understandability, and coverage of the EAQ items. Athletes responded with “Yes” 
or “No” answers and were able to provide suggestions and comments. Responses and comments 
were reviewed by the researchers. 
 
3.3.3 Reliability 
Modifications were made to the EAQ following content and face validation, prior to 
reliability testing (see Appendix B). Reliability was evaluated by repeated completion of the 
EAQ in a test-retest manner. Target population athletes were recruited through running and 
triathlon clubs as well as social media. Recruitment materials did not mention gastrointestinal 
issues, to not artificially inflate the proportion of participants with issues. The questionnaire was 
promoted as “aimed at characterizing the general health and nutrition habits.” Athletes were 
supplied a unique 5-digit passcode and a link to the EAQ on Qualtrics. One week after 
completing the EAQ, athletes were sent a link to an identical second round, in which they again 
entered their passcode. Of the 66 athletes expressing interest, 55 completed the 2 rounds. The 
average time between the test and retest (n = 55) was 10.2 days. Participants completing both 
rounds were entered into a drawing for gift card awards.   
 
3.3.4 Data Analysis 
Normality of the test-retest data was assessed by the Shapiro-Wilk test. This was 
performed on the total scores for each participant, the total open-ended scores, the total scores 
from the Manning criteria (from 0 to 6), and the scores from each question individually. The total 
scores were calculated from 121 questions that could be given a numerical score (not open-ended 




required a numerical response. Pearson correlation coefficient was used for the total scores due 
to the normal distribution and Spearman correlation coefficient was used for the total open-ended 
scores due to non-normal distribution. The nature of the EAQ did not lend itself to intraclass 
correlation, nor did exploratory factor analysis result in logical groupings of questions. As a 
result, paired comparison analysis was performed on each question as well as the Manning 
scores, fit to ≥ 2 Manning criteria (yes/no), fit to ≥ 3 Manning criteria (yes/no), fit to Rome III 
IBS criteria (yes/no), and fit to Rome III criteria for functional constipation (yes/no). This 
rigorous comparison method examined actual differences between test and retest responses for 
each person as opposed to correlations in responses. All paired comparisons were non-parametric 
due to non-normal distributions (or dichotomous data), except for a demographic question on 
height. A paired-samples t-test was used for this question. Otherwise, Wilcoxon signed-rank test 
or McNemar’s test were used for non-dichotomous and dichotomous data, respectively. 
Questions with significant differences between test and retest were examined in greater detail, 
including an examination of the Spearman correlation coefficient. Data were analyzed using 
IBM SPSS Statistics version 23 (IBM Corp., Armonk, NY) and P values less than 0.05 were 
considered significant for all tests. 
 
3.4 Results 
3.4.1 Content Validity 
Fourteen items of the 15-question survey received an average score above 4, 
corresponding with at least an “agree” for those quality measures. One question on the inclusion 




were examined in greater detail. Other input and comments were reviewed by the researchers 
and some minor modifications were made, primarily to clarify wording. 
 
3.4.2 Face Validity 
All athletes agreed that the questions were applicable to endurance athletes and covered 
all GI issues that they have experienced. Athlete feedback was used to clarify some of the 
language. Additional questions on education level, income, and tobacco and alcohol use were 
added based on suggestions by the athletes. 
 
3.4.3 Reliability 
Participant characteristics for the test-retest reliability analysis are shown in Table 3.1.  
The Pearson and Spearman correlation coefficients between the test and retest total and open-
ended scores were 0.839 and 0.946 (P < 0.001), respectively, indicating strong (>.70), significant 
correlations (Biddle et al. 2011). Paired comparison analysis was conducted on the Manning total 
score, fit to Rome III criteria for IBS, fit to Rome III criteria for functional constipation. There 
were no statistically significant differences between the test and retest for the Manning total 
score, fit to ≥ 2 Manning criteria, fit to ≥ 3 Manning criteria, fit to Rome III criteria for IBS, or 
fit to Rome III criteria for functional constipation. No participants met the criteria for functional 
diarrhea, so fit to these criteria between test and retest could not be compared. A total of 3 
participants met the Rome III IBS criteria and 2 participants met the Rome III functional 
constipation criteria in both rounds of the questionnaire. An additional 5 participants met 
Manning ≥2 criteria for IBS in both rounds and one participant had been diagnosed with IBS by 




and 1 reported suspected, yet unconfirmed celiac disease. Four participants indicated a 
particularly bad episode of GI symptoms within the last week on only 1 of the reliability rounds. 
Paired comparison analysis was also conducted on each appropriate individual question, 
as described in the methods. The questions with multiple parts and all questions in which 
participants could “select all that apply” were separated. This resulted in a total of 236 
individually analyzed responses (121 included in total score, 17 included in open-ended score, 98 
additional “select all that apply”). Ten questions of the 236 examined by paired comparison were 
found to be significantly different between test and retest, as shown in Table 3.2. These questions 
were examined in greater detail, particularly the 4 questions that were part of the Rome III 
Diagnostic Questionnaire, to ensure that they did not affect the fit to diagnostic criteria.  
Of the 10 questions, 9 had significant Spearman correlation coefficients, with 3 
coefficients greater than 0.70 (strong/high), 5 coefficients between 0.50 and 0.70 
(good/moderate), and 1 coefficient between 0.30 and 0.50 (fair/low) (Hinkle et al. 2003; Biddle 
et al. 2011). The question with the non-significant coefficient (rs = 0.306, P = 0.058) was “how 
often did this discomfort or pain get better or stop after you had a bowel movement.” This 
question was part of the Rome III criteria for IBS; however, changes in the response between test 
and retest did not result in any changes in fit to criteria. The other Rome III criteria for IBS 
question that was different between test and retest was “in the last three months, how often did 
you have discomfort or pain anywhere in your abdomen.” Changes in responses to this question 
only affected IBS diagnosis for one participant, who also indicated highly suspected, yet 
unconfirmed celiac disease, and would be removed from the total count of IBS as a result, since 
an actual IBS diagnosis would require the exclusion of other GI diseases/disorders with 




part of the diagnostic criteria for functional constipation. While this question had a 
good/moderate correlation coefficient (rs = 0.542, P < 0.001), changes in response between test 
and retest resulted in changed diagnosis for functional constipation for 2 participants. Again, 
however, there was no statistically significant difference between test and retest for functional 
constipation diagnosis overall. The final Rome III question with a difference did not affect the 
diagnosis of IBS, functional constipation, or functional diarrhea.  
 
3.5 Discussion 
This study detailed the systematic approach to the development and validation of a 
questionnaire to assess GI issues, IBS diagnosis (actual and fit to Rome III and Manning 
diagnostic criteria), symptom management, and nutritional habits among endurance athletes. 
Using robust statistical analysis, the EAQ proved to be a reliable measure of these elements in a 
test-retest of target population athletes. It was not as reliable for functional constipation since 
there was one question which altered diagnosis, however this was not the main focus of the 
questionnaire, and there was no significant difference in overall functional constipation 
diagnosis. Functional diarrhea reliability could not be demonstrated in the current study, as no 
participants met this diagnosis on test or retest. 
While the main purpose of this questionnaire is to be able to estimate IBS, there was also 
a desire to go more in depth on other aspects of athlete GI issues/experiences including medical 
professional consultation, management strategies, and nutrition. This information will be 
particularly interesting in the context of an athlete’s IBS classification for a few reasons. It would 
be helpful to know what drives athletes with GI issues to consult a medical professional, how 




professionals and athletes. The nutrition information is especially important in the context of 
recent nutritional interventions in patients with IBS involving restriction of fermentable short-
chain carbohydrates, which has potential applications to this population as well (Halmos et al. 
2014; Lis et al. 2016, 2018). It is important to note that there were no statistically significant 
differences in any of the nutritional components or questions relating to medical professional 
consultation. The two differences in basic demographics and management strategy questions are 
described in detail below, but are very minor in nature. 
Gastroenterology and nutrition experts agreed that the EAQ met various quality 
standards, with slight suggestions in wording. The main comments on the inclusion of all 
appropriate symptoms were directed towards possible inclusion of questions relevant to upper GI 
symptoms, however, these questions were not added due to the already extensive nature of the 
questionnaire and the primary goal of assessing IBS, a lower GI condition. Endurance athletes 
agreed that the EAQ was applicable and comprehensive, with the suggested addition of questions 
on education, income, and tobacco and alcohol use. There were no statistically significant 
differences in Manning score or fit to Rome III IBS or functional constipation criteria from test 
to retest. Reliability coefficients for total and open-ended scores were at or above those found in 
test-retest reliability analysis of other nutrition and health habit questionnaires, and indicates a 
precise questionnaire (Contento et al. 2002; Risica et al. 2007; Condrasky et al. 2011; Uggioni 
and Salay 2013). Additional question-by-question paired comparisons with only 10/236 (4.2%) 
resulting in significant differences between test and retest, and 9 of those 10 still significantly 
correlated further supports the reliability of the questionnaire. All 10 questions were maintained 
as part of the overall EAQ either because the differences were not particularly concerning in 




6 questions are described below, while details on the 4 Rome III questions are described in the 
results.  
The number of years participating in marathons was the first question that was 
significantly different between test and retest. Four participants indicated an additional year of 
participation in the retest. This could be due to the additional time that has passed or how 
participants chose to round their participation time, and is therefore not a major concern.  
There were significant differences in participant report of frequency of GI cramps/pains 
and bloating during rest as well as the urge to defecate during both training and competition. 
Participants tended to decrease their report of these complaints from test to retest. Participants 
may have altered their responses slightly in the retest after being exposed to all of the other GI 
symptoms when completing the first test. Symptoms at rest are evaluated over a longer period of 
time than those surrounding exercise and may be more difficult to estimate. Urge to defecate 
may be a bit more complex of a concept to differentiate from GI complaints such as cramps or 
flatulence. None of these differences were particularly concerning since there were not 
statistically significant differences in the responses for those symptoms at the other time points. 
The only significant difference among the “select all that apply” questions was in the 
“other” answer option of the question, “what steps have you taken to help ease your symptoms.” 
Upon examination, this discrepancy appears to be due to participants re-categorizing their 
response from “other” in the first round to a more specific response in the second round. In 
examining the open responses that were allowed with a response of “other,” the majority seem to 
actually be nutritional in nature and re-categorized as such in the second round. It is important to 




There was a fairly even distribution of males and females in the test-retest, at 40% and 
60%, respectively. This is consistent to the proportions found in other studies and surveys on 
endurance athlete demographics, particularly marathons and multisport events (TribeGroup LLC. 
2009; Eventbrite 2014; Running USA 2016a). The age distribution in this study was similar to 
previous literature on endurance event participation, with the majority of athletes ages 20-49 
(TribeGroup LLC. 2009; Eventbrite 2014; Running USA 2016a). Also consistent with the 
previous literature is the ethnic composition of the participants, with a large proportion (87%) 
being Caucasian (TribeGroup LLC. 2009; Running USA 2016b). The majority of participants 
competed in running events only, with 69% in marathons only and another 16% in both 
marathons and ultra-marathons. Running is a less expensive activity, particularly in terms of 
necessary equipment, and typically requires less training time than half and full-distance 
triathlons. The prevalence of athletes in running only events in this study is, therefore, 
understandable. The remaining 16% had participated in half-distance triathlons, some in 
combination with marathons and/or full-distance triathlons. 
There are a few potential limitations to this study. Recruitment for all portions of the 
study was conducted via web-based methods, which would exclude anyone without internet 
access from participation. This is likely not much of an issue, as the majority of runners and 
multisport athletes in previous surveys have reported average household incomes above $50,000 
(TribeGroup LLC. 2009; Running USA 2016b). Additionally, the timing of the reliability study 
may have impacted the responses, particularly when the Rome III questions mostly pertain to 
“the last three months.” The running and triathlon seasons are somewhat dependent on 
geographic location and temperature, but typically slow down in the late fall and winter in the 




some point during 2015. This portion was conducted in the fall of 2015; therefore, it is possible 
that some participants completed races much earlier in the season and were not currently training 
or racing at such a high level, with subsequent effects on GI symptoms. As it stands however, 9 
of 55 (16.4%) of participants were either diagnosed professionally, met the Rome III criteria for 
IBS, or met the Manning criteria (≥2), similar to the 10-20% prevalence estimates of IBS in the 
American population (Drossman et al. 1993; Saito et al. 2002; Hungin et al. 2005; Lovell and 
Ford 2012). As this was a reliability test of the questionnaire in a small sample (n = 55), 
conclusions cannot be drawn at this time as to the actual prevalence of IBS in endurance athletes; 
however, these results are within the realm of feasibility, and likely not significantly influenced 
by time of year. 
The Manning and Rome III criteria have not previously been applied to this population, 
although they have been validated to varying degrees in other populations (Dang et al. 2012; 
Mearin and Lacy 2012; Ford et al. 2013; Sood et al. 2015). This study does not include 
individual evaluation by a medical professional in order to validate the Manning or Rome III 
criteria against medical diagnostic measures or rule out other conditions that could be causing the 
symptoms, so it was not intended as a validity study of these criteria themselves. However, it 
does demonstrate the stability of these criteria over time in the assessment of potential IBS since 
there were no differences in the paired comparisons of these classifications between test and 
retest. Thus, the validity and reliability of this questionnaire are demonstrated, insofar as the 
EAQ will consistently classify athletes as having or not having IBS based on these criteria. 
Whether they would actually be diagnosed with IBS after full medical evaluation is another issue 




diagnostic criteria are commonly used to asses undiagnosed IBS within the general population 
(Drossman et al. 1993; Saito et al. 2000, 2003; Hungin et al. 2005). 
Furthermore, the EAQ did not include classification of athletes into IBS subtypes which 
include diarrhea predominant (IBS-D), constipation predominant (IBS-C), mixed (IBS-M), 
unsubtyped (IBS-U), and alternating (IBS-A) subtypes based on the predominant stool pattern of 
the individual (Longstreth et al. 2006; Dorn et al. 2009). This could have been done by changing 
the response scale used on some questions within the Rome III criteria. The nature of the 
symptoms experienced during exercise could potentially vary by subtype, with some being more 
problematic than others. Due to the already extensive nature of the questionnaire and use of 
different scales in other portions, the more simplistic version was used here. Additionally, there 
is little evidence that more recent nutritional interventions in IBS have success only in specific 
subtypes and the general nutritional habit findings from this questionnaire may be applicable to 
all symptomatic athletes regardless (Halmos et al. 2014; Rao et al. 2015). 
The validation of the EAQ was important for a variety of reasons. While similar 
questionnaires have been used in athletes in the past, none have been validated tools (Keeffe et 
al. 1984; Riddoch and Trinick 1988; Peters et al. 1999). Expert and athlete validity ensured that 
the questionnaire was complete and understandable for athletes. GI symptoms and nutritional 
habits were examined in a general sense with questions such as “how often do you typically 
eat/drink the following” or “how often do you have the following gastrointestinal complaints.” It 
was therefore valuable to ensure that participant responses were reliable instead of greatly 
influenced by daily variation. The stability of this questionnaire was further demonstrated by the 
fact that 4 participants indicated a bad episode within the last week on only 1 of the reliability 




diagnostic criteria. It was also reliable when including participants with inflammatory bowel 
disease and suspected celiac disease when these were excluded from being able to be diagnosed 
with IBS since these conditions would first be excluded by any diagnostic procedure.  
The EAQ is extensive in nature and is intended to be used as a research tool instead of a 
replacement for consultation with a medical professional. The validated EAQ will be used to 
evaluate diagnosed and undiagnosed IBS in endurance athletes as well as symptomatic athletes 
who do not fit the diagnostic criteria. This information will aid in describing the current state of 
GI issues among endurance athletes to help inform both medical professionals and the target 
population themselves. The nutritional data from the EAQ will be used to assess potential 
relationships to GI issues, which will, in turn, inform future studies on possible nutritional 
modifications for endurance athletes to help mitigate GI symptoms. Symptom mitigation may 
help improve athlete enjoyment of physical activity, which has been shown to promote positive 
affect and continued athletic participation (Salmon et al. 2003; Raedeke 2007). Additionally, the 
questionnaire may identify other areas of current athlete behaviors surrounding symptom 
mitigation strategies which could be the target of future outreach or interventions. Together, this 
knowledge has the potential to improve the care provided to these individuals, particularly by 
















3.6 Tables and Figure 
 
Table 3.1. Demographic Characteristics of Test-Retest Sample of Endurance Athletes (n = 55). 
Characteristic  n % 
Gender    
 Male 22 40 
 Female 33 60 
Age    
 20-29 17 31 
 30-39 22 40 
 40-49 9 16 
 50-59 4 7 
 60-69 3 5 
Ethnicity    
 Caucasian 48 87 
 Hispanic/Latino 1 2 
 Mixed 4 7 
 Prefer not to say 2 4 
Highest level of education    
 Some college, no degree 1 2 
 Trade/technical/vocational training 5 9 
 Associate degree 1 2 
 Bachelor’s degree 2 4 
 Master’s degree 22 40 
 Professional degree 20 36 
 Doctorate degree 1 2 
 Prefer not to say 3 5 
Total household income    
 Less than $25,000 4 7 
 $25,000 to $49,999 7 13 
 $50,000 to $74,999 13 24 
 $75,000 to $99,999 6 11 
 $100,000 to $149,999 13 24 
 $150,000 to $199,999 5 9 
 $200,000 and over 2 4 
 Prefer not to say 5 9 
Lifetime event type participation    
 Marathon only 38 69 
 Marathon & Ultra 9 16 
 Marathon & Half-Triathlon 2 4 
 Marathon & Half-Triathlon & Full-Triathlon 3 5 
 Half-Triathlon only 2 4 
 Half-Triathlon & Full-Triathlon 1 2 
Competition level    
 Beginner, amateur, or casual competitor 31 56 




Table 3.2. Questions with Significant (P < 0.05) Rest-Retest Differences (n = 55). 
Question Significance 
“How many years have you been participating in each race type?: Marathon” P = 0.05a 
  
“How often do you have the following gastrointestinal complaints during rest?: 
Gastrointestinal cramps/pains” 
P = 0.03 
  
“How often do you have the following gastrointestinal complaints during rest?: 
Bloating” 
P = 0.05a 
  
“How often do you have the following gastrointestinal complaints during 
training?: Urge to defecate” 
P = 0.03 
  
“How often do you have the following gastrointestinal complaints during 
competition?: Urge to defecate” 
P = 0.03 
  
“What steps have you taken to help ease your symptoms? (select all that apply): 
Other (if other, please specify)” 
 P = 0.03b 
  
“In the last three (3) months, how often did you have discomfort or pain 
anywhere in your abdomen?”bc 
P = 0.02 
  
“How often did this discomfort or pain get better or stop after you had a bowel 
movement?”c 
P = 0.01 
  
“In the last three (3) months, how often did you have a sensation that the stool 
could not be passed (i.e. was blocked), when having a bowel movement?”c 
P = 0.04 
  
“In the last three (3) months, how often did you have loose, mushy, or watery 
stools?”c 
P = 0.002 
aP is < 0.05, but rounds to 0.05 with 2 digits 
bMcNemar’s test used in this case; Wilcoxon for all others 
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CHAPTER 4: IRRITABLE BOWEL SYNDROME IS UNDERDIAGNOSED AND 
INEFFECTIVELY MANAGED AMONG ENDURANCE ATHLETES2 
 
4.1 Abstract 
 Lower gastrointestinal (GI) symptoms are common among endurance athletes and can 
impair performance. Symptom characteristics are similar to irritable bowel syndrome (IBS). No 
previous research has examined IBS diagnosis (medically or by diagnostic criteria) within this 
population. The objectives of this study were to determine the prevalence of IBS among 
endurance athletes and examine their GI symptom management strategies. A previously 
validated, online questionnaire assessed IBS diagnosis, fit to IBS diagnostic criteria (Rome III or 
Manning), general GI symptoms, and symptom mitigation strategies of endurance athletes. The 
questionnaire was distributed to U.S. athletes completing a marathon, ultra-marathon, half-
distance triathlon, or full-distance triathlon. Medically diagnosed IBS was reported by 2.8% of 
endurance athletes. The total prevalence of IBS (n=430) was 9.8% (medical diagnosis and Rome 
III) or 22.8% when also including Manning criteria ( 2). Athletes with IBS experienced more 
frequent symptoms during exercise as well as at rest; however, only 47.6% had consulted a 
medical professional. Over 56% of athletes experienced at least one symptom sometimes or more 
during training and competition and 18.6% had symptoms that at least sometimes 
interrupted/prevented training. Almost half (45.8%) of athletes and 80.0% of athletes with IBS 
reported trying nutritional modifications to help ease symptoms while 20.6% and 52.4% used 
                                                 
2Extended version of:  
Killian, L.A. and Lee, S.-Y. 2019. Irritable Bowel Syndrome is Underdiagnosed and 






over-the-counter medications, respectively. Most endurance athletes who suffer from IBS are 
undiagnosed, while even more experience GI symptoms but do not fit diagnostic criteria. Despite 
using various management methods, endurance athletes are still experiencing symptoms and 
could potentially benefit from current IBS-mitigating strategies. 
 
4.2 Introduction 
 Gastrointestinal (GI) symptoms are commonly reported by endurance athletes, with 
studies indicating that 30-70% suffer from issues such as abdominal cramps, flatulence, the urge 
to defecate, and diarrhea (Rehrer et al. 1989, 1992; Brouns and Beckers 1993; Peters et al. 1999; 
de Oliveira and Burini 2009; de Oliveira et al. 2014). The lower GI symptoms reported are 
analogous to those associated with irritable bowel syndrome (IBS). Additionally, many symptom 
patterns are similar, including a higher prevalence in women, younger demographics, and those 
experiencing high levels of stress (Drossman et al. 1982, 1993, 2002; Priebe and Priebe 1984; 
Sandler 1990; Talley et al. 1995; Saito et al. 2002; Hungin et al. 2005; Chey et al. 2015). IBS is a 
functional GI disorder affecting 5-20% of the U.S. population (Drossman et al. 1993, 2002; Saito 
et al. 2002; Hungin et al. 2005; Lovell and Ford 2012). It is a disorder of unknown etiology 
commonly characterized by the presence of lower abdominal pain accompanied by changes in 
bowel habits (Drossman et al. 2002). 
 Since there are no diagnostic tests for IBS, symptom-based diagnostic criteria are 
typically used. The first set of criteria developed for this purpose was the Manning criteria 
(Manning et al. 1978; Hatlebakk and Hatlebakk 2004; Dang et al. 2012). The Rome criteria for 
diagnosing IBS were established later, with subsequent updates to the current and most 




Drossman et al. 2016). At the time of this study, the most recent version was the Rome III 
criteria (Drossman et al. 2006). 
 IBS is commonly treated with over-the-counter or prescription medications, 
psychological/behavioral therapy, exercise, or diet (Chey et al. 2015). In fact, low to moderate 
physical activity is recommended for patients with IBS (Villoria et al. 2006; Johannesson et al. 
2011; Chey et al. 2015). However, when exercise is performed for ≥2 hours at ≥60% of maximal 
oxygen uptake (VO2max), additional physiological and mechanical factors begin to influence GI 
symptomatology (Costa et al. 2017). Recently, the concept of exercise-induced GI syndrome has 
been introduced to describe GI symptoms associated with exercise of this duration and intensity 
(Costa et al. 2017). As is true with IBS, dietary factors are hypothesized as one potential 
contributor to the symptoms associated with this syndrome. 
 A more recent strategy for IBS symptom improvement involves restriction of certain 
carbohydrates, known collectively as fermentable oligosaccharides, disaccharides, 
monosaccharides, and polyols (FODMAPs), that have been shown to be poorly absorbed, 
osmotically active, and highly fermentable (Barrett et al. 2010; Gibson and Shepherd 2010; Ong 
et al. 2010; Murray et al. 2014). Their restriction significantly reduces GI symptoms in 
approximately 70% of patients with IBS (Ong et al. 2010; Staudacher et al. 2012; Halmos et al. 
2014; Pedersen et al. 2014; Tuck et al. 2014; Böhn et al. 2015; Eswaran et al. 2016; Varney et al. 
2017; O’Keeffe et al. 2018). This concept is particularly relevant to athletes, since carbohydrates 
are recommended for energy and increased performance (Jeukendrup 2008). FODMAP 
restriction has shown preliminary promise for symptom improvement in athletes (Lis et al. 2016, 
2018; Gaskell and Costa 2019; Wiffin et al. 2019); however, it is unclear how many athletes may 




 In a study on the GI symptoms experienced by marathon runners, Keeffe et al. (1984) 
stated that various factors “may result in a higher incidence of the irritable bowel syndrome in 
runners than in nonrunners.” While GI symptoms in endurance athletes have been previously 
linked to IBS (Priebe and Priebe 1984; Gil et al. 1998; Schwellnus and Wright 2008; ter Steege 
et al. 2008; de Oliveira and Burini 2009; Wright et al. 2009; Costa et al. 2017; de Oliveira 2017), 
to the best of our knowledge, there have been no studies actually examining IBS diagnosis 
among this population. Since GI symptoms are commonplace among endurance athletes, many 
may consider their symptoms to be a natural consequence of their high levels of activity 
(Putukian and Potera 1997; Wright et al. 2009). This may keep them from consulting medical 
professionals for assessment and diagnosis, resulting in missed opportunities for treatment. It 
therefore becomes important to assess IBS, consultation with medical professionals, and current 
symptom mitigation strategies to determine the extent of this problem within this group. 
 The aim of this study was to characterize the IBS-related symptoms and treatment of 
endurance athletes. GI symptoms, medically diagnosed IBS, and fit to Rome III or Manning 
diagnostic criteria were examined to this end. Athletes’ symptom management strategies, both 
with and without medical professional consultation, were also assessed. It was hypothesized that 
IBS is underdiagnosed within this population and that IBS and IBS-like symptoms are not 
managed effectively. 
 
4.3 Materials and Methods 
The previously validated Endurance Athlete Questionnaire (EAQ) (Killian et al. 2018) 
was used in this study. Qualifying endurance athletes had completed or would complete a 




distance triathlon (3.8km swim, 180km bike, 42.2km run) that year. Participants were recruited 
through national running and triathlon clubs, social media, and connections through the Sports, 
Cardiovascular, and Wellness Nutrition (SCAN) Dietetics Practice Group of the Academy of 
Nutrition and Dietetics. This study was exempt from full Institutional Review Board (IRB) 
review after IRB review (protocol #16428; 7 December 2015) by the University of Illinois IRB 
and the Office of Protection of Research Subjects (Champaign, IL). The EAQ was distributed 
online via Qualtrics (Qualtrics Research Suite, 2015, Provo, UT) and completed by 430 
endurance athletes between December 2015 and January 2017. Demographic characteristics of 
the participants are shown in Table 4.1. The specific portions of the EAQ reported on below 
include medical diagnosis of IBS, fit to IBS diagnostic criteria, frequencies of various lower GI 
symptoms, and symptom management strategies/outcomes.  
Total IBS prevalence was calculated in two ways: the summation of medically diagnosed 
IBS and fitting Rome III IBS diagnostic criteria and this in combination with those fitting 
Manning criteria (≥ 2). The Manning criteria are rarely used for diagnostic purposes in current 
practice; however, they are utilized here to compare to previous studies (Hungin et al. 2005; 
Dang et al. 2012). Additionally, the inclusion of the highly validated Manning criteria 
demonstrates the potential breadth of IBS among endurance athletes since they are less stringent 
than Rome criteria and there is the lowest agreement between Manning and Rome III (Boyce et 
al. 2000; Dang et al. 2012; Ford et al. 2013). While the Manning criteria results are discussed 
briefly, statistical analysis involving IBS and non-IBS groups was conducted using the medically 
diagnosed and Rome III classified IBS as the IBS group. Athletes with other previously 




for further statistical analysis because many of the symptoms of these conditions overlap with 
IBS.  
 Lower GI symptoms were evaluated at rest, during training and competition, and after 
(within 2h of) training and competition. The symptoms at rest included GI cramps/pains, 
bloating, flatulence, diarrhea, and constipation, with other time points also including the 
symptoms urge to defecate and defecation. Frequency was reported on a 5-point scale of “never,” 
“rarely,” “sometimes,” “often,” and “always.” Frequencies were mainly used as ordinal variables 
during analysis; however, responses were also dichotomized for comparison to total prevalence 
and male/female prevalence differences from previous studies (Keeffe et al. 1984; Riddoch and 
Trinick 1988; Rehrer et al. 1989, 1992; Peters et al. 1999; ter Steege et al. 2008). Responses of 
“never” or “rarely” were dichotomized as the absence of symptoms while a response of 
“sometimes,” “often,” and “always” as the presence of symptoms. From this dichotomization, 
presence of at least one symptom during each time point was determined.  Symptoms were 
analyzed in relation to IBS diagnosis, but were not used in any way for diagnosis. 
 Details were provided regarding consultation with a medical professional, testing for 
various GI conditions, diagnosis, prescribed treatment, and treatment outcomes. If athletes did 
not consult a medical professional, they were able to report the reason for this. Athletes also 
reported other strategies that they used to manage symptoms and the type of resources consulted. 
Responses that were specified as “other” than those supplied were analyzed inductively to 
determine common themes. Other demographics were collected as described in the questionnaire 
validation (Killian et al. 2018). Body mass index (BMI) was calculated using athlete report of 




Data were analyzed using IBM SPSS Statistics version 23 (IBM Corp., Armonk, NY) and 
P values less than 0.05 were considered significant for all tests. Mann-Whitney U test was 
performed on symptom frequency distributions and frequency distributions for 
interruption/prevention of training and competition between IBS and non-IBS groups. 
Distributions of symptom frequencies for IBS and non-IBS groups were often not similar, as 
assessed by visual inspection, so mean ranks were used for group comparison. Logistic 
regression was used to identify demographic predictors of IBS, including the variables of gender, 
BMI, age, ethnicity, education, income, and competition level. Friedman’s test with post hoc 
pairwise comparison and Bonferroni correction was used to compare the frequencies of 
symptoms within each time point. It was also used to compare symptom frequencies across the 
time points of rest, training, and competition. Cochran’s Q test with Dunn’s post hoc test and 
Bonferroni correction was used to compare dichotomized symptom prevalence at each time 
point. Fisher’s exact test was used to compare the dichotomized prevalence of symptoms 
between males and females. 
 
4.4 Results   
4.4.1 Prevalence of IBS 
 The prevalence of medically diagnosed IBS, Manning 2 IBS, Rome III IBS, and total 
IBS (with or without Manning criteria) is shown in Table 4.2 with additional descriptive 
information. Another 3.0% had been diagnosed with other conditions; three with colitis, one with 
Crohn’s, four with H. pylori/ulcers, four with celiac disease, and one with both celiac disease and 
fructose malabsorption. Figure 4.1 displays a diagram of IBS diagnosis, including overlap 




model with demographic variables was statistically significant, 2(20) = 34.046, p = 0.026. 
Gender was the only statistically significant variable with females having 4.921 (confidence 
interval of odds ratio: 2.096 – 11.555) times higher odds of having IBS than males. IBS was seen 
in 14.6% of females but only 4.3% of males.  
 
4.4.2 Frequency and Prevalence of Lower GI Symptoms 
 The frequencies of athletes without other diagnosed conditions (n=417) experiencing 
various symptoms at rest, during training, within 2 hours after training, during competition, and 
within 2 hours after competition are displayed in Figures 4.2-4.6. For most symptoms at each 
time point evaluated, athletes with IBS had significantly greater symptom frequency than those 
without IBS (Table 4.3). When symptom responses were dichotomized, the percentage of 
athletes experiencing at least one symptom is shown in Table 4.4. Statistically significant 
comparisons of symptom frequency distributions between rest, training, and competition are 
shown in Table 4.5. When only those with IBS were considered, there were no statistically 
significant differences in symptom frequency for GI cramps/pain, bloating or flatulence between 
rest and exercise conditions. Frequency of diarrhea was significantly different (pairwise p < 
0.001) between rest (mean rank = 2.45) and competition (mean rank = 1.53), 2(2) = 23.835, p < 
0.001, n = 39. Frequency of constipation was also significantly different (pairwise p .033) 
between rest (mean rank = 2.31) and competition (mean rank = 1.73), 2(2) = 21.375, p 0<.001, 
n = 39. 
 A total of 18.6% and 11.6% of athletes reported that their GI symptoms sometimes, often, 
or always interrupted/prevented their training and competition, respectively. When considering 




interrupting/preventing training for those with IBS (mean rank = 280.29) was significantly 
higher than those without IBS (mean rank = 200.44), U = 10869.0, z = 4.417, p < 0.001, n = 416. 
Similarly, the frequency of symptoms interrupting/preventing competition for those with IBS 
(mean rank = 266.32) was significantly higher than those without IBS (mean rank 202.58), U = 
10288.5, z = 3.641, p < 0.001, n = 417. 
 
4.4.3 Consultation with Medical Professional 
 Out of all athletes, 13.5% (58 of 430) stated that they consulted a medical professional 
due to their GI symptoms, however, 12 of these athletes were diagnosed with other GI disorders. 
Of those without other diagnoses, 11% (46 of 417) had seen a medical professional and 12 were 
diagnosed with IBS as a result. Of the 12 athletes who were diagnosed with IBS after seeing a 
medical professional, 6 still fit Rome III criteria. Of the 34 athletes not diagnosed, 8 fit Rome III 
criteria. 
 These athletes (n=46) were prompted to see a medical professional because issues were 
interrupting and/or preventing their everyday life activities (45.7%), issues were interrupting 
and/or preventing their planned training or competition (43.5%), issues were becoming more 
severe (39.1%), or issues were becoming more prevalent (34.8%). Of the 46 athletes, 26.1% 
received a diagnosis of IBS, 16.7% of gastroesophageal reflux disease, and 4.8% of lactose 
intolerance. Another 45.7% reported an “other” diagnosis with comments including, 
“Inconclusive,” “Dr. basically said that blood flow goes where it is needed most. GI is a low 
priority, hence the problems,” and “Runners diarrhea.” The recommendations and prescriptions 
of the medical professionals reported by these athletes included diet/nutritional therapy or 




specialists (6.5%), and exercise modification (4.3%). Thirty-four athletes (73.9%) reported 
following the recommendations of the medical professional while 19.6% did not. These 
recommendations were thought to be helpful in lessening symptoms by 60.9% of the athletes, 
with 19.6% and 10.9% stating that the recommendations were not helpful or they were unsure, 
respectively. When asked if they were satisfied with the assessment and proposed treatment of 
the medical professional, 65.2% reporting being satisfied, 26.1% were not satisfied, and 4.3% 
were unsure. 
 
4.4.4 No Medical Professional Consultation 
 Of the athletes not consulting a medical professional, 69 (18.6%) fit at least one of the 
diagnostic criteria for IBS (22 fit Rome III, 63 fit Manning ≥2, 16 fit both). The reasons that 
athletes (n=371) indicated for not consulting a medical professional due to GI symptoms 
included issues not being severe enough (50.4%), not having any issues (41.5%), issues not 
preventing activities in everyday life, training, or competition (39.6%), issues not occurring often 
enough (35.6%), wanting to handle it another way (2.2%), and being afraid to see someone 
(1.3%). The themes that emerged for the “other” reasons (6.7%; n=25) for not consulting a 
medical professional included the symptoms being a normal result of their exercise, symptoms 
being nutrition related, managing their symptoms by themselves, feeling like a doctor would not 
understand or be able to help, not having time, feeling embarrassed or stupid, or being a medical 







4.4.5 Symptom Management Strategies 
 The athletes without other diagnosed conditions (n=417) reported consulting various 
people and resources regarding their symptoms (Figure 4.7a&b) as well as various steps taken to 
help ease their symptoms (Figure 4.8). The themes that emerged from the “other” responses to 
steps taken to help ease symptoms were mainly centered around changing training habits. 
Among athletes with IBS, 76.2% reported using nutritional modification to help ease symptoms, 
52.4% over-the-counter medication, and 50.0% stress management techniques. Of this group, a 
total of 9.5% indicated that the steps they have taken have not helped ease their symptoms, 
66.7% stated that they have helped, and 16.7% were unsure. Also among this group, 45.2% were 
satisfied with the outcomes of their efforts to lessen their symptoms, 40.5% were not satisfied, 
and 9.5% were unsure. 
 
4.5 Discussion 
 Overall, IBS is underdiagnosed within the endurance athlete population, specifically 
marathon, ultramarathon, half-distance triathlon, and full-distance triathlon participants. While 
2.8% had been diagnosed with IBS, another 7.0% met Rome III IBS diagnostic criteria but had 
not been diagnosed, for a total IBS prevalence of 9.8%. When Manning criteria were included, 
the prevalence increased to 22.8%. Underdiagnosis was obviously true for athletes who had not 
consulted a medical professional due to their GI symptoms, but also the case for those who had, 
as evidenced by the 8 athletes who met the Rome III criteria but had not received a diagnosis. 
Additionally, even more athletes than those with IBS experienced symptoms at rest and 




 Another main finding of this study was that IBS is ineffectively managed within this 
population. Again, this is obviously true for athletes who had not consulted a medical 
professional regarding their symptoms and were only consulting different resources and 
attempting to manage their symptoms through various strategies. While over 50% of athletes 
with IBS reported that the steps they are taking have helped ease their symptoms and over 45% 
are satisfied with the outcomes of their efforts, if these strategies were truly effective in 
managing their symptoms, athletes would ideally not still meet the diagnostic criteria for IBS. 
Similarly, while over 60% of athletes reported that a medical professional’s recommendations 
were helpful in lessening symptoms, 19.6% did not and 6 of the 12 athletes diagnosed with IBS 
still met Rome III diagnostic criteria. Furthermore, although symptoms tended to decrease 
between rest and exercise in general, athletes with IBS did not experience the same decreases in 
GI cramps, bloating, and flatulence during exercise as those without IBS. They also had 
symptoms interrupt/prevent their training and competition more frequently than those without 
IBS. This indicates that unmanaged symptoms at rest (hence an IBS diagnosis) may make it 
more difficult to manage symptoms during exercise, resulting in more frequent interruptions. 
 
4.5.1 Prevalence of IBS 
 The prevalence of IBS found in this study (9.8%) was in line with that typically found 
among the U.S. population. Estimates generally range from 10-20%, with some variation 
depending on the diagnostic criteria used for determination (Drossman et al. 1993, 2002, Saito et 
al. 2000, 2002; Hungin et al. 2005; Lovell and Ford 2012; Sperber et al. 2017). Hungin et al. 
(2005) reported an IBS prevalence of 14.1% overall with 3.3% diagnosed and an additional 




IBS in this study (2.8%) was comparable to that by Hungin et al. (2005). When the Manning 
criteria were included in IBS classification, the percent meeting IBS diagnostic criteria in this 
study was almost twice as much (20.0%) as that found by the Hungin et al. (2005). This could be 
due to the fact that Rome III criteria was used in this study, which has demonstrated the lowest 
agreement with Manning criteria, compared to the Rome I and II used by Hungin et al. (2005) 
(Ford et al. 2013). 
 Even though the prevalence rates are similar to those seen in the general U.S. population, 
it is important to note the different implications of symptoms within this population. IBS is 
known to affect patient health-related quality of life and result in work loss or impaired work 
performance (Hungin et al. 2005; Agarwal and Spiegel 2011). In the case of endurance athletes, 
symptoms also affect their ability to exercise, with symptoms interrupting/preventing training in 
close to 40% of athletes with IBS. This has additional implications as physical activity has been 
shown to improve HRQOL and prevention of activity could be detrimental (Rejeski et al. 1996). 
 This study also found increased IBS prevalence among females compared to males 
(14.6% and 4.3%, respectively). This matches the findings of numerous studies on IBS, which 
often also show prevalence ratios of approximately 2:1 or 3:1 (Sandler 1990; Drossman et al. 
1993, 2002; Talley et al. 1995; Hungin et al. 2005). Conversely, an age-associated relationship 
was not found, while higher prevalence rates in younger patients are typically seen within the 
IBS literature (Drossman et al. 1993; Talley et al. 1995; Saito et al. 2000; Hungin et al. 2005). 
This may be due to a “self-selection process” similar to that described by Rehrer et al. (1989) in 






4.5.2 Frequency and Prevalence of Lower GI Symptoms 
  The frequencies of most lower GI symptoms at each time point were non-normally 
distributed and skewed right. This is understandable, as most athletes do not experience every GI 
symptom frequently, while a few athletes experience symptoms very frequently. Further 
evidence of this is seen in the comparison of symptom frequencies between athletes with IBS 
and those without, where most symptoms are significantly more frequent among IBS sufferers 
(Table 4.3). 
 The dichotomized symptom prevalence at each time point was within the range of that 
found in other studies of GI symptoms of endurance athletes which typically ranged from 30-
70% depending on the exact symptoms and scales used (Keeffe et al. 1984; Riddoch and Trinick 
1988; Rehrer et al. 1989, 1992; Brouns and Beckers 1993; Peters et al. 1999; ter Steege et al. 
2008; de Oliveira and Burini 2009; de Oliveira et al. 2014). A 5-point scale was used for the 
rating of symptom frequency in this study. This was different than scales used previously in 
similar studies by Peters et al. (1999), Keeffe et al. (1984), or Riddoch and Trinick (1988) in an 
attempt to mitigate the shortcomings of the scales used in those studies. Peters et al. (1999) used 
a 4-point scale of “never,” “sometimes,” “often,” and “always” and dichotomized responses as 
present if the response was anything other than “never.” While this scale has fairly balanced 
scale points, the dichotomization used may have overinflated the prevalence since symptoms 
experienced even once would necessitate a response of “sometimes.” Keeffe et al. (1984) and 
Riddoch and Trinick (1988) used a 4-point scale of “never,” “rarely,” “occasionally,” and 
“frequently,” and dichotomized the symptom as present if the response was “occasionally” or 
“frequently.” This scale is less balanced since there is no positive scale point to “never” and the 




generally recommended in survey research (Friedman and Amoo 1999). The 5-point scale used 
in this study provides a balanced scale with a “rarely” option that was dichotomized as not 
present. A 5-point scale is commonly used within patient-reports outcome research (Østerås et al. 
2008) and 4-point scales have been shown to have lower reliability, validity, and data quality 
than scales with more points (Friedman and Amoo 1999; Preston and Colman 2000; Østerås et 
al. 2008) and be less able to fully capture respondents feelings (Preston and Colman 2000). 
Although the use of a different scale makes complete comparison between studies difficult, the 
findings can still be discussed within the context of previous studies due to the many similarities. 
Additionally, other than comparison with these similar studies, the data in this research was used 
as non-dichotomized, ordinal data to provide more robust analysis in conjunction with the IBS 
classification of athletes. 
 At least one symptom was reported by approximately 55-70% of athletes during exercise 
in this study, but only 18.6% and 11.6% of athletes stated that GI complaints sometimes, often, 
or always interrupted/prevented their training or competition, respectively. Other studies on 
endurance athlete GI symptoms commonly report the prevalence of such problems, but not 
always the impact on training or competition. While symptoms have been shown to impact 
performance (ter Steege et al. 2008; Wright et al. 2009; de Oliveira and Burini 2014; Stuempfle 
and Hoffman 2015), this is likely more due to acute severity as compared to the longer term 
frequency, which was measured in this study. It is possible that the variety of symptom 
mitigation strategies used by these athletes are able to reduce their symptom severity to not 
drastically affect their training and competition, even if they occur fairly frequently. It is 




without IBS also experienced symptoms during exercise and had their training and/or 
competition interrupted or prevented as a result. 
 
4.5.3 Consultation with Medical Professional 
 Only 13.5% of athletes had consulted a medical professional as a result of GI symptoms. 
This is similar to a population study by Talley et al. (1995) which found that only 11% of 
subjects had seen a physician due to abdominal pain and/or disturbed defecation within the last 
year. Approximately half (20 of 42; 47.6%) of the athletes with IBS had visited a medical 
professional, which is greater than the proportion reported by Drossman et al. (1982) and Talley 
et al. (1995) who found that 25% of those with IBS had been to a physician due to their bowel-
related issues. While this is encouraging, IBS was still not diagnosed for 8 athletes meeting 
Rome III criteria despite consultation. Hungin et al. (2005) found that 10% of patients who 
consulted a medical professional did so due to symptom frequency. In this study, 34.8% of 
athletes consulted a medical professional for increased symptom frequency. This larger 
percentage is potentially due to the impact of symptoms on training and competition, as an even 
larger percentage (43.5%) indicated consulting a medical professional because of symptoms 
interrupting or preventing training and competition. 
 Some of the write-in comments for athlete diagnosis reflected that doctors were unable to 
determine the cause of their symptoms or contributed them to exercise. This is in line with some 
of the beliefs of those not consulting medical professionals for their GI symptoms as discussed in 
the next section. In terms of recommendations for symptom mitigation, half of these athletes 
reported being prescribed diet/nutritional therapy or modifications. This is a fairly common 




(Drossman et al. 1997; Spiller et al. 2007; Hayes et al. 2014a, 2014b; Chey et al. 2015). The 
more recent successes with FODMAP restriction, particularly the preliminary investigations in 
athletes, provide further support for the recommendation of dietary modification in this group 
(Ong et al. 2010; Staudacher et al. 2012; Halmos et al. 2014; Pedersen et al. 2014; Böhn et al. 
2015; Eswaran et al. 2016; Lis et al. 2016, 2018; Gaskell and Costa 2019; Wiffin et al. 2019). In 
this study, exercise modifications were also recommended to 4.3% of those consulting a medical 
professional, which included changes to the type, amount, or intensity of exercise. As previously 
stated, while lower levels of physical activity have been shown to improve symptoms in patients 
with IBS, higher levels may exacerbate symptoms, so these recommendations were likely meant 
to decrease the exercise-induced stresses in this population (Colwell et al. 1998; Lustyk et al. 
2001; Villoria et al. 2006; Johannesson et al. 2011; Costa et al. 2017). This concept, while well-
intentioned, is also a reason that athletes stated for not consulting a medical professional.  
 
4.5.4 No Medical Professional Consultation 
 The majority of athletes in this study did not have GI symptoms or the symptoms were 
not severe, often, or troublesome enough to see a medical professional. Conversely, 6.9% of 
those not seeing a medical professional fit the IBS diagnostic criteria and would likely benefit 
from a consultation. Drossman et al. (1982) assumed that those who were symptomatic but did 
not consult a medical professional for their symptoms either considered their symptoms normal 
or did not think they were serious enough. This sense of “normal” is even further exaggerated in 
endurance athletes, with athletes often considering their symptoms a “normal” consequence of 
exercise (Putukian and Potera 1997; Wright et al. 2009) and indicating this within the free 




 In a critical review on health care seeking behavior among those with IBS and nonulcer 
dyspepsia, Koloski et al. (2001) discussed how those who do not consult medical professionals 
may do so for a variety of reasons including being better able to cope with their symptoms, being 
embarrassed by their symptoms, or having unfavorable opinions of health care. These reasons 
are supported by this study with 2.2% wanting to handle it another way, 1.3% being afraid to 
consult a medical professional, and others adding comments of feeling embarrassed or stupid, 
feeling like a doctor would not understand, or wanting to manage it by themselves. These 
reasons and comments have implications for both medical professionals and endurance athletes. 
Medical professionals can help make athletes feel validated about their symptom experience and 
not dismiss them as merely a result of heavy exercise. Similarly, athletes need to know that their 
symptoms may not be “normal,” there are people that they can consult, and there may be 
additional strategies they can use to mitigate symptoms. 
 
4.5.5 Symptom Management Strategies 
 Endurance athletes most commonly reported consulting friends, family, or coaches 
regarding their GI symptoms. These sources were also among the most reported sources of 
nutrition information by collegiate and elite adolescent athletes (Jacobson and Gemmell 1991; 
Froiland et al. 2004; Diehl et al. 2016). It is unknown how much knowledge any of these 
resources would have when it comes to these issues, and likely depends on their professions and 
training (Jacobson and Gemmell 1991). Coaches and other athletes have been shown to have 
inadequate nutrition knowledge that is lower than that of athletic trainers who have required 
nutrition training (Jacobson and Gemmell 1991; Shifflett et al. 2002; Rockwell et al. 2016; 




possible that this lack of knowledge also extends to GI symptom and appropriate symptom 
management strategies. Nutritionists or dietitians, on the other hand, would ideally have more 
training and experience with these issues, particularly regarding the role of FODMAPs in 
gastrointestinal symptoms. Nutritionists/dietitians were the fourth most consulted resource by 
endurance athletes (9.6%) ahead of trainers, who may also be able to provide more accurate 
nutrition information (Shifflett et al. 2002; Torres-McGehee et al. 2017). 
Athletes most commonly reported (38.4%) referencing the internet/websites for 
information and again, there is a wide range of health-related information quality found using 
this type of resource (Amante et al. 2015; Tan and Goonawardene 2017). Magazine sources of 
information, used by 12.0% of athletes, have the possibility of being “media hype and 
exaggerated advertisements largely unsupported by scientific research” (Jacobson and Gemmell 
1991). Conversely, journal articles and books, used as references by 12.9% and 10.6% of 
athletes, respectively, may contain more reliable information, especially if they are peer 
reviewed and written by qualified authors. 
Many of the steps taken by athletes to help mitigate their symptoms are those that are 
commonly recommended and used in patients with IBS (Drossman et al. 2002; Chey et al. 2015). 
Free responses to steps taken were similar to the comments in the study of GI complaints of 
marathon runners by Keeffe et al. (1984), with athletes changing the timing of eating or running 
to be able to go to the bathroom prior to exercise. A larger percentage of athletes with IBS 
(76.2%) reported using nutritional modifications to help ease symptoms compared to the 47% of 
IBS sufferers who altered their diet in the study by Hungin et al. (2005). This may be due to, in 
part, to the known association of nutrition with athletic performance benefits, which leads 




Hetherington 2005; Birkenhead and Slater 2015; Lis et al. 2015; Thomas et al. 2016). Regardless 
of the reason, the high percentage of athletes, both with and without IBS, who reported trying 
nutritional modifications shows their willingness to try this type of strategy. This is promising 
for the future application of low FODMAP strategies in this population. 
 
4.5.6 Limitations 
 This study was based on questionnaire data which has some inherent limitations that were 
described previously during validation (Killian et al. 2018). Recruitment was conducted using 
web-based methods which may exclude those without use of the internet, although that is likely 
not much of an issue in this population due to reported incomes of runners and multisport 
athletes of over $50,000 in other studies (TribeGroup LLC. 2009; Running USA 2016a). 
Athletes were recruited to participate in a study on the health and nutrition habits of endurance 
athletes, without any mention of GI symptoms to minimize the response bias that can occur with 
this type of research (Keeffe et al. 1984; Riddoch and Trinick 1988). The study demographics 
show slightly more female participation than has been found in endurance athlete demographic 
research, although this is common in survey research (TribeGroup LLC. 2009; Eventbrite 2014; 
Running USA 2016b). The large percentage of Caucasians and the majority of athletes in the 18-
49 age groups are consistent with previous findings on this population (TribeGroup LLC. 2009; 
Eventbrite 2014; Running USA 2016b, 2016a). Finally, this questionnaire was quite extensive in 
length, so it is possible that this deterred some athletes.  
 There was technically no way for athletes to report the severity of their symptoms, only 
the frequency with which they occur. This limitation occurs in other studies of athlete GI 




who also asked severity measures to lessen this issue. Their argument is that it can lead to 
inflated prevalence rates as athletes may have symptoms, but not be limited by them. That is part 
of the reason for including questions in this study on whether GI complaints interrupt or prevent 
training or competition. As it stands, the data in the current questionnaire can still be compared 
to previous studies and the addition of severity questions would have made the length 
impractical.  
 Another limitation to this study was that the categorization into IBS or non-IBS groups 
was primarily dependent on fit to diagnostic criteria. Particularly in patients not consulting a 
medical professional due to their GI symptoms, it is possible that symptomatic athletes had other 
undiagnosed digestive diseases or other organic conditions with overlapping symptoms and the 
prevalence rates are therefore overinflated. Drossman et al. (1993) described a similar situation 
in their population study; however, as in this case, the prevalence was comparable to others in 
the literature and those with diagnosed gastrointestinal conditions were excluded from further 
analysis. Finally, the EAQ did not classify athletes into IBS subtypes. While this information 




 The results from this study indicate that IBS is underdiagnosed among endurance 
athletes, as is true at approximately the same levels in the general population. GI symptoms are 
particularly problematic for these IBS sufferers because they also occur more frequently during 
exercise than for those without IBS and more frequently interrupt or prevent training and 




diagnostic criteria. Less than half of the athletes with IBS had consulted a medical professional 
for their symptoms and athletes, in general, tended to consult people and resources of 
questionable accuracy regarding their symptoms. Athletes should be encouraged to discuss their 
symptoms with appropriate medical professionals without regarding them as merely a result of 
high activity levels. This should include registered dietitian nutritionists, who may be able to 
assist athletes in following targeted and individualized dietary strategies for symptom mitigation, 






















4.7 Tables and Figures 
Table 4.1. Endurance Athlete Questionnaire participant demographics (n = 430) 
Characteristic n % 
Gender     
      Male 186 43.3 
      Female 244 56.7 
Age   
      18-29 77 17.9 
      30-39 141 33.1 
      40-49 122 28.6 
      50-59 65 15.3 
      60+ 19 4.4 
Ethnicity   
      Asian 14 3.3 
      Black/African American 5 1.2 
      Caucasian 373 86.7 
      Hispanic/Latino 16 3.7 
      > 1 Ethnicity 17 4.0 
      Prefer not to say/Other 5 1.2 
Competition level   
      Beginner/amateur/casual 202 47.0 
      Competitive age-grouper 219 50.9 
      Elite/professional 9 2.1 
Lifetime event type participation   
      Marathon 354 82.3 
      Ultra-marathon 131 30.5 
      Half-distance triathlon 241 70.9 
      Full-distance triathlon 133 30.9 
BMI category*   
      Underweight (<18.5) 9 2.1 
      Normal (18.5-24.9) 306 71.2 
      Overweight (25-29.9) 98 22.8 
      Obese (30+) 14 3.3 













Table 4.2. Prevalence of irritable bowel syndrome (medically diagnosed and using diagnostic 












Prevalence, n (%) 12 (2.8) 78 (18.1) 30 (7.0) 98 (22.8) 42 (9.8) 
Gender      
     Female (%) 91.7 69.2 76.7 72.4 81.0 
     Male (%) 8.3 30.8 23.3 27.6 19.0 
Age (years, %)      
     18-29 0.0 28.2 33.3 25.5 23.8 
     30-39 41.7 32.1 33.3 33.7 35.7 
     40-49 33.3 21.8 23.3 22.4 26.2 
     50-59 25.0 12.8 6.7 11.2 11.9 
     60+ 0.0 5.1 3.3 4.1 2.4 
Competitor Level (%)      
     Beginner 25.0 52.6 53.3 46.9 45.2 
     Competitive age-grouper 75.0 41.2 46.7 21.4 54.8 
     Elite 0.0 1.3 0.0 1.0 0.0 
Training Affected (%)* 50.0 39.7 33.3 38.8 38.1 
Competition Affected (%)* 33.3 26.9 30.0 26.5 31.0 



























Table 4.3. Mann-Whitney U-test results for frequency of gastrointestinal (GI) symptoms at each 
time point between endurance athletes with irritable bowel syndrome (IBS) and without IBS.* 
 Mean Ranks†    
Symptom IBS* (n) Non-IBS (n) U z p 
At Rest      
GI Cramps/Pain 310.86 (40) 195.28 (372) 11614.5 6.208 <0.001 
Bloating 274.34 (40) 199.21 (372) 10153.5 4.000 <0.001 
Flatulence 245.89 (41) 203.85 (374) 9220.5 2.222 0.026 
Diarrhea 304.96 (42) 196.5 (372) 11905.5 5.973 <0.001 
Constipation 243.03 (40) 202.01 (371) 8901.0 2.340 0.019 
During Training      
GI Cramps/Pain 293.95 (42) 197.74 (372) 11443.0 5.212 <0.001 
Bloating 256.67 (42) 201.95 (372) 9877.0 3.025 0.002 
Flatulence 249.94 (42) 202.14 (371) 9594.5 2.582 0.010 
Urge to Defecate 261.69 (42) 200.81 (371) 10088.0 3.285 0.001 
Defecation 251.99 (42) 200.77 (369) 9680.5 2.813 0.005 
Diarrhea 275.82 (42) 199.79 (372) 10681.5 4.252 <0.001 
Constipation 236.48 (42) 201.40 (367) 9029.0 2.366 0.018 
During Competition      
GI Cramps/Pain 265.07 (42) 201.57 (373) 10230.0 3.448 0.001 
Bloating 250.99 (42) 202.02 (371) 9638.5 2.746 0.006 
Flatulence 234.19 (42) 203.92 (371) 8933.0 1.638 0.102* 
Urge to Defecate 249.83 (42) 200.44 (368) 9590.0 2.704 0.007 
Defecation 231.17 (41) 202.08 (368) 8617.0 1.635 0.102* 
Diarrhea 246.00 (39) 200.11 (369) 8814.0 2.640 0.008 
Constipation 226.72 (41) 201.45 (366) 8434.4 1.834 0.067* 
2 Hours After Training      
GI Cramps/Pain 289.86 (42) 198.78 (373) 11371.0 4.953 <0.001 
Bloating 260.35 (42) 202.11 (373) 10031.5 3.247 0.001 
Flatulence 245.82 (41) 202.72 (372) 9217.5 2.301 0.021 
Urge to Defecate 249.06 (42) 202.81 (372) 9557.5 2.461 0.014 
Defecation 250.38 (42) 202.66 (372) 9613.0 2.540 0.011 
Diarrhea 280.61 (42) 199.25 (372) 10882.5 4.503 <0.001 
Constipation 228.45 (41) 203.51 (370) 8505.5 1.657 0.098* 
2 Hours After Competition      
GI Cramps/Pain 285.17 (42) 199.31 (373) 11074.0 4.662 <0.001 
Bloating 260.80 (41) 201.07 (372) 9832.0 3.297 0.001 
Flatulence 239.57 (42) 203.31 (371) 9159.0 1.954 0.051* 
Urge to Defecate 248.88 (41) 201.25 (370) 9343.0 2.536 0.011 
Defecation 250.29 (42) 200.96 (369) 9609.0 2.659 0.008 
Diarrhea 275.19 (42) 198.12 (369) 10655.0 4.291 <0.001 
Constipation 237.31 (42) 200.73 (366) 9064.0 2.504 0.012 
*IBS presence defined as medically diagnosed plus Rome III IBS 
†Mann-Whitney U-test is the non-parametric version of an independent samples t-test. Mean 





Table 4.4. Prevalence (in %) of at least one lower gastrointestinal (GI) symptoms at rest, during 
training, 2 hours after training, during competition, and 2 hours after competition 
 Overall (n=417) Males (n=184) Females (n=233) 
At Rest 66.0bc 58.7 71.7*b 
During Training 67.9c 63.6 71.2b 
2 Hours After Training 62.6abc 59.2 65.2ab 
During Competition 56.1a 52.7 58.8a 
2 Hours After Competition 60.2ab 58.2 61.8a 
*Significantly different between males and females 
Different superscript letters indicate statistically significant differences between time points 




Table 4.5. Statistically significant differences in symptom frequency between specific symptoms 











GI cramps/pain 17.445 (409) <0.001 Rest (1.91) Training (2.10) 0.018 
Bloating 50.337 (408) <0.001 Rest (2.17) Training (1.97) 0.013 
   Rest (2.17) Competition (1.86) <0.001 
Flatulence 55.529 (411) <0.001 Rest (2.16) Competition (1.82) <0.001 
   Training (2.02) Competition (1.82) 0.010 
Diarrhea 102.903 (405) <0.001 Rest (2.24) Training (1.98) 0.001 
   Rest (2.24) Competition (1.78) <0.001 
   Training (1.98) Competition (1.78) 0.011 
Constipation 131.888 (400) <0.001 Rest (2.23) Training (1.93) <0.001 
   Rest (2.23) Competition (1.84) <0.001 
*Test statistic is for Friedman 2(2) 
† Post hoc pairwise comparisons with Bonferroni correction  






Figure 4.1. Venn diagram of irritable bowel syndrome (IBS) prevalence among endurance 
athletes including those having medically diagnosed IBS, fitting Rome III IBS diagnostic 
criteria, and fitting ≥2 Manning criteria. Reported as: % (# of respondents). Respondents with 
other gastrointestinal (GI) conditions which could conflict with an IBS diagnosis included celiac 
disease, inflammatory bowel disorders, and peptic ulcers. Dotted gray line indicates IBS 
prevalence including medically diagnosed and Rome III. Dashed black line indicates total 






Figure 4.2. Symptom frequency distributions at rest. Frequencies are displayed as never (dark 
gray), rarely (light gray dot), sometimes (gray diagonal stripe), often (black and white), and 
always (light gray). Friedman’s test was used to compare frequencies of symptoms (p < 0.001). 
Different lowercase letters represent statistically significantly different pairwise comparisons. 






Figure 4.3. Symptom frequency distributions during training. Frequencies are displayed as never 
(dark gray), rarely (light gray dot), sometimes (gray diagonal stripe), often (black and white), and 
always (light gray). Friedman’s test was used to compare frequencies of symptoms (p < 0.001). 
Different lowercase letters represent statistically significantly different pairwise comparisons. 






Figure 4.4. Symptom frequency distributions 2 hours after training. Frequencies are displayed as 
never (dark gray), rarely (light gray dot), sometimes (gray diagonal stripe), often (black and 
white), and always (light gray). Friedman’s test was used to compare frequencies of symptoms (p 
< 0.001). Different lowercase letters represent statistically significantly different pairwise 






Figure 4.5. Symptom frequency distributions during competition. Frequencies are displayed as 
never (dark gray), rarely (light gray dot), sometimes (gray diagonal stripe), often (black and 
white), and always (light gray). Friedman’s test was used to compare frequencies of symptoms (p 
< 0.001). Different lowercase letters represent statistically significantly different pairwise 






Figure 4.6. Symptom frequency distributions 2 hours after competition. Frequencies are 
displayed as never (dark gray), rarely (light gray dot), sometimes (gray diagonal stripe), often 
(black and white), and always (light gray). Friedman’s test was used to compare frequencies of 
symptoms (p < 0.001). Different lowercase letters represent statistically significantly different 





Figure 4.7. People (a) and resources (b) consulted by endurance athletes regarding their 
gastrointestinal (GI) symptoms, expressed as a percentage of all athletes without other GI 






Figure 4.8. Steps taken by endurance athletes to help ease their gastrointestinal (GI) symptoms, 
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CHAPTER 5: HIGH FERMENTABLE OLIGOSACCHARIDES, DISACCHARIDES, 
MONOSACCHARIDES, AND POLYOLS (FODMAP) CONSUMPTION AMONG 




 Endurance athletes commonly experience gastrointestinal (GI) symptoms which are 
similar to those of irritable bowel syndrome (IBS). Recent research has shown promise for the 
restriction of fermentable oligosaccharides, disaccharides, monosaccharides, and polyols 
(FODMAP), a nutrition-based mitigation strategy for initially for IBS. However, the FODMAP 
content of athlete’s habitual diets, their nutritional strategies surrounding exercise, and popular 
sports nutrition products is unclear. This research aims to investigate the FODMAP content of 
endurance athlete diets by examining these three areas, in conjunction with GI symptoms. 
Nutritional habits surrounding exercise and GI symptoms were examined in 430 endurance 
athletes. A subset of this group (n=73) completed a FODMAP-specific food frequency 
questionnaire for habitual intake. The most commonly reported sports nutrition products were 
analyzed for FODMAP content. Athletes commonly consumed high FODMAP foods during pre-
race dinners and breakfasts. Nutrition product use, particularly solid, gel/gummy, and homemade 
products, was related to increased frequency of some GI symptoms. Many of the commonly used 
sports nutrition products tested high in FODMAP, especially when consumed in multiple 
servings, as is likely the case during endurance exercise. Average habitual FODMAP intake was 
26.1g and intake of some specific FODMAP types was higher in athletes exhibiting various 




habitually and surrounding exercise, with sports nutrition products often adding additional 
FODMAPs. Athletes (and related health professionals) can utilize this information when 
analyzing their diets and selecting appropriate foods to decrease GI symptoms. 
 
5.2 Introduction  
 Lower GI symptoms are common among endurance athletes, can interrupt or prevent 
training and competition, and impact performance (Rehrer et al. 1989, 1992; Brouns and Beckers 
1993; Peters et al. 1999; ter Steege et al. 2008; de Oliveira and Burini 2009; Wright et al. 2009; 
de Oliveira and Burini 2014; Ho 2009; Jeukendrup 2011; de Oliveira et al. 2014; Chapter 4: 
Sections 4.4.2 and 4.5.2). The symptoms experienced by athletes are similar to those of patients 
with IBS, a functional GI disorder characterized by abdominal pain and altered bowel habits that 
affects 10-20% of the population (Drossman et al. 1982, 1993, 2002; Priebe and Priebe 1984; 
Sandler 1990; Talley et al. 1995; Saito et al. 2002; Hungin et al. 2005; Lovell and Ford 2012; 
Chey et al. 2015). In fact, 9.8% of marathon, ultramarathon, half distance, or full distance 
triathlon athletes in a recent assessment had either been diagnosed with IBS or met Rome III IBS 
diagnostic criteria (Chapter 4: Table 4.2 and Figure 4.1). Additional athletes (13.0%) met 
Manning criteria (≥2) and even more reported experiencing symptoms, although they did not 
meet either criteria. 
Endurance athlete GI symptoms are hypothesized to be due to a combination of issues 
stemming from mechanical, psychological, physiological, and nutritional causes (ter Steege and 
Kolkman 2012; de Oliveira et al. 2014; Costa et al. 2017b; de Oliveira 2017). Of these factors, 
athletes have the most control over their nutrition. Recent studies in IBS patients have shown 




carbohydrates known as fermentable oligosaccharides, disaccharides, monosaccharides, and 
polyols (FODMAP) (Barrett et al. 2010; Gibson and Shepherd 2010; Ong et al. 2010; Halmos et 
al. 2014; Murray et al. 2014). These carbohydrates have been shown to be poorly absorbed, 
osmotically active, and highly fermentable, which contributes to the GI symptoms experienced 
by those with IBS (Ong et al. 2010; Staudacher et al. 2012; Halmos et al. 2014; Pedersen et al. 
2014; Böhn et al. 2015; Eswaran et al. 2016). Restriction of FODMAPs has been shown to 
improve symptoms in approximately 70% of patients with IBS (Ong et al. 2010; Staudacher et 
al. 2012; Halmos et al. 2014; Lomer 2015). Similar principles may be applied to endurance 
athletes, as carbohydrates are frequently consumed for energy during long-distance events to 
“improve endurance capacity and performance” (Jeukendrup 2008). If the types of carbohydrates 
consumed surrounding exercise or within athletes’ regular diets are high in FODMAP, this could 
be contributing to the GI symptoms they experience. 
Recent research has indicated that athletes may already be altering their diets to eliminate 
some FODMAP-containing foods to reduce GI distress without intentionally restricting 
FODMAPs specifically (Lis et al. 2016a).. Additionally, two case studies and two preliminary 
studies have suggested potential for a low-FODMAP diet in GI symptom management in athletes 
(Lis et al. 2016b, 2018; Gaskell and Costa 2019; Wiffin et al. 2019), yet it is unclear to what 
extent FODMAPs are currently consumed by endurance athletes. This information would be 
important if alteration to a low FODMAP diet was desired by athletes for symptom 
improvement. It would also provide further support for the potential of a low FODMAP diet for 
the management of endurance athlete GI symptoms. 
To date, there has not been a larger scale assessment of endurance athlete diets or sports 




symptoms. Many sports nutrition products have not yet been analyzed for FODMAP content, so 
athletes’ actual FODMAP intakes may be difficult to determine. Additionally, while athletes may 
be already restricting some FODMAPs (Lis et al. 2016a), their habitual intake levels and the 
association between intakes and GI symptoms are unknown. As such, the overall objective of 
this study was to evaluate the nutritional habits of endurance athletes in relation to FODMAPs, 
both surrounding exercise and habitually. The primary aim was to examine athlete nutrition 
surrounding training and competition in order to determine the prevalence of high FODMAP 
food consumption. The secondary aim was to determine the habitual FODMAP intake of 
endurance athletes and the relationship between this intake and GI symptoms. It was 
hypothesized that athletes commonly consume high FODMAP foods and that habitual FODMAP 
intakes would be associated with GI symptoms.  
 
5.3 Materials and Methods 
 Portions of the previously validated Endurance Athlete Questionnaire (EAQ) (Killian et 
al. 2018) were used in this study, as implemented in a recent assessment of IBS among 
endurance athletes (Chapter 4). A total of 430 athletes who had completed or would complete a 
marathon, ultra-marathon, half-distance triathlon, or full-distance triathlon that year completed 
the EAQ. Participant demographics are displayed in the previous work (Chapter 4: Figure 4.1). 
The nutrition-related portions of the EAQ were utilized in this study and the symptom 
frequencies previously reported (Chapter 4: Figures 4.2-4.6) were used to examine associations 
between nutrition and GI symptoms.  The nutrition-related portions included general nutrition 
habits, foods consumed during pre-race dinners and breakfasts, and nutrition used two hours 




drink/thirst quencher, sports drink/energy drink, solid food, gel/gummy, and homemade 
product/something else. When examining relationships with symptoms, athletes with previously 
diagnosed GI conditions which have overlapping symptoms with IBS were excluded from the 
analysis to not confound the relationships between nutritional information and symptoms 
(n=417).  
 
5.3.1 Nutrition Surrounding Exercise 
 Dinner and breakfast foods prior to competition were classified as specific high 
FODMAP if the athlete specifically named a high FODMAP food, based on FODMAP 
classification by the Monash University Low FODMAP Diet App (Monash University 
Department of Gastroenterology 2015). Examples of specific foods at dinner were pizza, pasta, 
bread, sweet potato, and avocado while examples of specific foods at breakfast were bagel, toast, 
bread, orange juice, and yogurt. Foods were classified as potentially high FODMAP if they were 
either a specifically mentioned high FODMAP food, a less specific item, or an item that may be 
high FODMAP based on its ingredients but has not been analyzed yet. Examples include 
responses like “carbs”, “anything”, “veggies”, “fruit”, or sports nutrition products.  
 Athletes listed the specific products that they used in the five categories of sports 
drink/thirst quencher, sports drink/energy drink, solid food, gel/gummy, and homemade 
product/something else. The first four categories of products were tabulated to determine the top 
five most commonly used products in each category (top six in the case of solid foods). The 
homemade product/something else foods were categorized as potentially high FODMAP in a 





5.3.2 Sports Nutrition Product Analysis 
 Product selection for FODMAP analysis was based on the three most frequently used 
product categories during competition from the EAQ, other than water. The top products in each 
of these categories (sports drink/thirst quencher, solid food, and gel/gummy) were examined for 
their popularity and ingredients. The top five sports drinks/thirst quenchers were selected. 
Although only one of these five was potentially high FODMAP based on ingredients, it was 
important to verify this assumption. From the solids category, three of the top six products were 
selected due to their commercial availability. The other three products in this category were not 
specifically sports nutrition products (banana, peanut butter and jelly sandwich, pretzels), so data 
from these products can be found in the Monash database or calculated by entering a recipe into 
the Monash University FoodWorks database (FoodWorks Professional 2007, Xyris Software, 
Highgate Hill, QLD, Australia) to assess the FODMAP content, if desired (Barrett and Gibson 
2010; Ong et al. 2010; Lis et al. 2016b). An additional solid product was added for FODMAP 
analysis on the basis of it being a gluten-free version of the second most popular solid sports 
nutrition product that was potentially lower FODMAP compared to the other solids. The top six 
products from the gel/gummy category were selected, which consisted of five gels and one 
gummy product; however, one gel brand was discontinued prior to FODMAP analysis, so four 
gel brands and one gummy product were analyzed. For two of the gel brands, two different 
flavors were tested to show potential variation in FODMAP content based on flavor and 
ingredient differences. Product ingredient lists are shown in Table 5.1. 
 Validated, standardized, and published methods for FODMAP analysis were conducted 
by researchers at Monash University (Muir et al. 2007, 2009; Biesiekierski et al. 2011). Samples 




included samples from three different product batches (Muir et al. 2007, 2009; Biesiekierski et 
al. 2011). Processing and extraction methods were followed (Muir et al. 2007, 2009; 
Biesiekierski et al. 2011). In summary, approximately 100-200g from each of three sample 
batches was randomly selected, pooled, and mixed. Three samples were freeze dried after which 
samples were homogenized by grinding into powder. Non-freeze dried samples were ground or 
mixed into a uniform mixture. From each of these powdered or mixture forms, 1g was extracted 
in triplicate. Analysis of fructose, mannitol, sorbitol, lactose, and galacto-oligosaccharides 
(GOS) involved high performance liquid chromatography (HPLC) with evaporative light 
scattering detection (ELSD) as described in previous FODMAP analysis research (Muir et al. 
2007, 2009; Biesiekierski et al. 2011). Total fructans were analyzed by enzymatic kit 
(Megazyme Fructan HK Assay kit; Megazyme International Ireland Ltd, Wicklow, Ireland; 
AOAC Method 999.03 and AACC Method 32.32). Averages of the triplicate measurements were 
calculated, with data reported on a per serving basis based on the serving size of each product. 
Low FODMAP cutoff values are based on the amount of each FODMAP type in a product 
consumed in one sitting (Varney et al. 2017). A sitting or meal is typically separated by 2-3 
hours; however, athletes commonly consume multiple servings of products in shorter time spans 
since 30-90 g/hr are recommended for endurance and ultra-endurance exercise (Thomas et al. 
2016). Thus, the number of servings consumed in one sitting that would result in the product 
exceeding the low FODMAP cutoff values was also calculated (Varney et al. 2017).  
 
5.3.3 Habitual Nutrition 
 Athletes who completed the EAQ and had given permission to be contacted regarding 




food frequency questionnaire. The Comprehensive Nutrition Assessment Questionnaire (CNAQ) 
was developed by researchers at Monash University and has been shown to be valid assessment 
of dietary FODMAP (Barrett and Gibson 2010). The CNAQ was administered through an online 
portal controlled by the researchers which sent instructions and follow-up emails to participants 
(http://www.cnaq.com.au). Qualifying athletes (n=234) were contacted with details of the follow 
up study, 120 consented to participate, and 80 completed the CNAQ. Three participants were 
excluded from the final analysis for reported daily intakes of greater than 5000kcal (Worme et al. 
1990; Burke et al. 2001; George et al. 2004; Navrkal 2015). Four were excluded due to 
previously diagnosed GI conditions as in the EAQ analysis (two with inflammatory bowel 
disease, one with celiac disease, and one with H. pylori/ulcers), for a final sample size of 73 
athletes, with demographic information shown in Table 5.2.  
Average intake values for all FODMAP categories were calculated. Total daily 
FODMAP intake (both including and excluding lactose) was categorized as low (≤12g) or high 
FODMAP based on levels shown to have therapeutic benefit in clinical trials (Tuck and Vanner 
2018). Using the methods of O’Keeffe et al. (2018), the individual foods on the CNAQ were 
categorized as high and low in each FODMAP (fructans, GOS, lactose, fructose, sorbitol, and 
mannitol). The proportion of athletes with a regular intake (at least once a week) of at least one 
food high in individual FODMAP was assessed (O’Keeffe et al. 2018). 
 
5.3.4 Statistical Analysis 
 A Shapiro-Wilk test was performed to assess normality of product consumption 
frequencies, symptom frequencies, and FODMAP intakes. Non-parametric statistical analysis 




compare product consumption frequency at each time point with post-hoc pairwise comparisons 
using a Bonferroni correction. The relationship between nutrition product type consumption 
frequency and symptom frequency at various time points was not monotonic, so Spearman’s 
correlation between the two was not valid. Instead, a Kruskal-Wallis test was conducted to 
determine if there were differences in symptom frequency between groups that differed in their 
nutrition product type intake frequency. Distributions of symptom frequencies were not similar 
for all groups, as assessed by visual inspection of boxplots. When statistically significant 
differences were found, Dunn’s procedure for post-hoc pairwise comparison with Bonferroni 
correction was used to determine differences in symptom frequency between intake levels.  
 Individual symptom frequencies were dichotomized with never and rarely as not present 
and sometimes, often, and always as present (Chapter 4: Section 4.3). If at least one symptom 
was present during a certain timepoint (rest, during training, during competition, 2-hours after 
training, and 2-hours after competition), the participant was classified as having symptom(s) at 
that time point. Mann-Whitney U tests were used as a non-parametric independent-samples t-test 
alternative comparing dichotomized symptom presence and continuous FODMAP intakes. 
Fisher’s Exact test or Pearson Chi-Squared test were conducted between total FODMAP 
classifications (high or low) and dichotomized symptom presence. Additionally, Mann-Whitney 
U tests were conducted to compare the individual symptom frequencies between those reporting 
low or high habitual FODMAP intakes. 
 All analyses were performed using SPSS software package version 25 (IBM SPSS 







 The percentage of athletes who reported following various diets is shown in Figure 5.1. 
Additionally, 65.3% reported following no specific diet. When asked how important their 
nutritional strategy is for training and competition, 23.3% and 66.0% of athletes reported that it 
is somewhat or very important, respectively. Athletes sometimes (21.9%), often (30.2%) and 
always (36.5%) used the race-provided foods/beverages during a race either from race packets or 
aid stations. The percentage of athletes reporting either a specific or potentially high FODMAP 
food for pre-race dinner was 65.5% and 87.2%, respectively. In terms of pre-race breakfast 
foods, 62.3% and 85.1% reported a specific or potentially high FODMAP food, respectively. 
 Figure 5.2 displays the consumption frequency of water, sports drink/thirst quencher, 
sports drink/energy drink, solid food, gel/gummy, and homemade product/something else before 
and during training and competition. When these frequencies were analyzed in conjunction with 
the reported symptom frequencies, there were some statistically significant differences in 
symptom frequencies at different levels of intake frequency (Appendix J: Tables S5.1-S5.8). Post 
hoc analysis revealed 69 significantly different pairs, 55 of which had a higher symptom 
frequency (reported as mean rank) with higher intake frequency. Associations with the more 
problematic symptoms (GI cramps/pains, urge to defecate, defecation, and diarrhea) are shown 
in Table 5.3. 
 The use frequency of the top reported products in the categories of sports drink/thirst 
quencher, solid, and gel/gummy during competition is displayed in Figure 5.3. The tested 
products in these categories were classified as low or high FODMAP based on the FODMAP 
analysis results and established cutoffs (Varney et al. 2017), with details shown in Table 5.4. 




reported products only used by up to 5.3% (23 of 430) of athletes. Of the 140 athletes who 
reported using a homemade product/something else during training, 64.3% reported a potentially 
high FODMAP product. Additionally, of the 122 athletes who reported using a similar product 
during competition, 63.9% were potentially high FODMAP. Commonly reported potentially 
high FODMAP foods included sandwiches and bites or bars made with dried fruit and/or honey. 
 Table 5.5 shows the individual habitual FODMAP intakes of endurance athletes. The 
percentages of athletes who consumed at least one high FODMAP food in each category at a 
frequency of at least once a week are shown in Table 5.6. There were no statistically significant 
differences in FODMAP intakes between those experiencing or not experiencing at least one 
symptom at each time point. When examined at the symptom level, there were statistically 
significant differences in some FODMAP intakes between athletes with or without specific 
symptoms. Distributions of FODMAP intakes for those with and without symptoms were 
similar, as assessed by visual inspection. Statistically significantly different median FODMAP 
intakes are shown in Table 5.7 with the respective symptoms.  
When using an overall FODMAP cutoff value of 12g including lactose, 11 of 73 athletes 
(15.1%) had habitual diets low in FODMAP while 62 (84.9%) consumed diets high in 
FODMAP. When excluding lactose in this 12g cutoff, 40 athletes (54.8%) and 33 athletes 
(45.2%) consumed low and high FODMAP daily diets, respectively. There were no statistically 
significant associations between FODMAP categorization including lactose and overall symptom 
presence at any time point or individual symptom presence. Similarly, there were no significant 
associations between FODMAP categorization excluding lactose and overall symptom presence 
at any time point. There was a statistically significant moderate association between FODMAP 




0.043,  = 0.239 (Rea and Parker 1992). Of those consuming high FODMAP diets, 39.4% (13 of 
33) experienced defecation during training while only 17.9% (7 of 39) of those in the low 
FODMAP group experienced this symptom. Differences in non-dichotomized individual 
symptom frequencies were examined between FODMAP categorizations with similar 
distributions between low and high categories, as assessed by visual inspection. Both post-
training (U = 871, z = 2.833, p = 0.005) and post-competition (U = 850, z = 2.602, p = 0.009) 
bloating median frequencies were statistically significantly greater for the high FODMAP group 
(median = 1.0; rarely) compared to the low FODMAP group (median = 0.0; never) when 
considering total FODMAP excluding lactose. 
 
5.5 Discussion 
 Overall, this study showed that FODMAP intake is high among endurance athletes both 
surrounding exercise and habitually. Only four athletes of 430 reported following a low 
FODMAP diet, despite twelve athletes having been diagnosed with IBS by a medical 
professional. Athletes commonly reported consuming high FODMAP foods for their pre-race 
dinners and breakfasts and many of the most commonly reported sports nutrition products were 
high FODMAP, particularly as servings increase beyond one portion. Furthermore, only 11 of 73 
athletes (15.1%) had a total daily FODMAP intake (including lactose) at a level that would be 
considered low FODMAP (Tuck and Vanner 2018). When lactose intake was excluded to 
calculate athletes at or below the 12g cutoff, there were still over 45% of athletes who consumed 
daily diets high in FODMAP (Tuck and Vanner 2018). There were various significant 
relationships between sports nutrition product type usage frequency and symptom frequency, 




was also true for relationships between FODMAP intake and symptoms, with more symptoms 
present in those with higher FODMAP intakes. Higher median intakes were also shown among 
those with individual symptoms present. 
 
5.5.1 Nutrition Surrounding Exercise 
High FODMAP pre-race dinners were common, with many of the reported dinners 
containing a wheat-based product (bread, pasta, pizza) that likely contain high levels of fructans 
(Biesiekierski et al. 2011). A dietary survey of ultraendurance cyclists similarly reported 89% of 
participants consuming pasta, pizza, or both within the 3 days leading up to a 210km cycle race 
(Havemann and Goedecke 2008). Additionally, many of these products include sauces which 
typically contain onion and garlic, which are also high in fructans (Muir et al. 2007). The same 
was true for many of the high FODMAP breakfast foods, including wheat-based bagels and 
toast, along with bananas. These foods were also the top four sources of fructans (wheat, onion, 
banana, garlic) in a study of fructan intakes of both patients with Crohn’s disease and healthy 
controls (Anderson et al. 2015). Similar high FODMAP foods and ingredients were listed as 
commonly consumed by athletes in recent reviews of low FODMAP diets and athletes (Lis et al. 
2019; Lis 2019) and pre-race dinners and breakfasts are similar to those reported by 
ultraendurance cyclists (Havemann and Goedecke 2008). 
 Water was the most commonly consumed product at all time points and showed no 
relationships with GI symptoms. Lower hydration levels and dehydration have been shown to be 
related to increased GI symptoms in ultramarathon and marathon runners (Rehrer et al. 1989; 
Stuempfle et al. 2013). In this study, reported intake levels were likely high enough in the 




frequently may use alternate sources of fluids such as a sports drink/thirst quencher. These 
products were used frequently by athletes, particular during exercise, and were associated with 
less GI cramps/pain and urge to defecate during training when consumed before training. Three 
of the top five products in this category were low FODMAP, so athletes may be able to consume 
additional fluid, typically with carbohydrates and electrolytes, but not consume additional 
FODMAPs. Contrastingly, in a similar study of endurance athlete nutritional habits by Peters et 
al. (1999), thirst quenchers were found to be related to an increased relative risk of GI symptoms. 
Other studies have also shown increased GI symptoms due to carbohydrate sports drink 
consumption (Rehrer et al. 1992; Van Nieuwenhoven et al. 2005), with factors such as 
osmolality and impaired intestinal absorption due to running as hypothesized causes. It is 
important to note that the two most commonly used products in this category tested as high 
FODMAP in one serving. While this study did not find the same relationships, this new 
FODMAP information may help to explain the previous findings (Peters et al. 1999).  
 Frequency of consuming sports drinks/energy drinks was fairly low in this population 
despite other reports of common use as in endurance sports and benefits to endurance 
performance (Tarnopolsky 1994; Cox et al. 2002; Desbrow and Leveritt 2006; Jeukendrup 2011; 
Southward et al. 2018). Intake of these beverages prior to training was associated with diarrhea 
after training as well as some other minor GI symptoms. This is contrary to previous work that 
demonstrated no effect on GI symptoms with addition of caffeine to a sports drink in athletes 
completing an 18-km run (Van Nieuwenhoven et al. 2005); however, caffeine is included in lists 
of supplements to be avoided before and during exercise for athletes who experience GI 
symptoms such as diarrhea (Putukian and Potera 1997; Murray 2006; Ho 2009). Due to the 




traditional dietary guidelines for IBS, while their inclusion is recommended to promote motility 
in patients with constipation (Staudacher et al. 2011; Böhn et al. 2015; Halmos 2017). 
 Both solids and gels were related to various GI symptoms, including half of the more 
problematic symptoms listed in Table 5.3. These products were also more commonly used than 
sports drink/energy drinks or homemade products. Previous research on nutritional habits of 
ultraendurance cyclists showed common consumption of these two forms of carbohydrate, along 
with carbohydrate beverages, particularly during races (Havemann and Goedecke 2008). In a 
study of nutrition during various endurance events, gels were found to account for 28% to 45% 
of carbohydrate intake during an amateur long-distance cycling race and marathon, respectively 
(Pfeiffer et al. 2012). Solids accounted for 15% of carbohydrate intake during and Ironman 
triathlon race and 37% of intake by professional cyclists (Pfeiffer et al. 2012).  
Gels in particular are a common and convenient way for athletes to ingest high levels of 
carbohydrate (Havemann and Goedecke 2008; Pfeiffer et al. 2009, 2010) Previous research on 
gel use and GI discomfort has shown mixed results. It appears that, in general, gels are well 
tolerated by most athletes (Pfeiffer et al. 2009; Guillochon and Rowlands 2017); however, a few 
athletes experience significant GI symptoms which can affect performance (Burke et al. 2005; 
Pfeiffer et al. 2009). In this study, more frequent gel/gummy use during both training and 
competition resulted in increased urge to defecate in some groups compared to those who never 
used these products. Of the six gels and one gummy tested for FODMAP content, three were 
high FODMAP in one serving and the others became high after two, four, five, and seven 
servings, so it is possible that the FODMAPs in these products are contributing to symptoms.  
More frequent solid product use before training was associated with more frequent 




be associated with lower GI symptoms  and a study of different carbohydrate formats during 
intense cycling showed that abdominal cramps were more likely when bars were consumed 
compared to gels (Guillochon and Rowlands 2017). Of the solid products tested for FODMAP 
content, two were high FODMAP in one serving and the other two were high after two and four 
servings. The other top products listed by athletes in this category were banana, peanut butter 
and jelly sandwich, and pretzels, all of which are potentially high FODMAP depending on 
factors such as ingredients, processing, and serving sizes (Muir et al. 2009; Biesiekierski et al. 
2011; Anderson et al. 2015; Varney et al. 2017; Tuck et al. 2018).  
 Alternatively, athletes who reported always consuming solid food during training 
experienced less frequent GI cramps/pain during training compared to all other groups. The same 
was true for those always consuming gel/gummies before training compared to sometimes. In 
these cases, it is possible that athletes who always consume these products experienced some 
training of the gut to be able to tolerate higher levels of carbohydrates without adverse GI 
symptoms, although previous work in this area was not specific to FODMAP (Murray 2006; Cox 
et al. 2010; Costa et al. 2017a).  
Many of the products in the sports drink/thirst quencher, solid, and gel/gummy categories 
are made available to athletes at races either in race packets or at aid stations (Lis et al. 2016a). 
The majority of athletes reported using the products available, although it is unclear how often 
they train with the same products. This could be problematic in race situations as athletes may be 
consuming products high in FODMAPs when they are not used to training with them (Eberle 
2008; ter Steege et al. 2008). 
 Although less frequently used, homemade products/something else were associated with 




competition. This would very likely impact an athlete’s performance as they would need to take 
the time to stop and use a restroom (Sullivan et al. 1994). Many of the products reported in this 
category were potentially high FODMAP and although there was a wide range of different 
products reported, many shared common high FODMAP ingredients (Lis et al. 2016a, 2019). 
 
5.5.2 Habitual Nutrition 
 FODMAP contribution to GI symptoms can be explained using a bucket concept 
(Thalheimer 2016). An individual’s bucket represents their unique threshold for specific types of 
FODMAPs. They can fill their bucket without any issues by consuming some FODMAP; 
however, at a certain point the bucket will begin to overflow, resulting in symptoms. If an athlete 
habitually consumes a diet low in FODMAP, then consumption of high FODMAP products 
surrounding training and competition may not be in sufficient quantities to elicit symptoms, since 
their “bucket” does not start out very full. Alternatively, if their habitual diet is already high in 
FODMAP, they may already have high enough levels to elicit symptoms or the additional 
FODMAP from sports nutrition products could tip the scales.  
This research demonstrated that, in general, endurance athletes’ habitual diets are high in 
FODMAP and consumption of foods high in each FODMAP type is common. Limited 
application of the relatively new CNAQ and no previous research detailing the individual 
FODMAP intakes of more than one athlete make comparisons difficult for this present work. 
FODMAP intake appears to be consistent with the high levels in habitual diets of the general 
population and other studies of athletes (Staudacher et al. 2012; Halmos et al. 2014; Lis et al. 
2016b, 2018; O’Keeffe et al. 2018). The total daily FODMAP level seen here (26.1g) was 




in a study of the effects of a low FODMAP diet on IBS symptoms (Halmos et al. 2014). It was 
also similar to the habitual diet FODMAP intakes (29.4g and 29.6g) in studies on long-term low 
FODMAP diet effectiveness (O’Keeffe et al. 2018) and effects on microbiota in patients with 
IBS (Staudacher et al. 2012), respectively. Additionally, it is above the high FODMAP diet 
intake cut off (20g) used to qualify participants in a study of low FODMAP diet effectiveness for 
athletes. In a recent study of the effects of a 6-day low FODMAP diet on exercise-related GI 
symptoms in recreational runners, average habitual FODMAP intake was 28.04g, although it is 
unclear how the habitual diet was analyzed for FODMAPs in this case (Wiffin et al. 2019). 
Furthermore, the percentage of athletes consuming products of each FODMAP type at least once 
a week was generally three-fold higher than those who went back to consuming a “habitual” diet 
in the study of long-term low FODMAP diet effectiveness, which also used the CNAQ to 
measure FODMAP intake (O’Keeffe et al. 2018). This indicates that while athletes are not 
necessarily consuming diets higher in overall FODMAP content, more athletes appear to 
commonly consume foods that are high in individual FODMAPs.  
 The lactose intake of endurance athletes was higher than all other FODMAPs in this 
study. In fact, lactose accounted for approximately half of the total FODMAP intake, which was 
also seen in other studies of habitual intakes (Halmos et al. 2014; O’Keeffe et al. 2018). There 
was also a wide range of lactose intakes among athletes. In a case study of a symptomatic 
endurance athlete who was placed on a low FODMAP diet, Lis et al. (2016b) discussed why 
dairy consumption may be higher among athletes; however, lactose-containing foods were also 
the most commonly restricted by athletes to help improve GI symptoms (Lis et al. 2016a). 
Lactose intakes were not significantly different between those without or without symptoms at 




who have GI trouble due to lactose are already restricting this FODMAP and those that do not 
have a problem are able to consume higher quantities (Lis et al. 2016a). None of the sports 
nutrition products tested contained lactose. 
Over two-thirds of oligosaccharide consumption was as fructooligosaccharides or 
fructans, which is consistent with common consumption of the high fructan-containing foods 
during dinners and breakfasts reported on the EAQ. Additionally, 15 of the 16 products tested 
contained some level of fructans and five contained some level of GOS. Importantly, the most 
common sports nutrition beverage, both bars, and the gummy all tested high in oligosaccharides. 
The source of these FODMAPs is clear in some cases (soy or wheat ingredients), but less so in 
others (potentially gums or maltodextrins) (Monash University Department of Gastroenterology 
2015). Comparison of dichotomized symptom presence showed that total oligosaccharide, 
fructan, and GOS intakes were higher in athletes experiencing constipation during training or 
competition, with raffinose intakes greater during the former and stachyose during the latter. 
Stachyose intakes were also higher among athletes experiencing constipation at rest, and diarrhea 
during training. This indicates that high habitual intakes, coupled with high levels of these 
FODMAPs in popular sports nutrition products, could be contributing to symptoms. 
 Foods high in excess fructose were also commonly consumed by athletes. There were no 
statistically significant differences in excess fructose intakes between athletes experiencing or 
not experiencing symptoms at various time points. However, the top two most commonly 
reported gels (Gel1 and Gel2A) and the second most reported sports drink/thirst quencher (Bev2) 
were high in excess fructose. These products were not included in the CNAQ assessment, and 
may help to explain some of the relationships seen between increased frequency of more severe 




in these products is likely coming from ingredients such as fructose, honey, apple juice (in a Gel 
3B which contained excess fructose but was not high in one serving), and high fructose corn 
syrup (Monash University Department of Gastroenterology 2015).  
 Polyol intake had the lowest habitual consumption of the FODMAP categories, but 
higher intakes were found in those experiencing constipation at rest (mannitol), defecation 
during training (mannitol and total polyols), and constipation during training and competition 
(mannitol, sorbitol, and total polyols). Mannitol is a sugar alcohol that commonly occurs in fruits 
and vegetables such as button mushrooms, cauliflower, snow peas, sweet potatoes, and 
watermelon (Muir et al. 2009). This highlights a complex issue for athletes in relation to 
FODMAPs in their habitual diets, since FODMAPs such as mannitol are found in many whole 
foods. Individuals who exercise frequently also tend to engage in other health-related behaviors 
including eating a healthful diet (Glanz et al. 1998; Birkenhead and Slater 2015), which typically 
includes foods such as fruits, vegetables, whole grains, and low fat dairy. Furthermore, over 15% 
of endurance athletes reported following either vegan or vegetarian diets on the EAQ. These 
diets have the potential to be high in FODMAP, but by selecting specific foods and using certain 
processing techniques (cooking and straining, pickling, etc.), a vegetarian or vegan diet can still 
be low FODMAP (Tuck et al. 2018). Only three of the tested sports nutrition products contained 
mannitol (two at very low levels; 0.01g/serving) and none contained sorbitol, so it appears that 
consumption of these potentially problematic FODMAPs can easily be avoiding during exercise. 
When lactose was excluded from the overall FODMAP intake cut off of ≤12g, some 
significant differences were seen in symptomology between low and high FODMAP habitual 
diets, including defecation during training and bloating after training and competition. This 




intake of ≤12g and support this cut-off level of total FODMAP (Barrett et al. 2010; Ong et al. 
2010; Halmos et al. 2014; Harvie et al. 2017; Staudacher et al. 2017; Tuck and Vanner 2018). 
The cut-off was analyzed both including and excluding lactose due to habitually high lactose 
levels in this population and the likelihood that athletes sensitive to lactose are already excluding 
this FODMAP, as explained above and evidenced by the variable intakes found in this study (Lis 
et al. 2016a, 2016b, 2018).  
 
5.5.3 Limitations 
 While this study demonstrated the potential for FODMAPs to be playing a role in the GI 
symptoms of endurance athletes due to high usage rates and some relationships with symptoms, 
there are a few limitations. When a low FODMAP diet is implemented in a patient with GI 
symptoms such as with IBS, it is not intended as a long-term diet. Initially, all FODMAPs are 
restricted and then categories of FODMAPs are reintroduced to find individual sensitivities and 
thresholds which are unique to each person (Lomer 2015; Tuck and Barrett 2017). That person 
can then safely consume the FODMAPs that do not cause symptoms while continuing to limit 
the ones that do. This highly individualized nature of FODMAPs makes drawing generalized 
relationships between foods or intakes and symptoms tenuous. It is also currently unknown if or 
how the stressors of exercise affect the proposed cutoff level of 12g (Tuck and Vanner 2018). It 
is possible that those with exercise-induced GI symptoms experience a lowering of their 
thresholds due to physiological changes that occur during exercise, particularly in the lower GI 
(Costa et al. 2017b).  
 Additional limitations were with the CNAQ portion of this study. Due to the nature of the 




FODMAP and with or without symptoms). While a larger sample size may find additional 
relationships between FODMAPs and symptoms, there are many reasons why such associations 
may not appear, mainly due to the individual susceptibilities and thresholds mentioned 
previously in the bucket concept.  A linear relationship between intakes and symptoms would not 
be expected and it is possible that those with high intakes of certain FODMAPs have found that 
they can safely consume such amounts. Additionally, it was necessary for athletes completing 
the CNAQ to have also previously completed the EAQ, and that limited the pool of potential 
athletes. The CNAQ was also validated for use in a healthy, Australian population and not U.S. 
endurance athletes. The gender and age demographics are similar between the validation 
population and this study; however, the participating endurance athletes had higher incomes and 
potentially more education, although differences in demographic collection made direct 
comparisons difficult.  
 A final limitation was due to all data being collected via online questionnaires, which has 
inherent limitations as discussed in previous work with the EAQ (Killian et al. 2018; Chapter 4: 
Section 4.5.6). Of the 234 athletes who qualified to participate, 80 completed the CNAQ and it is 
unclear what factors led to final participation. The demographics of the athletes who completed 
the CNAQ are similar to those who completed the EAQ, although the proportion of athletes with 
diagnosed or undiagnosed IBS was greater among those completing the CNAQ (19.2% 
compared to 9.8%). 
 
5.5.4 Practical Applications 
 The questionnaires (EAQ and CNAQ), in conjunction with the FODMAP analysis data, 




areas within athletes’ diets where consumption of FODMAP is particularly high or specific 
FODMAP types that are consumed at high levels. This approach exploits the individualized 
nature of FODMAP sensitivities discussed previously and could be a preliminary approach to 
FODMAP reduction by athletes. Traditionally, a low FODMAP diet intervention involves a strict 
exclusion diet for a period of at least 4 weeks, followed by gradual re-challenge or reintroduction 
of small amounts of different FODMAP groups (Lomer 2015; Tuck and Barrett 2017). This 
restrictive period may be difficult for athletes who want to continue training during this time if 
calories and other nutrients are not sufficiently replaced. Alternatively, athletes could first try the 
so-called bottom-up approach (Halmos 2017), which involves cutting back on certain FODMAPs 
that they are consuming at high levels. This could be achieved by focusing on habitual foods but 
also specifically by changing their nutrition surrounding exercise to lower FODMAP options. 
Furthermore, athletes who already have experience with FODMAPs and know their specific 
sensitivities can utilize the sports nutrition product information to inform their fueling choices. 
Caution should be taken when selecting different products to use, since ingredient lists are not 
always accurately predictive of FODMAP content (Varney et al. 2017). 
 
5.6 Conclusions 
 While this study highlighted some of the relationships between nutrition product types or 
FODMAP intakes and lower GI symptoms, the key finding was the overall high FODMAP 
intake levels by endurance athletes, both habitually and surrounding exercise. This was 
emphasized by the high FODMAP pre-race food choices and the high levels found in many 
popular sports nutrition products. This is particularly true of the sports nutrition products when 




when the recommended carbohydrate intake is 30-90g/hour (Thomas et al. 2016). The 
FODMAPs in these products are added on to high habitual levels reported on the CNAQ. While 
more work is needed to directly relate low FODMAP nutrition interventions with symptom 
reduction in this population, these findings provide further evidence for the potential of low 
FODMAP interventions to help mitigate GI symptoms of endurance athletes, with targets of 





































5.7 Tables and Figures 
 
Table 5.1. Sports nutrition products analyzed for FODMAP content with specific flavor and 
product ingredients. Sports drink/thirst quenchers are abbreviated with Bev (for beverage), solids 
with either Bar or Waf (for waffle), and gel/gummies with either Gel or Gum (for gummy). 





      Bev1 lemon-lime water, sugar, dextrose, citric acid, salt, sodium citrate, monopotassium 
phosphate, gum arabic, glycerol ester of rosin, natural flavor, yellow 5 
 
      Bev2 berry water, high fructose corn syrup, less than 0.5% of: citric acid, salt and 
magnesium chloride and calcium chloride and mono-potassium 
phosphate (electrolyte sources), natural flavors, modified food starch, 
calcium disodium EDTA (to protest color), medium chain 
triglycerides, sucrose acetate isobutyrate, vitamin B3 (niacinamide), 
vitamin B6 (pyridoxine hydrochloride), vitamin B12, Blue 1 
 
      Bev3 lemon-lime sodium (bicarbonate and carbonate), potassium (bicarbonate), 
magnesium (sulfate), calcium (carbonate), vitamin c (as ascorbic acid), 
citric acid, dextrose (d-glucose), natural flavors, monk fruit extract, 
stevia leaf extract, avocado oil, riboflavin (for color) 
 
      Bev4 unflavored dextrose (glucose), sucrose, citric acid, sodium citrate, sea salt, organic 
flavor, potassium chloride, magnesium citrate, calcium carbonate 
 
      Bev5 lemon-lime cane sugar, dextrose, sodium citrate, citric acid, magnesium lactate, 
calcium citrate, potassium citrate, lemon oil, lime oil, lemon juice, lime 
juice, ascorbic acid (vitamin C) 
Solid   




organic brown rice syrup, organic rolled oats, soy protein isolate, 
organic cane syrup, organic roasted soybeans, rice flour, macadamia 
nuts, organic cane sugar, organic oat fiber, organic soy flour, cocoa 
butter, organic high oleic sunflower oil, natural flavors, organic cocoa 
butter, sea salt, soy flour, barley malt extract, soy lecithin, mixed 
tocopherols (antioxidant), dicalcium phosphate, magnesium oxide, 
ascorbic acid (vit C), DL-alpha tocopheryl acetate (vit E), beta carotene 
(vit A), niacinamide (vit B3), ergocalciferol (vit D2), thiamine 
mononitrate (vit B1), pyridoxine hydrochloride (vit B6), riboflavin (vit 
B2), cyanocobalamin (vit B12) 
 
      Waf1 honey organic wheat flour, organic palm fruit oil, organic rice syrup, organic 
can sugar, organic honey, organic whole wheat flour, organic soy flour, 
sea salt, soy lecithin, organic spices, baking soda 
 
      Bar2 salted 
caramel 
brown rice syrup, gluten-free oats, cashew butter, brown rice flour, 
honey, salted caramel toffee pieces (cane sugar, butter, sea salt, soy 
lecithin, citric acid), peanuts, rice protein, crisp rice (rice flour, sugar, 





Table 5.1 cont. 
Products Flavor Ingredients 
      Waf2 salted 
caramel 
gluten free flour blend (organic rice flour, organic potato starch, 
organic tapioca flour), organic palm fruit oil, organic brown rice 
syrup, organic cane sugar, organic eggs, organic soy flour, sea salt, 
organic honey, natural flavor, xanthan gum, baking soda, soy lecithin 
Gel/Gummies   
      Gel1 vanilla maltodextrin, water, fructose, l-leucine, potassium citrate, sodium 
citrate, citric acid, calcium carbonate, l-valine, sea salt, natural flavor, 
green tea (leaf) extract (contains caffeine), gellan gum, l-isoleucine, 
sunflower oil, sodium benzoate (preservative), potassium sorbate 
(preservative) 
 
      Gel2A honey honey, water, potassium citrate, salt, niacinamide (vit B3), calcium 
pantothenate (vit B5), pyridoxine hydrochloride (vit B6), riboflavin 
(vit B2), thiamine monocitrate (vit B1), cyanocobalamin (vit B12) 
 
      Gel2B vanilla organic tapioca syrup, organic honey, water, potassium citrate, organic 
vanilla flavor, citric acid, salt 
 
      Gel3A vanilla maltodextrin, water, energy smart ® (grape juice, rice dextrin), vanilla 
extract, cultured dextrose, citric acid, potassium chloride, salt, l-
leucine, l-alanine, l-valine, l-isoleucine 
 
      Gel3B apple 
cinnamon  
maltodextrin, water, apple juice concentrate, energy smart ® (grape 
juice, rice dextrin), cultured dextrose, cinnamon, ascorbic acid, vanilla 
extract, malic acid, potassium carbonate, salt, l-leucine, l-alanine, l-
valine, l-isoleucine 
 
      Gel4 vanilla organic maltodextrin, organic dried cane syrup, water, natural flavor, 
sea salt, potassium citrate 
 
      Gum1 citrus organic tapioca syrup, organic dried cane syrup, organic maltodextrin, 
pectin, citric acid, potassium citrate, natural flavor, sea salt, organic 


















Table 5.2. Comprehensive Nutrition Assessment Questionnaire (CNAQ) endurance athlete 
participant demographics (n = 73). 
Characteristic n % 
Gender     
      Male 31 42.5 
      Female 42 57.5 
Age   
      18-29 17 23.3 
      30-39 23 31.5 
      40-49 18 24.7 
      50-59 12 16.4 
      60+ 3 4.1 
Ethnicity   
      American Indian or Alaskan Native 1 1.4 
      Black/African American 1 1.4 
      Caucasian 66 90.4 
      Hispanic/Latino 1 1.4 
      > 1 Ethnicity 4 5.5 
Competition Level   
      Beginner/amateur/casual 36 49.3 
      Competitive age-grouper 35 47.9 
      Elite/professional 2 2.7 
Lifetime Competition Participation   
      Marathon 59 80.8 
      Ultra-marathon 23 31.5 
      Half-distance triathlon 40 54.8 
      Full-distance triathlon 25 34.2 
BMI Category   
      Underweight (<18.5) 2 2.7 
      Normal (18.5-24.9) 57 78.1 
      Overweight (25-29.9) 13 17.8 
IBS Classification*   
     Non-IBS 59 80.8 
     IBS 14 19.2 















Table 5.3. Associations of nutrition product category consumption frequency with more 











GI cramps/pain Before training During training Always < All others† 
 Urge to 
defecate 




Diarrhea Before training 2hrs after 
training 
Rarely > Never 
Solid food GI cramps/pain Before training During training Often > Never 
 GI cramps/pain During training During training Always < All others† 
 Urge to 
defecate 
Before competition 2hrs after 
competition 
Sometimes > Never 
 Defecation Before competition 2hrs after 
competition 
All others > Never 
Gel/gummy GI cramps/pain Before training During training Always < Sometimes† 
 Urge to 
defecate 
During training During training Sometimes > Never 
 Urge to 
defecate 
During training 2hrs after 
training 
Sometimes, Often, & 
Always > Never 
 Defecation During training 2hrs after 
training 
Sometimes, Often, & 
Always > Never 
 Urge to 
defecate 
During competition During 
competition 







Before training 2hrs after 
training 
Always > Never 
 GI 
cramps/pains 
During training 2hrs after 
training 
Rarely > Never 
 GI 
cramps/pains 
Before competition During 
competition 
Sometimes > Never 
 Defecation Before competition During 
competition 
Sometimes > Never 
 GI cramps/pain Before competition 2hrs after 
competition 
Sometimes > Never 
 GI cramps/pain During competition 2hrs after 
competition 
Rarely > Never 
*Relationships shown are product consumption frequencies based on Kruskal-Wallis H test with 
post hoc pairwise comparisons using Dunn’s procedure and Bonferroni correction comparing 
mean ranks. A < B means the mean rank of A was less than the mean rank of B. A > B means the 
mean rank of A was greater than mean rank of B. Details of relationships are shown in Appendix 
J Supplementary Tables S5.1-S5.8. 











Lactose Fructose Glucose Excess 
fructose 











     g per serving (355mL) 
0.39 0.00 0.00 4.37 4.89 0.00 0.00 0.00 0.00 0.39 High 1 
Bev2 
     g per serving (360mL) 
0.03 0.00 0.00 5.71 3.58 2.14 0.00 0.00 0.00 2.16 High 1 
Bev3† 
     g per serving (5.2g) 
0.00 0.00 0.00 0.00 0.35 0.00 0.00 0.00 0.00 0.00 Low - 
Bev4† 
     g per serving (27g) 
0.07 0.00 0.00 0.00 10.66 0.00 0.00 0.00 0.00 0.07 Low 3 
Bev5† 
     g per serving (22g) 
0.04 0.00 0.00 0.06 1.08 0.00 0.00 0.00 0.00 0.02 Low 5 
Bar1 
     g per serving (68g) 
0.16 0.06 0.00 0.63 4.77 0.00 0.01 0.00 0.01 0.23 High 1 
Waf1 
     g per serving (30g) 
0.13 0.00 0.00 0.36 1.63 0.00 0.00 0.00 0.00 0.13 Low 2 
Bar2 
     g per serving (49g) 
0.40 0.11 0.00 0.84 3.99 0.00 0.12 0.00 0.12 0.62 High 1 
Waf2 
     g per serving (30g) 
0.06 0.00 0.00 0.06 1.15 0.00 0.00 0.00 0.00 0.06 Low 4 
Gel1 
     g per serving (32g) 
0.03 0.12 0.00 4.82 0.12 4.71 0.00 0.00 0.00 4.85 High 1 
Gel2A 
     g per serving (34g) 
0.14 0.00 0.00 6.67 5.64 1.04 0.00 0.00 0.00 1.18 High 1 
Gel2B 
     g per serving (32g) 
0.05 0.00 0.00 0.26 3.08 0.00 0.00 0.00 0.00 0.05 Low 4 
Gel3A 
     g per serving (33g) 
0.04 0.11 0.00 0.07 0.24 0.00 0.00 0.00 0.00 0.16 Low 2 
Gel3B 
     g per serving (33g) 
0.03 0.00 0.00 0.28 0.25 0.03 0.01 0.00 0.01 0.06 Low 5 
Gel4 
     g per serving (34g) 
0.03 0.00 0.00 0.03 0.12 0.00 0.00 0.00 0.00 0.03 Low 7 
Gum1 
     g per serving (30g) 
0.10 0.13 0.00 0.19 0.56 0.00 0.00 0.00 0.00 0.23 High 1 
*GOS: galacto-oligosaccharides 




Table 5.5. Habitual FODMAP intakes of endurance athletes (n=73). 
 Daily Intake (g) 
Specific FODMAP Mean±SD Min Max Median 
(IQR)* 
Total Oligosaccharides 4.4±2.3 1.0 11.5 3.8 (3.0) 
     Fructooligosaccharides 3.0±1.5 0.6 6.7 2.8 (1.8) 
     Galacto-oligosaccharides 1.4±1.1 0.1 5.8 1.1 (1.2) 
          Raffinose 0.6±0.5 0.0 2.4 0.5 (0.7) 
          Stachyose 1.2±1.0 0.0 5.3 0.9 (0.8) 
Lactose 13.5±13.8 0.0 80.1 11.4 (13.1) 
Excess Fructose 5.0±6.6 0.2 34.0 2.9 (3.9) 
Total Polyols 3.3±2.4 0.5 14.9 2.5 (3.3) 
     Mannitol 0.9±0.8 0.1 5.4 0.8 (0.8) 
     Sorbitol 2.4±2.0 0.2 9.8 1.9 (2.5) 
Total FODMAP 26.1±15.9 3.0 100.9 23.0 (18.9) 
Total FODMAP (not lactose) 12.7±9.2 2.9 54.6 11.5 (8.5) 
*Median listed for comparison to Mann-Whitney U statistic results of intake differences between 




Table 5.6. Percentage of endurance athletes (n=73) consuming high FODMAP foods at least 
once a week. 
Specific FODMAP Consumed at least once a 











Table 5.7. Significant differences in median FODMAP intakes between individual symptom presence categories. 






U* z p 
Constipation during rest Stachyose 0.8 (63) 1.3 (9) 434.0 2.569 0.010 
 Mannitol 0.8 (63) 1.3 (9) 402.5 2.030 0.042 
Defecation during training Total Polyols 2.4 (52) 4.9 (20) 693.5 2.182 0.029 
 Mannitol 0.8 (52) 1.1 (20) 676.0 1.965 0.049 
Diarrhea during training Stachyose 0.8 (57) 1.2 (15) 599.0 2.384 0.017 
Constipation during training Total Oligosaccharides 3.5 (65) 7.7 (6) 324.5 2.678 0.007 
 Fructooligosaccharides 2.7 (65) 5.3 (6) 336.5 2.927 0.002 
 Galacto-oligosaccharides 1.0 (65) 2.8 (6) 316.0 2.505 0.010 
 Raffinose 0.4 (65) 1.1 (6) 305.5 2.296 0.019 
 Stachyose 0.9 (65) 2.3 (6) 340.5 3.016 0.001 
 Total Polyols 2.4 (65) 5.7 (6) 323.5 2.657 0.006 
 Mannitol 0.7 (65) 1.5 (6) 314.5 2.476 0.011 
 Sorbitol 1.7 (65) 1.5 (6) 308.5 2.348 0.016 
Constipation during competition Total Oligosaccharides 3.5 (65) 8.3 (5) 265.5 2.350 0.015 
 Fructooligosaccharides 2.7 (65) 5.3 (5) 273.0 2.521 0.009 
 Galacto-oligosaccharides 1.0 (65) 3.0 (5) 264.5 2.330 0.017 
 Stachyose 0.9 (65) 2.3 (5) 295.0 3.030 0.001 
 Total Polyols 2.4 (65) 5.7 (5) 279.5 2.669 0.005 
 Mannitol 0.7 (65) 1.6 (5) 261.0 2.251 0.022 














Figure 5.2. Median consumption frequency of nutrition product categories at various time points 
surrounding exercise. Product categories include water (solid dark gray), sports drink/thirst 
quencher (light gray with polka dot), sports drink/energy drink (light gray diagonal stripe), solid 
foods (black with white rectangles), gel/gummy (solid light gray), homemade product (black 
diagonal stripe). Different lowercase letters represent statistically significantly different median 
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Figure 5.3. Top 5 products in each nutrition category by percentage of total endurance athletes 
(n = 430) reporting product use during competition. Code names correspond to products in Table 
1. Sports drink/thirst quenchers are abbreviated with Bev (for beverage), solids with either Bar or 
Waf (for sports waffle), and gel/gummies with either Gel or Gum (for gummy). Additional 
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CHAPTER 6: SENSORY ACCEPTANCE AND AVAILABILITY OF HIGH AND LOW 
FODMAP SPORTS NUTRITION PRODUCTS BY ENDURANCE ATHLETES 
 
6.1 Abstract 
 Lower gastrointestinal symptoms similar to those of irritable bowel syndrome are 
common among endurance athletes. Restriction of fermentable oligosaccharides, disaccharides, 
monosaccharides, and polyols (FODMAP) has been shown to reduce symptoms in irritable 
bowel syndrome sufferers and has recently been applied to athletes exhibiting symptoms during 
exercise with preliminary promise. It therefore becomes necessary to understand key factors 
surrounding sports nutrition product selection by endurance athletes in conjunction with 
FODMAP content, should athletes decide to use low FODMAP nutritional strategies during 
exercise. The primary objective of this study was to determine the sensory acceptance of 
common sports nutrition products by endurance athletes in relation to FODMAP content. 
Availability at popular endurance races and major online retailers and price points were also 
examined. Consumer acceptance of four gel and four solid products was evaluated by endurance 
athletes (n = 90). The overall liking, assessed using a 9-point scale, was higher for gels and bars 
with lower FODMAP content, although cluster analysis indicated that this trend was not true for 
all panelists. Gels available at aid stations of popular endurance races were a mix of low, high, 
and unknown FODMAP contents while the solids tested in this study were rarely available. 
Products were generally available at online retailers with little difference in price. Overall, this 
research demonstrates that acceptable low FODMAP gel and solid sports nutrition products are 
available and accessible on today’s market, although athletes desiring to use these products may 





 Gastrointestinal (GI) symptoms during exercise are common among endurance athletes 
and can impact both training and competition (Rehrer et al. 1989, 1992b, 1992a; Brouns and 
Beckers 1993; Peters et al. 1999; ter Steege et al. 2008; de Oliveira and Burini 2009; Wright et 
al. 2009; Ho 2009; Jeukendrup 2011; Pfeiffer et al. 2012; de Oliveira et al. 2014; Chapter 4: 
Table 4.2, Table 4.4, Section 4.4.2). Common lower GI symptoms such as bloating, cramping, 
and diarrhea are similar to those characteristic of irritable bowel syndrome (IBS), a functional 
gastrointestinal disorder (Keeffe et al. 1984; Drossman et al. 2002; Hungin et al. 2005; 
Longstreth et al. 2006; Chey et al. 2015). Recent research has shown that IBS is underdiagnosed 
among endurance athletes, as in the general population, with 7.0% meeting Rome III IBS 
diagnostic criteria but only 2.8% who had been previously diagnosed (Hungin et al. 2005; 
Chapter 4: Table 4.2).  Additional athletes that did not meet diagnostic criteria exhibited 
symptoms that could still prove problematic during exercise. These athletes demonstrated 
varying degrees of the recently introduced term “exercise-induced gastrointestinal syndrome” 
(Costa et al. 2017). 
 Nutritional interventions in individuals with IBS involving restriction of fermentable 
oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) have demonstrated 
symptom reduction in approximately 75% of patients (Staudacher et al. 2012; Halmos et al. 
2014; Tuck et al. 2014; Lomer 2015). Recently, this strategy has been applied to symptomatic 
athletes with some success (Lis et al. 2016, 2018; Gaskell and Costa 2019; Wiffin et al. 2019). 
Case studies have shown symptom improvement in endurance athletes after following a low 
FODMAP diet (Lis et al. 2016; Gaskell and Costa 2019). Additionally, athletes in a small 




FODMAP intervention, although exercise bouts were likely not long enough to elicit the more 
problematic symptoms experienced by endurance athletes (Lis et al. 2018). A second randomized 
crossover study of recreationally active runners showed decreased IBS symptom severity scores 
(IBS-SSS) with a 7-day low FODMAP diet under free-living conditions, as well as increased 
perceived habitual exercise frequency and intensity (Wiffin et al. 2019). However, there was no 
difference in exercise duration or any information given about how long/far these runners were 
exercising, so applicability to an endurance athlete population is tenuous. 
 The low FODMAP approach lends itself well to application in the endurance athlete 
population as athletes consume carbohydrates for energy and performance enhancement benefits, 
especially prior to and during long exercise bouts (Jeukendrup 2008). A recent analysis of the 
FODMAP content of endurance athlete diets showed high habitual levels that correlated to 
various GI symptoms (Chapter 5: Sections 5.4 and 5.5.2). Athletes also commonly reported 
consuming high FODMAP foods during the dinners and breakfasts prior to competition and 
many of the popular sports nutrition products were found to be high in FODMAPs, particularly 
in the number of servings generally used by athletes in endurance events (Chapter 5: Sections 5.4 
and 5.5.1). 
 While more research needs to be done to further demonstrate the efficacy of low 
FODMAP interventions for symptom reduction in endurance athletes, specifically during 
exercise, the preliminary research in athletes and success in patients with IBS suggests promise 
in this area (Staudacher et al. 2012; Pedersen et al. 2014; Böhn et al. 2015; Eswaran et al. 2016; 
Lis et al. 2016, 2018; Gaskell and Costa 2019; Wiffin et al. 2019). Even without rigorous studies, 
low FODMAP foods are beginning to be recommended to symptomatic athletes by dietitians 




be starting to use this strategy in some form, especially in the lead up to key racing events (Lis et 
al. 2019). Some low FODMAP substitutions for regular diet components are fairly 
straightforward; however, selecting low FODMAP sports nutrition products is a little more 
complex. As a result, it becomes important to examine some key factors in the use of sports 
nutrition products by endurance athletes in relation to their FODMAP content in order to 
facilitate the use of low FODMAP products, if desired. 
 Taste is generally considered a major factor in food product choice by the general 
population (Clark 1998; Glanz et al. 1998; Eertmans et al. 2001; Birkenhead and Slater 2015). In 
athletes, this factor is often moderated by health and performance related aspects of food 
products (Robins and Hetherington 2005; Lamont et al. 2012; Newland et al. 2012; Birkenhead 
and Slater 2015; Pelly et al. 2018); however, it is still an important factor and a product must be 
reasonably well liked for an athlete to choose to use it during training or competition. Therefore, 
the primary objective of this study was to determine the sensory acceptance of common sports 
nutrition products by endurance athletes in relation to their FODMAP content. Due to the high 
prevalence of GI symptoms among endurance athletes and the popularity of high FODMAP 
sports nutrition products (Chapter 5: Table 5.4), it was hypothesized that product acceptability 
would be higher for products with higher FODMAP content. If the higher FODMAP options 
were significantly more accepted, this would have implications for athletes, as they may need to 
sacrifice taste for GI comfort, and for the food industry who may want to consider reformulations 
or new product development.  
 Another key factor in food choice is availability (Bellisle 1999; Eertmans et al. 2001). 
Taste can only be a driving factor in product selection if that product is available to a consumer 




lower FODMAP content if these products are not accessible. Thus, the secondary objective of 
this study was to assess the accessibility of high and low FODMAP sports nutrition products. 
This was primarily done in the context of availability or provision at the most popular endurance 
races in the U.S., as the majority of athletes reported using race-provided foods and beverages 
during a race (Chapter 5: Section 5.4). Product prices and availability at top online retailers were 
also examined to determine accessibility for use during training or self-provision at races. For the 
same reasons as with sensory acceptance, it was hypothesized that high FODMAP products are 
more accessible and have lower price points.  
  
6.3 Materials and Methods 
6.3.1 Product Selection 
 Four energy gels and four solid sports nutrition products were selected for sensory 
analysis. Selection was based on the most commonly reported brands from a nationwide 
implementation of the Endurance Athlete Questionnaire (EAQ) which assessed nutrition habits 
of endurance athletes (Chapter 5: Figure 5.3). The top four energy gel brands were chosen in a 
common vanilla flavor. The top three solid, commercial sports nutrition products consisted of 
two bars and one sports waffle. A second, lower FODMAP waffle was used for comparison. 
There was no common flavor across all four products, so product selection was based on brand 
report of the most popular flavor while keeping the flavor similar and non-polarizing. Product 
flavors and ingredients are displayed in Table 6.1. All products were analyzed for their 
FODMAP content, as reported previously (Chapter 5: Figure 5.4). The popularity of each 




classification, and the number of servings after which the product becomes high FODMAP are 
shown in Table 6.2. 
  
6.3.2 Sensory Acceptance 
6.3.2.1 Panelists 
 All recruitment and testing methods were performed with prior approval by the 
University of Illinois Institutional Review Board (IRB #18730). Panelists were recruited from 
the pre-race expo at the 2018 Illinois Marathon. Athletes who had completed or would complete 
a marathon, ultramarathon, half-distance triathlon, or full-distance triathlon within 2018, were 18 
years of age or older, and had no known food allergies qualified for participation. Electronic 
flyers were sent out prior to the expo as part of athlete’s race packets and researchers had a booth 
at the expo to explain the test and recruit further. Panelists were compensated for their time. A 
total of 90 panelists completed the test, with demographic characteristics displayed in Table 6.3. 
  
6.3.2.2 Testing Method 
 Panelists began the test by reading and signing a consent form. The ballot was primarily 
completed electronically via Qualtrics (Qualtrics, Provo, UT) with athletes either texting to 
receive a link or using provided tablets. Hard copy ballots were also available for use if technical 
issues were encountered. Panelists first completed a preliminary screener to ensure that they fit 
the qualifying criteria. The first set of samples evaluated was the four gel samples. Gels were 
repackaged and provided in opaque, foil laminated, tip style pouches with a tear notch (IMPAK 
Corporation, Los Angeles, CA), similar to typical energy gel packaging (Figure 6.1a). Gels were 




were instructed to match the sample code to that on the ballot. All samples were first evaluated 
for overall liking, with panelists instructed to save enough sample to taste again.  Rating was 
done on a 9-point hedonic scale with end anchors of “1=dislike extremely” and “9=like 
extremely” and a central anchor of “5=neither like nor dislike.” Samples were then individually 
rated for flavor, sweetness, and mouthfeel. Panelists were instructed to follow a rinse protocol of 
warm water, carbonated water, and room temperature water before and in between all samples 
and to expectorate all samples and rinses.  
 Panelists received a five-minute break in between sample sets. The second sample set 
was the four solids which were served in 162.7mL plastic cups labeled with three-digit codes 
(Figure 6.1b). The rectangular bars were cut into approximately 2.5cm by 3.8cm pieces and the 
circular waffles were cut in half. The rating procedure and rinses were the same as with the gels. 
Next, panelists answered a portion of the EAQ (Killian et al. 2018), which included questions on 
race participation, level of competitor, everyday diet followed, GI symptoms at rest and 
surrounding exercise, GI-specific diagnoses, and general demographics. 
 
6.3.2.3 Statistical Analysis 
 Qualtrics ballot data were exported into Microsoft Excel and any paper ballot data were 
added. Data were primarily analyzed using IBM SPSS Statistics version 23 (IBM Corp., 
Armonk, NY) and P values less than 0.05 were considered significant for all tests. Differences in 
overall liking as well as flavor, sweetness, and mouthfeel liking scores were determined using 
analysis of variance (ANOVA). Fisher’s least significant difference (LSD) was used to identify 
differences between product pairs. FODMAP contents were converted to a standardized gram 




Hierarchical agglomerative cluster analysis was conducted on overall liking scores for gels and 
solids, separately. Chi-square tests of independence were conducted between clusters and 
demographic variables. Kruskal-Wallis H-tests were used to compare lower GI symptom 
frequency distributions across clusters.  
 
6.3.3 Availability Measures 
6.3.3.1 Race Provision  
 Since the popularity of the gel and solid products came from a 2016 implementation of 
the EAQ, popular races from 2016 were examined for the nutrition provided at aid stations at 
both the 2016 race and the most current race. The most current race was either one that occurred 
in 2018 (with information from the 2019 race not available yet), one that occurred in 2019 (with 
information from the 2020 race not available yet), or one set to occur in 2019 (with information 
available). The largest races data portal by runningusa.org was used to determine the top U.S. 
marathons in 2016 in terms of race finishers. There were 31 marathons listed in the top 100 
races. The largest U.S. ultramarathon races from 2016 were found using ultrarunning.com, and 
the top 38 ultramarathons (races with over 250 finishers) were used in this study. Triathlete.com 
and trifind.com were used to identify all full and half distance triathlon events in the U.S. in 
2016. Race websites and athlete/event guides were used to determine the types/brands of 
products available at aid stations during the events, specifically in the gel and solid categories. 
Figure 6.2 shows the number of races of each type in 2016, the number of races for which aid 
station nutrition information was found for 2016 or the current race, and the number of races for 





6.3.3.2 Price and Online Availability 
 Product price and availability was accessed by searching for each product at the top 
online retailers of Amazon.com and Walmart.com. A Google search for each product was also 
conducted and the lowest price and number of retailers selling the product was recorded. Product 
price data from the company website was also determined. All data were taken from searches 
conducted on March 28, 2019. 
 
6.4 Results and Discussion 
6.4.1 Panelist Demographics 
 The panelist demographics seen here were somewhat similar to that in our previous work 
in this population, with some key differences that are explainable by the test setting (Killian et al. 
2018; Chapter 4: Table 4.1) . There was a higher proportion of males in the current work; 
however, previous research in marathon statistics have shown greater male participation 
(Andersen and Nikolova 2019; Hanson et al. 2019). There were also larger proportions of 
panelists ages 18-29 and of Asian ethnicity. The marathon expo where the test took place was on 
a large college campus with a sizeable population of Asian students (both domestic and 
international) (Division of Management Information 2017; Illinois International Student & 
Scholar Services 2018). Finally, there were more athletes who had participated in marathons and 
less in triathlons, which was understandable given the recruitment from a marathon expo. 
 
6.4.2 Sensory Acceptance 
 Overall and attribute liking scores are shown in Tables 6.4 and 6.5 for gel and solid 




the lowest FODMAP content of those in their respective category. G4 had the lowest popularity 
in our previous study and S4 was the gluten-free version of the second most commonly used 
solid product, S2. The flavor and sweetness of G4 was liked more than that of other gels and S4 
was liked more in all specific attributes compared to the other solids. This indicates that while 
low FODMAP options are present in the market and well-liked by athletes, they may not be as 
commonly consumed.Athletes may make some sacrifices in taste for products with real or 
perceived health- or performance-related benefits (Lamont et al. 2012; Birkenhead and Slater 
2015), so there may be other aspects of the higher FODMAP gels (nutritional composition, 
nutrient/health claims, social influences, etc.) that result in them being more commonly used 
(Furst, T., Connors, M. Bisogni, C.A., Sobal, J., Falk 1996; Birkenhead and Slater 2015; Pelly et 
al. 2018).  
 When FODMAP content was converted to a standard serving size of 33g for gels and 30g 
for solids, both product categories showed the same trend in overall liking (Figures 6.3 and 6.4). 
As FODMAP content increased for both gels and solids, overall liking decreased. It is not 
hypothesized that panelists are able to sense the FODMAP content of a product and use this to 
influence their overall liking scores; however, this is an interesting relationship that further 
demonstrates that lower FODMAP products are well liked overall. 
 
6.4.3 Cluster Analysis 
 Hierarchical agglomerative cluster analysis resulted in three clusters of panelists for the 
overall liking scores of both gel and solid products. Average overall liking scores for each cluster 
are shown in Figures 6.5 and 6.6. Gel Cluster 1, the largest cluster (n=56), rated all samples 




G2 and G3 the most. Gel Cluster 2 rated all gels similarly and at a low level (around 3 on the 9-
point scale). This is in the “dislike” region of the scale. While panelists were not asked about 
their use of gels during exercise, it is possible that panelists in this cluster did not use gels 
frequently or did not like this particular flavor. Prior experience with a product has been shown 
to increase the acceptability (Pliner 1982; Capaldi 1992; Eertmans et al. 2001). This can be due 
to mere exposure or association with some sort of favorable post-ingestive consequence, i.e. the 
energy for exercise or a good performance (Pliner 1982; Rozin and Zellner 1985; Capaldi 1992; 
Eertmans et al. 2001). Athletes who habitually use some of these products may have rated them 
more favorably. Furthermore, the post-ingestive experience of nausea has been shown to lead to 
dislike of a food (Pelchat and Rozin 1982), so it is possible that Gel Cluster 2 panelists had a 
negative experience with similar products in the past. 
There were no statistically significant differences between gel clusters for gender, age, or 
frequency of interruption/prevention of training or competition. Kruskal-Wallis H tests were 
conducted to determine if there were differences in lower GI symptom frequencies between 
clusters, and there were statistically significantly different symptom frequencies between clusters 
for constipation during competition (2(2) = 8.782, p = 0.012), within 2 hours after competition 
(2(2) = 7.990, p = 0.018), and within 2 hours after training (2(2) = 7.172, p = 0.028). Symptom 
frequency distributions were not similar for all clusters, as assessed by visual inspection of 
boxplots, so values are reported in mean ranks. Gel Cluster 2 (58.12) experienced significantly 
more frequent constipation during competition than Gel Cluster 1 (43.63) (p = 0.024) and Gel 
Cluster 3 (40.08) (p = 0.020). Similarly, Gel Cluster 2 (58.56) experienced significantly more 
frequent constipation in the 2 hours after competition compared to both Gel Cluster 1 (43.66) (p 




significantly more frequent constipation in the 2 hours after training compared to Gel Cluster 3 
(37.75) (p = 0.025). These relationships are interesting given the overall low gel liking scores by 
Cluster 2 and our previously stated hypothesis that this could be due to less gel use. Sports gels, 
particularly those with a combination of glucose and fructose, have been shown to increase 
gastrointestinal discomfort and loose stools of runners (Burke et al. 2005; Pfeiffer et al. 2009). If 
Gel Cluster 2 panelists are not typically gel consumers, they may be encountering the opposite 
problem.  
Solid Clusters 1 and 2 had the same pattern of overall liking for the products, but liking 
scores for Solid Cluster 2 were consistently higher than those of Solid Cluster 1. Solid Cluster 3 
reversed this pattern, with higher liking of S3 and lower of S2; however, this cluster was the 
smallest of the three (n=16). There were no statistically significant differences between clusters 
for gender, age, interruption/prevention of training or competition, or any symptoms at rest, 
during training or competition, or two hours after training or competition. 
 
6.4.4 Race Availability 
Table 6.6 displays the percentage of races (for which gel or solid aid station nutrition 
information was found) providing the gels and solid products used in the sensory portion of this 
work. Gels available at marathon aid stations were primarily brands other than those used in this 
study that had been reported most often by athletes in our previous work (Chapter 5: Table 5.1 
and Figure 5.3). The FODMAP contents of these other brands are unknown. The high use of 
other brands was primarily due to one popular marathon race series using different branded 
products at both 2016 and current races. Data on gels at both the 2016 and the current race were 




products, two remained with the same gel brand in the current race, one switched from a 
discontinued gel brand to G1, and one switched between two other brands. The availability of 
G1, G2, and G4 was fairly even for current popular marathons; however, no marathons reported 
providing G3.  
Little data from 2016 ultramarathons were found for gels or solids, although G1 (high 
FODMAP) was provided at 3 of 4 races for which information was found. In the current 
ultramarathons, the primary gels provided were G1 and G3, which is in contrast to the lack of G3 
that was found at marathon races. In half and full distance triathlon events, over half of the 2016 
races provided low FODMAP product G4. This amount went down for the current triathlons, 
primarily due to the largest and most popular half and full distance triathlon company switching 
from providing G4 to G1 at their current races. This represents a major change from a lower 
FODMAP gel (high in 7 servings) to a high FODMAP gel, which has potential implications for 
athletes who commonly race in this popular series. Two other races switched from the 
discontinued brand to G1 and two from an unspecified brand to G1. Again, G3 was fairly 
common at triathlons, as in ultramarathons. While this product is low FODMAP in one serving, 
it becomes high FODMAP after only two gels.  
In general, the solids tested in this study were not commonly provided at aid stations of 
endurance races, with the exception of the 2016 half and full distance triathlons. There were 
fewer solid products served at marathon races, which are shorter in distance and duration than 
the other endurance events. The solids provided included bananas, oranges, candy, and salty 
snacks. Some solids were provided at ultramarathon events but S1 was only served at one current 
race. Ultramarathons had the widest selection of other solid foods, which included items such as 




extended durations and athletes are often required to check in at aid stations where they can 
sometimes have their own food available and can rest (Stuempfle et al. 2013). Solids in this 
study were more commonly provided at half and full distance triathlons, but these events also 
included other solids foods such as fruit and salty snacks. As with the gels, the largest and most 
popular half and full distance triathlon company switched from providing high FODMAP S1 to 
another brand not tested for FODMAP content at their current races.  
 
6.4.5 Price and Online Availability 
 Pricing and online availability information is shown in Table 6.7. All gel products had 
fairly similar price points. The lowest FODMAP option (G4) had the lowest price through 
company website, Amazon, Walmart, and Google Shopping. Product G3, which is low 
FODMAP in one serving but high thereafter, was not available at Amazon or Walmart and had 
less Google Shopping sellers. 
 The lowest FODMAP solid option (S4) was moderately priced. It was $0.17-0.25 more 
expensive than high FODMAP option S1, but was less than highest FODMAP option S3 and 
fairly comparable in price to S2, which was low FODMAP in one serving but high thereafter. 
Product S3 had the highest price point, sometimes over twice that of S1, and was not available at 
all online retailers included in this study. This price, combined with the generally lower liking 
scores other than by Solid Cluster 3 panelists, may partially explain why this product was only 








 This study has practical applications for endurance athletes who want to use low 
FODMAP nutritional strategies as a method for managing the GI symptoms they experience 
during exercise or are otherwise following a low FODMAP dietary lifestyle. Acceptable low 
FODMAP gel and solid products are currently available in the market at likely non-prohibitive 
price points and can be purchased online if not available at local retailers. While the low 
FODMAP gel (G4) was available at some current marathon, ultramarathon, and half and full 
distance triathlons, other gels with either high or unknown FODMAP contents were common as 
well. Considering 88.6% of endurance athletes previously reported using race provided 
foods/beverages (Chapter 5: Section 5.4), athletes wanting to use lower FODMAP options 
should consider using or carrying their own gels and solids, if needed.  
 
6.4.7 Limitations 
 The main limitation of this study was that liking of the sports nutrition products was 
measured only at rest. Previous studies have shown that exercise can change the hedonic value of 
products or basic taste solutions (Horio and Kawamura 1998; Lluch et al. 1998; Leshem et al. 
1999; Passe et al. 2000, 2004). This has been used in the past to encourage fluid intake during or 
after exercise by the use of beverage flavors with higher acceptability (Wilmore et al. 1998; 
Passe et al. 2000), but even less acceptable flavors improved acceptability with exercise and 
increased fluid intake compared to water (Passe et al. 2000). The assumption in this study was 
that liking at rest would influence an athlete’s food or beverage choice during exercise; however, 
liking of products may increase during exercise to the point where athletes would choose them 




 Although some of the panelists had also participated in ultramarathon and triathlon 
events, recruitment at a marathon event meant that the majority were marathoners. The 
demographics in this study were similar to those in our previous work (Killian et al. 2018), but 
future work could examine the sensory acceptability of these products in additional 
ultramarathoners or triathletes. 
 An additional limitation related to the solid products was the fact that there was no 
common flavor among all four products, as with the gels. Products were selected to be as similar 
as possible, with no polarizing flavors. Liking of flavor could have influenced the overall liking; 
however, both S3 and S4 were in a salted caramel flavor and the flavor of S4 was rated 
significantly higher than other solids while S3 had a significantly lower flavor rating than all 




 Overall, this study yielded results contrary to the initial hypotheses. Products with lower 
FODMAP content had higher overall liking scores in both the gel and solid product categories. 
In fact, when standardized for serving size, overall liking scores decreased with increasing 
FODMAP content. Cluster analysis of overall liking scores displayed that these trends were not 
true of all panelists, so while liking of low FODMAP products is still somewhat individualized, 
these results show that acceptable low FODMAP products are available in the market. Low 
FODMAP gels were available at some popular endurance races, although gels with higher or 
unknown FODMAP content tended to be more common, particularly at current races. The solids 




these or specific gel products may want to carry their own. Both the low FODMAP gels and 
solids used in this study were sold by major online retailers at costs comparable to other 
products. Athletes desiring to use low FODMAP nutritional strategies during exercise can utilize 





6.6 Tables and Figures 
Table 6.1. Ingredients in and flavor of gel and solid sports nutrition products used in sensory 
acceptance test. 
Products Flavor Ingredients 
Gels   
      G1 vanilla maltodextrin, water, fructose, l-leucine, potassium citrate, sodium 
citrate, citric acid, calcium carbonate, l-valine, sea salt, natural flavor, 
green tea (leaf) extract (contains caffeine), gellan gum, l-isoleucine, 
sunflower oil, sodium benzoate (preservative), potassium sorbate 
(preservative) 
 
      G2 vanilla organic tapioca syrup, organic honey, water, potassium citrate, 
organic vanilla flavor, citric acid, salt 
 
      G3 vanilla Maltodextrin, water, energy smart ® (grape juice, rice dextrin), 
vanilla extract, cultured dextrose, citric acid, potassium chloride, salt, 
l-leucine, l-alanine, l-valine, l-isoleucine 
 
      G4 vanilla organic maltodextrin, organic dried cane syrup, water, natural flavor, 
sea salt, potassium citrate 
Solids   




organic brown rice syrup, organic rolled oats, soy protein isolate, 
organic cane syrup, organic roasted soybeans, rice flour, macadamia 
nuts, organic cane sugar, organic oat fiber, organic soy flour, cocoa 
butter, organic high oleic sunflower oil, natural flavors, organic cocoa 
butter, sea salt, soy flour, barley malt extract, soy lecithin, mixed 
tocopherols (antioxidant), dicalcium phosphate, magnesium oxide, 
ascorbic acid (vit. C), DL-alpha tocopheryl acetate (vit E), beta 
carotene (vit A), niacinamide (vit B3), ergocalciferol (vit D2), 
thiamine mononitrate (vit B1), pyridoxine hydrochloride (vit B6), 
riboflavin (vit B2), cyanocobalamin (vit B12) 
 
      S2 honey organic wheat flour, organic palm fruit oil, organic rice syrup, organic 
can sugar, organic honey, organic whole wheat flour, organic soy 
flour, sea salt, soy lecithin, organic spices, baking soda 
 
      S3 salted 
caramel 
brown rice syrup, gluten-free oats, cashew butter, brown rice flour, 
honey, salted caramel toffee pieces (cane sugar, butter, sea salt, soy 
lecithin, citric acid), peanuts, rice protein, crisp rice (rice flour, sugar, 
salt, calcium carbonate), flaxseeds, natural flavors, sea salt 
 
      S4 salted 
caramel 
gluten free flour blend (organic rice flour, organic potato starch, 
organic tapioca flour), organic palm fruit oil, organic brown rice 
syrup, organic cane sugar, organic eggs, organic soy flour, sea salt, 







Table 6.2. Popularity and fermentable oligosaccharides, disaccharides, monosaccharides, and 













Gels      
     G1 38.1 32 4.85 High 1 
     G2 11.9 34 0.05 Low 4 
     G3 11.2 33 0.16 Low 2 
     G4 10.9 34 0.03 Low 7 
Solids      
     S1 14.0 68 0.23 High 1 
     S2 8.8 30 0.13 Low 2 
     S3 4.4 49 0.62 High 1 
     S4 N/A† 30 0.06 Low 4 
*Percentage of total endurance athletes (n=430) reporting use of each brand (Chapter 5: Figure 
5.3). 
































Table 6.3. Demographic characteristics of sensory participants 
Characteristic n % 
Gender     
      Male 55 61.1 
      Female 35 38.9 
Age   
      18-29 38 42.2 
      30-39 19 21.1 
      40-49 14 15.6 
      50-59 12 13.3 
      60+ 7 7.8 
Ethnicity   
      Asian 9 10.0 
      Black/African American 2 2.2 
      Caucasian 70 77.8 
      Hispanic/Latino 1 1.1 
      > 1 Ethnicity 6 6.7 
      Prefer not to say/Other 2 2.2 
Competition level   
      Beginner/amateur/casual 53 58.9 
      Competitive age-grouper 35 38.9 
      Elite/professional 2 2.2 
Lifetime event type participation   
      Marathon 85 94.4 
      Ultra-marathon 15 16.7 
      Half-distance triathlon 18 20.0 














G1 4.43b 4.02c 4.49b 5.08 
G2 5.49a 5.37b 4.98b 5.60 
G3 4.46b 4.04c 4.68b 5.09 
G4 5.82a 6.01a 5.88a 5.21 
*Average liking scores on a 9-point hedonic scale, anchored 9 = like extremely, 5 = neither like 
nor dislike, 1 = dislike extremely. 
†Different superscript letters in each column represent statistically significant pairwise 
















S1 6.42b 6.01b 5.96bc 6.04b 
S2 5.98bc 6.06b 6.24bc 6.13b 
S3 5.27c 5.01c 5.31c 4.97c 
S4 7.29a 7.23a 7.00a 7.38a 
*Average liking scores on a 9-point hedonic scale, anchored 9 = like extremely, 5 = neither like 
nor dislike, 1 = dislike extremely. 
†Different superscript letters in each column represent statistically significant pairwise 




Table 6.6. Percent of endurance races listing availability of gel and solid sports nutrition 
products at aid stations 
 Marathon (%) Ultramarathon (%) Half/Full Distance 
Triathlon (%) 
Product 2016 Current 2016 Current 2016 Current 
Gels n = 14 n = 27 n = 4 n = 19 n = 42 n = 68 
     G1† 7.1 11.1 75.0 31.6 0.0 41.2 
     G2 7.1 14.8 0.0 5.3 0.0 2.9 
     G3 0.0 0.0 0.0 31.6 11.9  29.4 
     G4 7.1 18.5 25.0 10.5 54.8  8.8 
     Other* 78.6 55.6 0.0 5.3 33.3 17.6 
Solids n = 3 n = 8 n = 8 n = 26 n = 35 n = 66 
     S1‡ 0.0 0.0 0.0 3.8 57.1 6.1 
     S2 0.0 0.0 0.0 0.0 0.0 0.0 
     S3 0.0 0.0 0.0 0.0 0.0 0.0 
     S4 0.0 0.0 0.0 0.0 0.0 0.0 
     Other* 100.0 100.0 100.0 96.2 42.9 93.9 
* Includes not specified products and other brands. In the case of solids, also includes solid foods 
other than bars 
† Includes a caffeinated version of G1 with additional amino acids but same ingredients 
otherwise 














Table 6.7. Price* and online availability information for gel and solid products. 









# of Google 
Shopping 
Sellers 
Gels      
     G1 1.50 1.19 1.47 1.25 54 
     G2 1.50 1.12 1.44 1.12 46 
     G3 1.40 (1.25 for 12+) Not available Not available 1.40 26 
     G4 1.39 (0.99 for 192) 1.03 1.09 0.79 49 
Solids      
     S1 1.79 (1.25 for 192) 0.94 0.94 0.94 41 
     S2 1.39 1.11 1.11 1.11 37 
     S3 2.50 2.08 Not available 1.92 43 
     S4 1.49 1.19 1.19 1.11 60 
*Price was often for 12, 16, or 24 count boxes. When the price for a single serving was lower 
than in bulk, this lower price was used. 




a.       b. 
 
Figure 6.1. Gel (a) and solid (b) samples set up on trays for sensory evaluation. Rinses from left 
to right included warm water, carbonated water, and room temperature water. Panelists were 










Figure 6.2. Number of races of each type examined for aid station nutrition information, the 
number of races for which aid station nutrition information was found for 2016 or the current 
race, and the number of races for which information was found specifically for gel and solid 









Figure 6.3. Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols 







Figure 6.4. Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols 









Figure 6.5. Overall liking of gel samples for each cluster of panelists. Bars correspond to G1 
(dark gray), G2 (light gray dot), G3 (gray diagonal stripe), and G4 (black and white checker). 
Different letters show statistically significant differences between liking scores for gel products 






















Figure 6.6. Overall liking of solid samples for each cluster of panelists. Bars correspond to S1 
(dark gray), S2 (light gray dot), S3 (gray diagonal stripe), and S4 (black and white checker). 
Different letters show statistically significant differences between liking scores for each solid 
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CHAPTER 7 : CONCLUSIONS AND FUTURE DIRECTIONS 
 
 When this research was initiated, very little previous work existed associating the 
FODMAP in athlete’s diets to their GI symptoms. While a couple of case and preliminary studies 
have been published since that time, there is still a tenuous link between the two. This research 
served to strengthen this connection by investigating the range of endurance athletes who may be 
able to benefit from low FODMAP interventions and the extent to which high FODMAP foods 
are a part of their diets. This was done by examining IBS and IBS-like symptoms among 
endurance athletes, the relationships between these symptoms and habitual FODMAP intake, 
athlete’s pre-race dinners and breakfasts from a FODMAP perspective, the FODMAP content of 
popular sports nutrition products, and key factors that may influence athlete selection of low or 
high FODMAP sports nutrition products. 
 Previous studies on endurance athlete GI symptoms and nutritional habits have used a 
variety of unvalidated questionnaires. This research first validated a questionnaire to assess GI 
symptoms, IBS diagnosis, nutritional habits, and symptom management strategies. This was of 
particular importance given the transient nature of GI symptoms coupled with the desire to 
evaluate them over a period of time instead of acutely. Experts and athletes demonstrated content 
and face validity of the EAQ, respectively, and target population athletes (those competing in a 
marathon, ultramarathon, half distance triathlon or full distance triathlon within the calendar 
year) provided test-retest reliability. 
 A nationwide implementation of the EAQ in 430 endurance athletes revealed that while 
2.8% had been diagnosed with IBS, an additional 7.0% fit Rome III IBS diagnostic criteria, the 




sometimes impacted or prevented training or competition, and over half of the athletes 
experienced at least one lower GI symptom during exercise. Despite using various symptom 
mitigation strategies, including almost half of the athletes trying nutritional modifications, many 
athletes were still experiencing lower GI symptoms. The resources they reported consulting 
regarding their issues were of questionable accuracy and less than half of those with IBS 
(diagnosed plus Rome III) had consulted a medical professional. 
 Athletes commonly reported consuming high FODMAP foods at pre-race dinners and 
breakfasts. The use of some sports nutrition product types, particularly solid, gel/gummy, and 
homemade products was related to increased frequency of various lower GI symptoms. Many of 
the sports nutrition products tested for FODMAP content were high in FODMAP, particularly in 
the multiple serving sizes that athletes typically consume during endurance events. Athletes also 
had high habitual FODMAP intakes, with higher intakes of some FODMAP types by those with 
certain lower GI symptoms. Since sports nutrition products were not included in the FODMAP-
specific food frequency questionnaire assessing habitual intake, this means that many athletes are 
adding the high FODMAP content of these products onto already high FODMAP habitual 
intakes when they exercise. 
 Finally, factors in sports nutrition gel and solid product selection by athlete were 
examined to determine whether acceptable low FODMAP options were available and accessible, 
should athletes desire to use low FODMAP nutritional strategies. Products with low FODMAP 
content were rated higher in overall liking by endurance athletes, although cluster analysis 
revealed different patterns in overall liking, indicating that the low FODMAP products were not 
always rated the highest by panelists. Low FODMAP products were fairly similar in price point 




available at some popular marathon, ultramarathon, half distance triathlon and full distance 
triathlon events, although products with high or unknown FODMAP content tended to be more 
common.  
 The carbohydrate group known collectively as FODMAPs plays a prominent role in the 
diets of endurance athletes and may be contributing to the prevalent IBS and IBS-like GI 
symptoms experienced during exercise. While the research on low FODMAP diets for 
symptomatic improvement in endurance athletes is still in its infancy, acceptable lower 
FODMAP products are available and accessible in the current market should athletes decide to 
try this nutritional strategy. This research supports continued efforts in this emerging area and 
provides the foundation for future work. 
 Since the development of the EAQ, a new version of the Rome criteria for IBS was 
developed. Similar work in the future may want to revalidate the questionnaire, replacing Rome 
III criteria with Rome IV and also altering the questions to be able to evaluate IBS subtypes, 
which was a limitation of the current EAQ. Additional work involving IBS and IBS-like 
symptoms of athletes could include examination of how medical professionals work with 
patients presenting with these symptoms. Athletes reported either thinking that their symptoms 
were merely due to high levels of exercise or that this would be the opinion of medical 
professionals, who would then recommend decreased activity levels. This made some athletes 
reluctant to seek a medical opinion. Bringing awareness to this issue and understanding how 
medical professionals view GI symptoms in endurance athletes may help symptomatic athletes 
feel more comfortable with consultation. 
 The main area ripe for continued research specifically involves FODMAPs and 




troublesome considering the high energy requirements that are needed for endurance activities. 
To decrease unnecessary restriction, it is important to determine the ideal length of time that 
symptomatic athletes would want to utilize a low FODMAP diet. This research provided key 
targets of sports nutrition products used during exercise as well as pre-race dinners and 
breakfasts. Future interventions should start with changing the foods consumed at these times to 
low FODMAP alternatives to see effects on symptoms during exercise. If this does not result in a 
significant decrease in symptoms, habitual low FODMAP diets should be examined in the day(s) 
leading up to key training sessions or competitions.  
 Research investigating the link between low FODMAP nutritional strategies and 
gastrointestinal symptoms during exercise can be conducted in two ways. Additional 
randomized, controlled, crossover studies should be conducted to extend the work previously 
done in this area to longer, more endurance-type exercise. This should include examination of 
both gastrointestinal symptoms during exercise as well as impacts on performance. Performance 
has the potential to be impacted by low FODMAP nutritional strategies as a result of 
mechanisms such as enhanced absorption of nutrients during exercise or increased GI comfort. 
The randomized, controlled, crossover studies would show the potential benefits of low 
FODMAP nutritional strategies for athletes, but their use of a fully restricted low FODMAP diet 
would not be practical or recommended for the long term. Therefore, research in parallel should 
focus on the individualized nature of FODMAPs. This would utilize the bottom-up approach for 
reducing specific FODMAP types consumed in large quantities by individual athletes as well as 
the traditional approach of individualized low FODMAP diets following the reintroduction 
phase. Customizing the low FODMAP foods needed by each athlete would decrease the 




athlete that would be better at meeting their energy needs. Additionally, this method would be 
more comparable to real-life application by athletes. As in the general low FODMAP literature, 
research in athletes should also investigate the effectiveness of nutrition education regarding 
FODMAPs to support athletes in selecting appropriate foods to reduce their exercise-induced GI 
symptoms. 
 In conjunction with the work described above, there should be continued FODMAP 
analysis of other sports nutrition products to be able to provide athletes and researchers with 
more comprehensive lists of suitable low FODMAP products. This information would also be 
valuable for the food industry to improve product development of low FODMAP sports nutrition 
products where necessary and desired. 
 Dietitians are already beginning to recommend low FODMAP diets to athletes with GI 
symptoms during exercise, despite the limited evidence. Thus, it is necessary to understand when 
and how dietitians are doing so and how to best equip these nutrition professionals so that they 
can provide the best counsel to their patients. As mentioned above, while intervention studies 
may provide low FODMAP diets to participants, in the real world athletes will require education 
and training on how to implement low FODMAP nutritional strategies on their own. This goes 
beyond the traditional low FODMAP dietary advice given to patients with IBS considering the 
already unique dietary requirements of endurance activity. 
 Finally, strategies similar to those used here can be implemented to understand FODMAP 
consumption and relation to GI issues in other populations. Particularly, these concepts could be 
applied to similar physically demanding and stressful professions such as military, firefighters, 
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APPENDIX B: ENDURANCE ATHLETE QUESTIONNAIRE (EAQ) 
 
Endurance Athlete Questionnaire 
 
1) Which of the following race types have you participated in during your lifetime? (select all 
that apply) 
❑ Marathon 
❑ Ultra-marathon (or any running distance over 26.2 miles) 
❑ Half-distance triathlon (70.3) 
❑ Full-distance triathlon (140.6) 
 




























Marathon                    
Ultra-
marathon  








                  
 
4) For each race type, indicate how many you have completed in this calendar year (January 1, 
201X – current date). 








5) For each race type, indicate how many additional races you plan to complete between now 







6) What is your fastest race time for the following events? (record time as XX:XX = 
hours:minutes and leave blank if you have not completed that type of event) 
Marathon _____________ 




7) How many hours do you typically spend training in the disciplines below per week? (estimate 
an average week of training during this calendar year) 




8) What level of competitor would you consider yourself? 
 Beginner, amateur or casual competitor 
 Competitive age-grouper 
 Elite/Professional 
 
9) Do you typically follow any of the diets below in everyday life? (select all that apply) 
❑ Atkins 
❑ Carb cycling (Train Low/Compete High) 
❑ Gluten free 





❑ No specific diet 
❑ Other (if other, please specify) ____________________ 
 
10) Do you avoid certain foods in everyday life? 






11) Why do you avoid these foods? (select all that apply) 
❑ Allergy/intolerance 
❑ I feel sluggish/slow after eating it  
❑ I experience headaches after eating it 
❑ I feel sick after eating it 
❑ I feel guilty eating it 
❑ I do not like it  
❑ Other (if other, please specify) ____________________ 
 
12) Do you avoid certain foods specifically during training that you do not typically avoid in 
everyday life? 
 Yes (if yes, please name all foods that you avoid during training)  ____________________ 
 No  
 
13) Do you avoid certain foods specifically during racing that you do not typically avoid in 
everyday life? 
 Yes (if yes, please name all foods that you avoid during racing)  ____________________ 
 No  
 





15) Is this dinner meal always the same? 
 Yes; I bring food with me 
 Yes; I find very similar food wherever I am 
 No; I try to eat similar food, but sometimes vary  
 No; my food is variable 
 





17) Is this breakfast meal always the same? 
 Yes; I bring food with me 
 Yes; I find similar food wherever I am 
 No; I try to eat similar food but sometimes vary 











18) How often do you typically eat/drink the following in the two (2) hours before 
TRAINING? 
 Never Rarely Sometimes Often Always 
Water           
Sports drink/thirst 
quencher 
          
Sports 
drink/energy drink  
          
Solid food            




          
 
19) How often do you typically eat/drink the following in the two (2) hours 
before COMPETITION? 
 Never Rarely Sometimes Often Always 
Water           
Sports drink/thirst 
quencher 
          
Sports 
drink/energy drink 
          
Solid food           




          
 
20) How often do you typically eat/drink the following during TRAINING? 
 Never Rarely Sometimes Often Always 
Water           
Sports drink/thirst 
quencher 
          
Sports 
drink/energy drink 
          
Solid food           










21) How often do you typically eat/drink the following during COMPETITION? 
 Never Rarely Sometimes Often Always 
Water           
Sports drink/thirst 
quencher 
          
Sports 
drink/energy drink  
          
Solid food           




          
 





23) If you use a sports drink/energy drink (with caffeine), what do you use? (please name 
brand(s)) 
During Training__________________________________________________________ 
During Competition __________________________________________________________ 
 
24) If you use solid food, what do you use? (please name brand(s)) 
During Training__________________________________________________________ 
During Competition __________________________________________________________ 
 
25) If you use a gel/gummy, what do you use? (please name brand(s)) 
During Training __________________________________________________________ 
During Competition __________________________________________________________ 
 
26) If you use a homemade product/something else, what do you use? (please name brand(s) if 
appropriate) 
During Training __________________________________________________________ 
During Competition __________________________________________________________ 
 
27) How often do you use race-provided foods/beverages during a race? (i.e. from aid stations 




 Often  












29) How important is your nutritional strategy for training and competition? 
 Very Unimportant 
 Somewhat Unimportant 
 Neither Important nor Unimportant 
 Somewhat Important 
 Very Important 
 
30) How often do you have the following gastrointestinal complaints AT REST? (the two (2) 
hours directly after exercise are not included in this period) 
 Never Rarely Sometimes Often Always  
Gastrointestinal 
cramps/pains 
          
Bloating            
Flatulence            
Diarrhea            
Constipation            
 
31) How often do you have the following gastrointestinal complaints during TRAINING? 
 Never Rarely Sometimes Often Always 
Gastrointestinal 
cramps/pains  
          
Bloating            
Flatulence            
Urge to 
defecate  
          
Defecation            
Diarrhea            






32) How often do you have the following gastrointestinal complaints during COMPETITION? 
 Never Rarely  Sometimes Often Always 
Gastrointestinal 
cramps/pains 
          
Bloating           
Flatulence           
Urge to 
defecate 
          
Defecation           
Diarrhea           
Constipation            
 
33) How often do you have the following gastrointestinal complaints in the two (2) hours 
directly after TRAINING? 
 Never Rarely Sometimes Often Always  
Gastrointestinal 
cramps/pains 
          
Bloating            
Flatulence           
Urge to 
defecate  
          
Defecation            
Diarrhea            
Constipation            
 
34) How often do you have the following gastrointestinal complaints in the two (2) hours 
directly after COMPETITION? 
 Never Rarely Sometimes Often Always  
Gastrointestinal 
cramps/pains 
          
Bloating            
Flatulence            
Urge to 
defecate  
          
Defecation            
Diarrhea            








35) How often do gastrointestinal complaints interrupt and/or prevent your TRAINING? 
 Never  
 Rarely  
 Sometimes  
 Often  
 Always  
 
36) How often do gastrointestinal complaints interrupt and/or prevent your COMPETITION? 
 Never  
 Rarely  
 Sometimes  
 Often  
 Always  
 
37) Have you seen a medical professional as a result of gastrointestinal issues? 
 Yes  
 No  
If No Is selected, then skip to Question 47 
 
38) How recently have you seen a medical professional as a result of any of the previous 
gastrointestinal issues? 
 Within the last month 
 Within the last 3 months 
 Within the last 6 months 
 Within the last year 
 Over a year ago  
 
39) What prompted you to see a medical professional? (select all that apply) 
❑ Issues becoming more prevalent 
❑ Issues becoming more severe  
❑ Issues interrupting and/or preventing planned training or competitions  
❑ Issues interrupting and/or preventing everyday life activities  
❑ Other (if other, please specify)  ____________________ 
 
40) What types of tests did the medical professional perform? (select all that apply) 
❑ Blood test  
❑ Breath test  
❑ Colonoscopy  
❑ Endoscopy  
❑ Imaging (MRI, CT scan, Ultrasound, etc.)  
❑ Stool/fecal test  
❑ Transit test  
❑ Not sure  





41) What conditions were you tested for? (select all that apply) 
❑ Cancers (i.e. colorectal)  
❑ Celiac Disease  
❑ Fructose Malabsorption  
❑ Gastroesophageal reflux disease (i.e. heartburn, reflux) 
❑ H. pylori/ulcers  
❑ Inflammatory Bowel Diseases (including Crohn's and Colitis)  
❑ Lactose Intolerance  
❑ Small Intestinal Bacterial Overgrowth (SIBO)  
❑ Not Sure 
❑ Other (if other, please specify) ____________________ 
 
42) What diagnosis did you receive? (select all that apply) 
❑ Cancers (i.e. colorectal)  
❑ Celiac Disease  
❑ Fructose Malabsorption  
❑ Gastroesophageal reflux disease (i.e. heartburn, reflux) 
❑ H. pylori/ulcers  
❑ Inflammatory Bowel Diseases (IBD including Crohn's and Colitis)  
❑ Irritable Bowel Syndrome (IBS)  
❑ Lactose Intolerance  
❑ Small Intestinal Bacterial Overgrowth (SIBO)  
❑ Not Sure  
❑ Other (if other, please specify)  ____________________ 
 
43) What recommendations/prescriptions did the medical professional provide? (select all that 
apply) 
❑ Diet/Nutritional therapy or modifications  
❑ Exercise modifications (changing the type, amount or intensity)  
❑ Medication  
❑ Stress management techniques  
❑ Referral to a specialist  
❑ None  
❑ Other (if other, please specify)  ____________________ 
 
44) Have you followed the recommendations/prescriptions of the medical professional? 
 Yes  
 No (if no, please state why not)  ____________________ 
 
45) Have the recommendations/prescriptions for treatment been helpful in lessening your 
symptoms? 
 Yes  
 No  





46) Are you satisfied with the assessment and proposed treatment of the medical professional? 
 Yes  
 No  
 Unsure (if unsure, please state why)  ____________________ 
 
Display Question 47 is No was selected in Question 37                                                                      
47) Why haven't you seen a medical professional as a result of gastrointestinal issues? (select all 
that apply) 
❑ I do not have any issues 
❑ Issues are not severe enough 
❑ Issues do not occur often enough 
❑ Issues do not prevent my activities in everyday life, training or competition 
❑ I am afraid to see someone 
❑ I want to handle it another way  
❑ Other (if other, please specify)  ____________________ 
 
Display Questions 48-52 if anything other than “I do not have any issues” was selected in Question 47 
48) What people have you consulted regarding your symptoms? (select all that apply) 
❑ Coach  
❑ Family member  
❑ Friend  
❑ Nutritionist/Dietitian  
❑ Trainer  
❑ None  
❑ Other (if other, please specify)  ____________________ 
 
49) What resources have you consulted regarding your symptoms? (select all that apply) 
❑ Books  
❑ Brochures  
❑ Internet/Websites  
❑ Journal articles  
❑ Magazines  
❑ None  
❑ Other (if other, please specify)  ____________________ 
 
50) What steps have you taken to help ease your symptoms? (select all that apply) 
❑ Exercise modifications (changing the type, amount or intensity) 
❑ Nutritional modifications  
❑ Over-the-counter medications (i.e. Tums, Pepcid, etc.) 
❑ Stress management techniques  
❑ None  
❑ Other (if other, please specify)  ____________________ 
 
51) Have these steps been helpful in lessening your symptoms? 
 Yes  
 No  





52) Are you satisfied with the outcomes of your effects to lessen your symptoms? 
 Yes  
 No  
 Unsure (if unsure, please sate why)  ____________________ 
 
53) Do you experience any of the following? 
 Yes  No  
Onset of pain linked to more 
frequent bowel movements  
    
Looser stools associated with the 
onset of pain  
    
Pain relieved by the passage of 
stool  
    
Noticeable abdominal bloating      
Sensation of incomplete 
evacuation more than 25% of the 
time  
    
Diarrhea with mucus more than 
25% of the time  
    
 
54) Have you had a particularly bad episode of gastrointestinal symptoms within the last week? 
 Yes  
 No  
 
55) In the last three (3) months, how often did you have discomfort or pain anywhere in your 
abdomen? 
 Never  
 Less than one day a month  
 One day a month  
 Two to three days a month  
 One day a week  
 More than one day a week  
 Every day  
If Never Is selected, then skip to Question 66 
 
56) Did you have pain only (not discomfort or a mixture of discomfort and pain)? 
 Never or rarely 
 Sometimes  
 Often  
 Most of the time  





57) For women: Did this discomfort or pain occur only during your menstrual bleeding and not 
at other times? 
 No  
 Yes  
 Does not apply because I have had the change in life (menopause) or I am a male  
 
58) When you had this pain, how often did it limit or restrict your daily activities (for example, 
work, household activities, and social events)? 
 Never or rarely  
 Sometimes  
 Often  
 Most of the time  
 Always  
 
59) Have you had this discomfort or pain six (6) months or longer? 
 No  
 Yes 
 
60) How often did this discomfort or pain get better or stop after you had a bowel movement? 
 Never or rarely  
 Sometimes  
 Often  
 Most of the time  
 Always  
 
61) When this discomfort or pain started, did you have more frequent bowel movements? 
 Never or rarely  
 Sometimes  
 Often  
 Most of the time  
 Always  
 
62) When this discomfort or pain started, did you have less frequent bowel movements? 
 Never or rarely  
 Sometimes  
 Often  
 Most of the time  
 Always  
 
63) When this discomfort or pain started, were your stools (bowel movements) looser? 
 Never or rarely  
 Sometimes  
 Often  
 Most of the time  





64) When this discomfort or pain started, how often did you have harder stools? 
 Never or rarely  
 Sometimes  
 Often  
 Most of the time  
 Always  
 
65) How often was this pain or discomfort relieved by moving or changing positions? 
 Never or rarely  
 Sometimes  
 Often  
 Most of the time  
 Always  
 
66) In the last three (3) months, how often did you have fewer than three bowel movements (0-2) 
a week? 
 Never or rarely  
 Sometimes  
 Often  
 Most of the time  
 Always  
 
67) In the last three (3) months, how often did you have hard or lumpy stools? 
 Never or rarely  
 Sometimes  
 Often  
 Most of the time  
 Always  
 
68) In the last three (3) months, how often did you strain during bowel movements? 
 Never or rarely  
 Sometimes  
 Often  
 Most of the time  
 Always  
 
69) In the last three (3) months, how often did you have a feeling of incomplete emptying after 
bowel movements? 
 Never or rarely  
 Sometimes  
 Often  
 Most of the time  





70) In the last three (3) months, how often did you have a sensation that the stool could not be 
passed (i.e., was blocked), when having a bowel movement? 
 Never or rarely  
 Sometimes  
 Often  
 Most of the time  
 Always  
 
71) In the last three (3) months, how often did you press on or around your bottom or remove 
stool in order to complete a bowel movement? 
 Never or rarely  
 Sometimes  
 Often  
 Most of the time  
 Always  
 
72) In the last three (3) months, how often did you have difficulty relaxing or letting go to allow 
the stool to come out during a bowel movement? 
 Never or rarely  
 Sometimes  
 Often  
 Most of the time  
 Always  
 
73) Did any of the symptoms of constipation listed previously begin more than six (6) months 
ago? 
 No  
 Yes  
 
74) In the last three (3) months, how often did you have four (4) or more bowel movements in a 
day? 
 Never or rarely  
 Sometimes 
 Often  
 Most of the time  
 Always  
 
75) In the last three (3) months, how often did you have loose, mushy, or watery stools? 
 Never or rarely 
 Sometimes  
 Often  
 Most of the time  
 Always  





76) In the last three (3) months, were at least three-fourths (3/4) of your stools loose, mushy, or 
watery? 
 No  
 Yes  
 
77) Did you begin having frequent loose, mushy, or watery stools more than six (6) months ago? 
 No  
 Yes  
 
78) In the last three (3) months, how often did you have to rush to the toilet to have a bowel 
movement? 
 Never or rarely  
 Sometimes  
 Often  
 Most of the time  
 Always  
 
79) In the last three (3) months, how often was there mucus or slime in your bowel movement? 
 Never or rarely  
 Sometimes  
 Often  
 Most of the time  
 Always  
 
80) In the last three (3) months, how often did you have bloating or distention? 
 Never  
 Less than one day a month  
 One day a month  
 Two to three days a month  
 One day a week  
 More than one day a week  
 Every day  
If Never is selected, then skip to Question 82 
 
81) Did your symptoms of bloating or distention begin more than six (6) months ago? 
 No  















82) What is your age? 
 18-19 years old  
 20-29 years old  
 30-39 years old  
 40-49 years old  
 50-59 years old  
 60-69 years old 
 over 70 years old  
  
83) What is your gender? 
 Male  
 Female  
 
84) How do you describe yourself? (check all that apply) 
❑ American Indian or Alaskan Native  
❑ Asian  
❑ Black or African American  
❑ Caucasian  
❑ Hispanic or Latino  
❑ Native Hawaiian or Other Pacific Islander  
❑ Prefer not to say  
❑ Other (if other, please specify)  ____________________ 
 
85) What is the highest degree or level of education that you have completed? 
 High school graduate, diploma or equivalent (i.e. GED) 
 Some college, no degree 
 Trade/technical/vocational training 
 Associate degree 
 Bachelor’s degree 
 Master’s degree 
 Professional degree 
 Doctorate degree 
 Prefer not to say 
 Other (if other, please specify) ____________________ 
 
86) What is your total annual household income before any taxes? 
 Less than $25,000 
 $25,000 to $49,999 
 $50,000 to $74,999 
 $75,000 to $99,999 
 $100,000 to $149,999 
 $150,000 to $199,999 
 $200,000 and over 
 Unsure 
 Prefer not to say 
 
87) Please provide your height (in inches). 





88) Please provide your body weight (in pounds). 
      __________________ 
 
Display Question 89 if “Female” is selected in Question 83 
89) Were you pregnant within the last year or are you currently pregnant? 
 Yes  








90) During the past month, how often did you: 
 














Smoke part or all of a 
cigarette  
              
Use other tobacco 
products  
              
Drink one or more 
drinks of an alcoholic 
beverage 
              
 
91) Have you taken antibiotics during 201X? 
 Yes, within the last three (3) months  
 Yes, but more than three (3) months ago  
 No  
 
 
92) Please list any health issues that you have been diagnosed with and indicate if they influence 





93) Please list any medications/supplements that you use in the following situations. 
General use___________________________________________________________________ 
For sports-related symptoms _____________________________________________________ 













APPENDIX D: EXPERT PANEL ASSESSMENT SURVEY 
 
Consent Document- To continue, must select “Yes” to the question “I understand the above 
information and voluntarily consent to participate in the study described above.”  
 
 
Please take time to review the Endurance Athlete Questionnaire in the attached Word document. 
 Please add comments to the document regarding any questions/issues that you have with any of 
the questions.  Suggestions of ways to improve the questions are greatly appreciated.  Once you 















































The questions are direct and 
specific 
          
Only one question is asked at 
a time (no double-barreled 
questions)  
          
The participants should be 
able to understand what is 
asked  
          
There are no unnecessary 
words 
          
Questions are asked using 
affirmative language 
          
No response covers more 
than one choice  
          
All possible responses are 
considered 
          
Listed responses allow 
participants to respond 
appropriately  
          
There are no ambiguous 
questions 
          
The questions are unbiased 
and do not lead the 
participants to a response  
          
The terms used should be 
understandable by the target 
population 
          
There are no clichés or 
hyperboles used in the 
questions 
          
The use of technical language 
is minimal and appropriate 
          
All appropriate symptoms 
have been included 
          
Questions are suitable for 
participants with and without 
GI issues 






2) If the questionnaire failed to meet your standards for any of the statements below, please 
provide the question number(s) that need to be revised according to that statement. (Please also 
mark and provide comments on these questions in the Questionnaire Word document) 
 Question Numbers  
The questions are direct and specific  
Only one question is asked at a time (no double-
barreled questions) 
 
The participants should be able to understand what 
is asked 
 
There are no unnecessary words  
Questions are asked using affirmative language  
No response covers more than one choice  
All possible responses are considered  
Listed responses allow participants to respond 
appropriately 
 
There are no ambiguous questions  
The questions are unbiased and do not lead the 
participants to a response 
 
The terms used should be understandable by the 
target population 
 
There are no clichés or hyperboles used in the 
questions  
 
The use of technical language is minimal and 
appropriate 
 
All appropriate symptoms have been included   
Questions are suitable for participants with and 
without GI issues  
 
 
3) If you would like to receive a $50 VISA gift card for completing the review and assessment, 
please leave your name and mailing address below.  If not, please leave blank. 
 
Name           ________________________________ 
Address        ________________________________ 
Address 2     ________________________________ 
City              ________________________________ 
State             ________________________________ 
Postal Code  ________________________________ 
Country        ________________________________ 
 
Thank you for reviewing the Endurance Athlete Questionnaire and completing the Assessment 
Survey.  Please save a version of the Questionnaire document with your comments and send the 
file to graduate student researcher Lauren Killian at endurance.athlete.research@gmail.com. 
 Thank you again for your assistance in the questionnaire validation process.  Your edits will be 




questions, please contact Lauren Killian at endurance.athlete.research@gmail.com.  You will be 





APPENDIX E: ATHLETE PANEL ASSESSMENT SURVEY 
 
Consent Document- To continue, must select “Yes” to the question “I understand the above 
information and voluntarily consent to participate in the study described above.” 
 
Please take time to review the Endurance Athlete Questionnaire in the attached Word document. 
 Please feel free to make any comments that you may have in the document.  Once you have 
reviewed the questionnaire, please fill out the following Assessment Survey. 
 
1) Were there any questions that you think might be difficult for someone taking the 




If Yes Is Selected in Question 1, display Question 2 
2) Please provide the question numbers that you think may be difficult for someone to 
understand and describe your reasons why. 
 





If Yes Is Selected in Question 3, display Question 4 
4) Please provide the question numbers that you would not want to answer and describe your 
reasons why. 
 





If Yes Is Selected in Question 5, display Question 6 
6) Please provide the question numbers that you felt were not applicable to you or other 
endurance athletes and describe your reasons why. 
 
7) Were there any specific aspects of your nutritional habits that were not covered by these 
questions but you feel could benefit this line of research?  If yes, please describe. 
 Yes __________________________________________________________ 
 No 
 
8) Were there any specific aspects of gastrointestinal issues that you experience that were not 
covered by these questions but you feel could benefit this line of research?  If yes, please 
describe. 
 Yes ___________________________________________________________ 





9) Were there any specific aspects of how you deal with gastrointestinal issues that were not 
covered by these questions but you feel could benefit this line of research?  If yes, please 
describe. 
 Yes  ___________________________________________________________ 
 No  
 
10) If you would like to receive a $20 VISA gift card for completing the review and assessment, 
please leave your name and mailing address below.  If not, please leave blank. 
 
Name           ________________________________ 
Address        ________________________________ 
Address 2     ________________________________ 
City              ________________________________ 
State             ________________________________ 
Postal Code  ________________________________ 
Country        ________________________________ 
 
 
Thank you for reviewing the Endurance Athlete Questionnaire and completing the Assessment 
Survey.  If you made comments in the Questionnaire document, please save a version with your 
comments and send the file to graduate student researcher Lauren Killian at 
endurance.athlete.research@gmail.com.  Thank you again for your assistance in the 
questionnaire validation process.  Your edits will be taken into consideration in the development 









You are invited to participate in a pilot test of a questionnaire aimed at characterizing the general 
health and nutritional habits of marathon, ultra-marathon, half-distance triathlon and full-distance 
triathlon athletes.  You qualify for participation if you have completed at least one of these four 
types of events within the calendar year or are planning to complete at least one before the end of 
the year.  You must be 18 years of age or older to participate. 
 
Complete participation requires you to complete a questionnaire two separate times within 
approximately two weeks.  The questionnaire should take approximately 20-30 minutes to 
complete each time.  If you would like to participate, please send an email to Lauren Killian at 
endurance.athlete.research@gmail.com.  You will be provided with a link to the questionnaire 
and a unique 5-digit passcode.  You must then complete the questionnaire once within the next 
10 days.  A week after completing the questionnaire, you will receive an email with a link to 
complete the questionnaire a second time.   
 
After successfully completing the questionnaire both times, you will be entered into a drawing 
for one four $25, two $50, and one $100 VISA gift cards.  Exact chances of winning a gift card 
depend on the total number of participants in the test, but will be approximately 1 in 10. 
 
If you have any questions regarding this test, please contact Lauren Killian (Graduate Student 
Researcher, 217-265-8459, endurance.athlete.research@gmail.com).  
This research is being conducted by University of Illinois researchers.  




































I am a researcher at the University of Illinois and I am currently conducting a study on the health 
and nutritional habits of endurance athletes.  I have developed a questionnaire for athletes who 
have completed (or will complete) a marathon, ultra-marathon, half-distance triathlon or full-
distance triathlon during 2016.  The questionnaire should take athletes 20-30 minutes to 
complete.  They will then be entered into a drawing for gift cards with odds of winning a $20 gift 
card set at approximately 1 in 25 and a grand prize of $75 set at approximately 1 in 500.  I was 
wondering if ________ would be willing to help me distribute the questionnaire by posting on 





I would love the opportunity to discuss my research with you further.  If you have any questions, 
feel free to contact me at lkillia2@illinois.edu. 
 
I look forward to hearing from you. 
Lauren Killian 
 
Graduate Research Fellow 
Division of Nutritional Sciences 
University of Illinois Urbana-Champaign 

































APPENDIX J: CHAPTER 5 SUPPLEMENTARY TABLES 
 
 
Supplementary Table 5.1. Nutrition product type consumed before training and symptoms 
during training. 




Group 1 (n, 
mean rank)† 









































































































*Kruskal-Wallis H value is also 2(4) 
† Post hoc pairwise comparisons with Dunn’s procedure and Bonferroni correction 







Supplementary Table 5.2. Nutrition product type consumed before training and symptoms 
within 2hrs after training. 




Group 1 (n, 
mean rank)† 





















































*Kruskal-Wallis H value is also 2(4) 
† Post hoc pairwise comparisons with Dunn’s procedure and Bonferroni correction 






























Supplementary Table 5.3. Nutrition product type consumed during training and symptoms 
during training. 




Group 1 (n, 
mean rank)† 







































































*Kruskal-Wallis H value is also 2(4) 
† Post hoc pairwise comparisons with Dunn’s procedure and Bonferroni correction 






















Supplementary Table 5.4. Nutrition product type consumed during training and symptoms 
within 2hrs after training. 




Group 1 (n, 
mean rank)† 
























































































*Kruskal-Wallis H value is also 2(4) 
† Post hoc pairwise comparisons with Dunn’s procedure and Bonferroni correction 















Supplementary Table 5.5. Nutrition product type consumed before competition and symptoms 
during competition. 




Group 1 (n, 
mean rank)† 



















































*Kruskal-Wallis H value is also 2(4) 
† Post hoc pairwise comparisons with Dunn’s procedure and Bonferroni correction 





























Supplementary Table 5.6. Nutrition product type consumed before competition and symptoms 
within 2hrs after competition. 




Group 1 (n, 
mean rank)† 











































































*Kruskal-Wallis H value is also 2(4) 
† Post hoc pairwise comparisons with Dunn’s procedure and Bonferroni correction 





















Supplementary Table 5.7. Nutrition product type consumed during competition and symptoms 
during competition. 




Group 1 (n, 
mean rank)† 















































*Kruskal-Wallis H value is also 2(4) 
† Post hoc pairwise comparisons with Dunn’s procedure and Bonferroni correction 




Supplementary Table 5.8. Nutrition product type consumed during competition and symptoms 
within 2hrs after competition. 




Group 1 (n, 
mean rank)† 














*Kruskal-Wallis H value is also 2(4) 
† Post hoc pairwise comparisons with Dunn’s procedure and Bonferroni correction 




























Dear Endurance Athlete, 
 
Thank you for your recent completion of the Endurance Athlete Questionnaire, a study 
conducted by researchers at the University of Illinois. Based on your responses, you are invited 
to participate in a follow-up research study further examining your nutritional habits. This study 
involves completion of a food frequency questionnaire, indicating how often during the year you 
consume various foods and beverages. The questionnaire should take approximately 20-30 
minutes to complete. You will then be entered into a drawing for gift cards with odds of winning 
a $20 gift card set at approximately 1 in 25 and a $75 gift card set at approximately 1 in 200. 
 
If you are interested in participating in this follow-up study, you first need to complete a consent 
form found by following THIS LINK. Once you have completed that form, you will be contacted 
with further directions including a link to the questionnaire and your own personal, secure login 
details. 
 
If you have any questions about this research or your past participation, please feel free to 
contact Graduate Student Researcher Lauren Killian at endurance.athlete.research@gmail.com. 
 




Graduate Research Fellow 
Division of Nutritional Sciences 
University of Illinois at Urbana-Champaign 





































APPENDIX O: BALLOT ACCESS AND GENERAL INSTRUCTIONS FOR SPORTS 
NUTRITION SENSORY ACCEPTANCE TEST 
 
Ways to Access the Ballot 
 
1. QR Code 
 
2. Link: https://illinoisaces.co1.qualtrics.com/jfe/form/SV_b1MDxpiMm7fSHtj 
3. Text CODE to 1-717-682-8067 to receive the link 
4. Use a tablet 
5. Use a paper ballot 
 
General Instructions: 
1. Before each sample, please rinse in the following manner:  
a. Rinse your mouth with warm water and expectorate water. 
b. Rinse your mouth with carbonated water and expectorate water. 
c. Rinse your mouth with room temperature water and expectorate 
water.   
2. Check to ensure that the 3-digit code on the sample cup matches the 
one above the question.  
3. Rate each sample for overall liking, saving some of the sample for 
questions later on.     
4. Repeat the rinse procedure between each sample and evaluate the samples 






APPENDIX P: SPORTS NUTRITION SENSORY ACCEPTANCE TEST BALLOT 
 
Sports Nutrition Acceptance Test 




Do you have any known food allergies? 
 Yes 
 No  
 
Did you train for and participate in at least one of the following events within this calendar 
year (January 1, 2018 - current date):   
     1) marathon (26.2 miles)   
     2) ultra-marathon (any running distance longer than 26.2 miles)   
     3) half-distance triathlon (70.3 miles)    




Are you currently training for and planning to participate in at least one of the following events 
by the end of this calendar year (current date - December 31, 2018):   
     1) marathon (26.2 miles)   
     2) ultra-marathon (any running distance longer than 26.2 miles)   
     3) half-distance triathlon (70.3 miles)    





Please raise your hand to have a researcher check this page to make 










Instructions:    
1. Before each sample, please rinse in the following manner:   
 a. Rinse your mouth with warm water and expectorate water. 
 b. Rinse your mouth with carbonated water and expectorate water. 
 c. Rinse your mouth with room temperature water and expectorate water.   
 
 2. Check to ensure that the 3-digit code on the sample cup matches the one above the 
question.  
 
3. Rate each sample for overall liking, saving some of the sample for questions later on.     
    
4. Repeat the rinse procedure between each sample and evaluate the samples in the order they 
are presented in the testing ballot. 
 
 
Sample Number: 576   
 
How much do you like this sample overall? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 














Sample Number: 755 
 
 How much do you like this sample overall? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 









PLEASE RINSE NOW: Rinse with warm water, carbonated water, and then room 
temperature water. 
 
Sample Number: 899 
 
 How much do you like this sample overall? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 














Sample Number: 234   
 
 How much do you like this sample overall? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 

























Instructions:    
1. Before each sample please rinse in the following manner:   
 a. Rinse your mouth with warm water and expectorate water. 
 b. Rinse your mouth with carbonated water and expectorate water. 
 c. Rinse your mouth with room temperature water and expectorate water. 
     
2. Check to ensure that the 3-digit code on the sample cup matches the one written below. 
     
3. Rate each sample for each individual attribute asked below. 
  
4. Repeat the rinse procedure between each sample and evaluate the samples in the order they 
are presented on the testing ballot. 
 
 
Sample Number: 576 
 
How much do you like the flavor of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 
How much do you like the sweetness of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 
How much do you like the mouthfeel of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 










Sample Number: 755 
 
How much do you like the flavor of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 
How much do you like the sweetness of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 
How much do you like the mouthfeel of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 























Sample Number: 899 
 
How much do you like the flavor of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
How much do you like the sweetness of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
How much do you like the mouthfeel of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 






















Sample Number: 234 
 
How much do you like the flavor of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 
How much do you like the sweetness of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
How much do you like the mouthfeel of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 








You will now have a 5 minute break before tasting the 
second set of samples. Please notify the researchers now so 











Instructions:    
1. Before each sample, please rinse in the following manner:   
 a. Rinse your mouth with warm water and expectorate water. 
 b. Rinse your mouth with carbonated water and expectorate water. 
 c. Rinse your mouth with room temperature water and expectorate water.   
 
2. Check to ensure that the 3-digit code on the sample cup matches the one above the 
question.  
 
3. Rate each sample for overall liking, saving some of the sample for questions later on.     
    
4. Repeat the rinse procedure between each sample and evaluate the samples in the order they 
are presented in the testing ballot. 
 
 
Sample Number: 146 
 
 How much do you like this sample overall? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 

















Sample Number: 585 
 
 How much do you like this sample overall? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 












Sample Number: 402 
 
 How much do you like this sample overall? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 















Sample Number: 307 
 
 How much do you like this sample overall? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 















Instructions:    
1. Before each sample please rinse in the following manner:   
 a. Rinse your mouth with warm water and expectorate water. 
 b. Rinse your mouth with carbonated water and expectorate water. 
 c. Rinse your mouth with room temperature water and expectorate water. 
     
2. Check to ensure that the 3-digit code on the sample cup matches the one written below. 
     
3. Rate each sample for each individual attribute asked below. 
  
 4. Repeat the rinse procedure between each sample and evaluate the samples in the order they 
are presented on the testing ballot. 
 
 
Sample Number: 146 
 
 How much do you like the flavor of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 
How much do you like the sweetness of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
How much do you like the texture of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 







Sample Number: 585 
 
How much do you like the flavor of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 
How much do you like the sweetness of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 
How much do you like the texture of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 



























Sample Number: 402 
 
How much do you like the flavor of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 
How much do you like the sweetness of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
How much do you like the texture of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 


















Sample Number: 307 
 
How much do you like the flavor of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
How much do you like the sweetness of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
 
How much do you like the mouthfeel of this sample? 
 
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 





        




Which of the following race types have you participated in during your lifetime? (select all  
that apply) 
❑ Marathon 
❑ Ultra-marathon (or any running distance over 26.2 miles) 
❑ Half-distance triathlon (70.3) 
❑ Full-distance triathlon (140.6) 
 
What level of competitor would you consider yourself? 
 Beginner, amateur or casual competitor 




Do you typically follow any of the diets below in everyday life? (select all that apply) 
❑ Atkins 
❑ Carb cycling (Train Low/Compete High)  
❑ Gluten free  
❑ Low FODMAPs  
❑ Paleo/primal  
❑ Ketogenic   
❑ Vegan/plant-based  
❑ Vegetarian  
❑ No specific diet  







How often do you have the following gastrointestinal complaints AT REST? (the two (2) hours 
directly after exercise are not included in this period) 
 Never Rarely Sometimes  Often Always 
Gastrointestinal 
cramps/pains            
Bloating           
Flatulence            
Diarrhea           





How often do you have the following gastrointestinal complaints during TRAINING? 
 Never  Rarely Sometimes  Often Always 
Gastrointestinal 
cramps/pains            
Bloating           
Flatulence            
Urge to defecate            
Defecation            
Diarrhea            





How often do you have the following gastrointestinal complaints during COMPETITION? 
 Never Rarely Sometimes  Often Always 
Gastrointestinal 
cramps/pains            
Bloating           
Flatulence           
Urge to defecate           
Defecation           
Diarrhea            
Constipation            
 
How often do you have the following gastrointestinal complaints in the (two) 2 hours 
directly after TRAINING? 
 Never Rarely Sometimes  Often Always 
Gastrointestinal 
cramps/pains            
Bloating           
Flatulence           
Urge to defecate           
Defecation           
Diarrhea            





How often do you have the following gastrointestinal complaints in the two (2) hours directly 
after COMPETITION? 
 Never Rarely Sometimes  Often Always 
Gastrointestinal 
cramps/pains            
Bloating           
Flatulence           
Urge to defecate           
Defecation           
Diarrhea            
Constipation            
 
 
How often do gastrointestinal complaints interrupt and/or prevent your TRAINING? 
 Never  
 Rarely  
 Sometimes  
 Often  
 Always 
 
How often do gastrointestinal complaints interrupt and/or prevent your COMPETITION? 
 Never  
 Rarely  
 Sometimes  
 Often  
 Always 
 
Have you been diagnosed with any of the below gastrointestinal conditions? (select all that 
apply) 
❑ Cancers (i.e. colorectal)  
❑ Celiac Disease  
❑ Fructose Malabsorption  
❑ Gastroesophageal reflux disease (i.e. heartburn, reflux)  
❑ H. pylori/ulcers 
❑ Inflammatory Bowel Diseases (IBD including Crohn's and Colitis) 
❑ Irritable Bowel Syndrome (IBS) 
❑ Lactose Intolerance  
❑ Small Intestinal Bacterial Overgrowth (SIBO)  
❑ Not Sure  








What is your age? 
 18-19 years old  
 20-29 years old  
 30-39 years old  
 40-49 years old  
 50-59 years old  
 60-69 years old  
 over 70 years old  
 
What is your gender? 
 Male  
 Female  
 
How do you describe yourself? (check all that apply) 
❑ American Indian or Alaskan Native 
❑ Asian  
❑ Black or African American  
❑ Caucasian  
❑ Hispanic or Latino  
❑ Native Hawaiian or Other Pacific Islander  
❑ Prefer not to say   




You have now completed this sensory test. Thank you for your 
participation! 
Please inform the researchers that you are finished. 
 
 
 
